<!DOCTYPE html>
<head><meta charset="utf-8"></meta>
 <meta content="minimum-scale=1, initial-scale=1, width=device-width, shrink-to-fit=no" name="viewport"></meta>
 <link type="text/css" href="static/css/tabler-icons.min.css" rel="stylesheet"></link>
 <link type="text/css" href="static/css/style.css" rel="stylesheet"></link>
 <link type="text/css" href="static/css/custom.css" rel="stylesheet"></link>
 <link type="text/css" href="static/css/export.css" rel="stylesheet"></link>
 <link href="static/img/logo.png" type="image/png" rel="shortcut icon"></link>
 <link href="static/img/logo.png" sizes="192x192" rel="shortcut icon"></link>
 <link href="static/img/logo.png" rel="apple-touch-icon"></link>
 <meta name="apple-mobile-web-app-title"></meta>
 <meta name="apple-mobile-web-app-capable" content="yes"></meta>
 <meta name="apple-touch-fullscreen" content="yes"></meta>
 <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"></meta>
 <meta name="mobile-web-app-capable" content="yes"></meta>
 <meta property="og:title"></meta>
 <meta content="site" property="og:type"></meta>
  <meta content="static/img/logo.png" property="og:image"></meta>
 <meta property="og:description"></meta>
 <title></title>
 <meta property="og:site_name"></meta>
 <meta></meta>
</head>
 <body><div id="root"></div>
 <script>window.logseq_db="[logseq____&quot;~#datascript/DBlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:schemalogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:ast/versionlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:file/contentlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/properties-text-valueslogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/aliaslogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:db/valueTypelogseq____&quot;,logseq____&quot;~:db.type/reflogseq____&quot;,logseq____&quot;~:db/cardinalitylogseq____&quot;,logseq____&quot;~:db.cardinality/manylogseq____&quot;],logseq____&quot;~:block/pre-block?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/uuidlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:db/uniquelogseq____&quot;,logseq____&quot;~:db.unique/identitylogseq____&quot;],logseq____&quot;~:block/prioritylogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/propertieslogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/journal?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/namespacelogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;],logseq____&quot;~:block/updated-atlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/repeated?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:db/typelogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:file/handlelogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/leftlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;~:db/indexlogseq____&quot;,true],logseq____&quot;~:block/refslogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^8logseq____&quot;,logseq____&quot;^9logseq____&quot;],logseq____&quot;~:block/scheduledlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/properties-orderlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/created-atlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/deadlinelogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/collapsed?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^Glogseq____&quot;,true],logseq____&quot;~:block/journal-daylogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/formatlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/tagslogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^8logseq____&quot;,logseq____&quot;^9logseq____&quot;],logseq____&quot;~:block/contentlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:recent/pageslogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/macroslogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^8logseq____&quot;,logseq____&quot;^9logseq____&quot;],logseq____&quot;~:db/identlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^logseq____&lt;logseq____&quot;,logseq____&quot;^=logseq____&quot;],logseq____&quot;~:block/path-refslogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^8logseq____&quot;,logseq____&quot;^9logseq____&quot;],logseq____&quot;~:block/parentlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^Glogseq____&quot;,true],logseq____&quot;~:block/typelogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/pagelogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;,logseq____&quot;^Glogseq____&quot;,true],logseq____&quot;~:block/namelogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^logseq____&lt;logseq____&quot;,logseq____&quot;^=logseq____&quot;],logseq____&quot;~:file/pathlogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^logseq____&lt;logseq____&quot;,logseq____&quot;^=logseq____&quot;],logseq____&quot;~:block/filelogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^6logseq____&quot;,logseq____&quot;^7logseq____&quot;],logseq____&quot;~:block/markerlogseq____&quot;,[logseq____&quot;^ logseq____&quot;],logseq____&quot;~:block/original-namelogseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^logseq____&lt;logseq____&quot;,logseq____&quot;^=logseq____&quot;],logseq____&quot;~:schema/versionlogseq____&quot;,[logseq____&quot;^ logseq____&quot;]],logseq____&quot;~:datomslogseq____&quot;,[logseq____&quot;~#listlogseq____&quot;,[[logseq____&quot;~#datascript/Datomlogseq____&quot;,[1,logseq____&quot;^12logseq____&quot;,2,536870913]],[logseq____&quot;^15logseq____&quot;,[2,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[2,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cardlogseq____&quot;,536870913]],[logseq____&quot;^15logseq____&quot;,[2,logseq____&quot;^11logseq____&quot;,logseq____&quot;cardlogseq____&quot;,536870913]],[logseq____&quot;^15logseq____&quot;,[2,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ubee6e060-f71b-43ea-b11d-3e8c624a888blogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[3,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[3,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;canceledlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[3,logseq____&quot;^11logseq____&quot;,logseq____&quot;CANCELEDlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[3,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u4af13b65-e219-4043-8f75-1e586f99f66elogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[4,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[4,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;todologseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[4,logseq____&quot;^11logseq____&quot;,logseq____&quot;TODOlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[4,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u970ea1a6-6c5d-415e-a01f-07166b578998logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[5,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[5,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;nowlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[5,logseq____&quot;^11logseq____&quot;,logseq____&quot;NOWlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[5,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u7cd04dc4-3255-443c-9935-39df8072634blogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[6,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[6,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;laterlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[6,logseq____&quot;^11logseq____&quot;,logseq____&quot;LATERlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[6,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ud6663a82-f968-4d4c-8313-5a7592ae3415logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[7,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[7,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;donelogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[7,logseq____&quot;^11logseq____&quot;,logseq____&quot;DONElogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[7,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u4c0f4280-c438-4f24-886e-186414c20fdelogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[8,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[8,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;doinglogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[8,logseq____&quot;^11logseq____&quot;,logseq____&quot;DOINGlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[8,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u9a6f6fb0-ced6-45f7-8c31-281f6893cb9dlogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[9,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[9,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;in-progresslogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[9,logseq____&quot;^11logseq____&quot;,logseq____&quot;IN-PROGRESSlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[9,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ubad4cfff-5b9f-455a-af38-ebea73f1f061logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[10,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[10,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;clogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[10,logseq____&quot;^11logseq____&quot;,logseq____&quot;Clogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[10,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u8cafec81-7b83-43b3-888f-d1c4848e688alogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[11,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[11,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;blogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[11,logseq____&quot;^11logseq____&quot;,logseq____&quot;Blogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[11,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u32bed5f8-14d0-4a4f-8a8a-3f2a49c64388logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[12,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[12,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;contentslogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[12,logseq____&quot;^11logseq____&quot;,logseq____&quot;Contentslogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[12,logseq____&quot;^;logseq____&quot;,logseq____&quot;~uc9d71e29-01d3-4917-b7f6-1ef753d81141logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[13,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[13,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;waitinglogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[13,logseq____&quot;^11logseq____&quot;,logseq____&quot;WAITINGlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[13,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u8b71df76-3125-4147-9a60-4813871d6044logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[14,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[14,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;favoriteslogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[14,logseq____&quot;^11logseq____&quot;,logseq____&quot;Favoriteslogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[14,logseq____&quot;^;logseq____&quot;,logseq____&quot;~uc1e9bca4-229e-4f34-a6a5-0d9bb4d6d76flogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[15,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[15,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;alogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[15,logseq____&quot;^11logseq____&quot;,logseq____&quot;Alogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[15,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u111ca643-cad4-4e22-babe-661624a15fa8logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[16,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[16,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cancelledlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[16,logseq____&quot;^11logseq____&quot;,logseq____&quot;CANCELLEDlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[16,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ub2891f5f-31a0-4f42-8e1d-30ce725f0775logseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[17,logseq____&quot;^@logseq____&quot;,false,536870914]],[logseq____&quot;^15logseq____&quot;,[17,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;waitlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[17,logseq____&quot;^11logseq____&quot;,logseq____&quot;WAITlogseq____&quot;,536870914]],[logseq____&quot;^15logseq____&quot;,[17,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ue529d6e9-7dad-47d2-93d9-ad72f503eb6clogseq____&quot;,536871979]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{renderer :tocgen2, [[amgen pipeline]]}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Ologseq____&quot;,logseq____&quot;~:markdownlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Flogseq____&quot;,12,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Slogseq____&quot;,22,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Xlogseq____&quot;,12,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Vlogseq____&quot;,12,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^Ulogseq____&quot;,12,536870916]],[logseq____&quot;^15logseq____&quot;,[21,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-83b3-431f-a631-4b7c130f8eablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[22,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:logseq.macro-namelogseq____&quot;,logseq____&quot;rendererlogseq____&quot;,logseq____&quot;~:logseq.macro-argumentslogseq____&quot;,[logseq____&quot;:tocgen2logseq____&quot;,logseq____&quot;[[amgen pipeline]]logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[22,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[22,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;renderer :tocgen2 [[amgen pipeline]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^Klogseq____&quot;,1691874784545,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;abp 654logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^11logseq____&quot;,logseq____&quot;ABP 654logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:publiclogseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^Blogseq____&quot;,1691874784545,536870916]],[logseq____&quot;^15logseq____&quot;,[24,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6a3e-48d6-8c43-a9505de3be42logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;~:block/invalid-propertieslogseq____&quot;,[logseq____&quot;~#setlogseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Flogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Xlogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Vlogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Ulogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[25,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8737-4642-86b1-70ebdb87f85dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Flogseq____&quot;,25,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Xlogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Vlogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^Ulogseq____&quot;,24,536870916]],[logseq____&quot;^15logseq____&quot;,[26,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3736-480d-b1f4-06c4f40c5591logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^Klogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;abp 938logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^11logseq____&quot;,logseq____&quot;ABP 938logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^Blogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[28,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c9d5-4c52-abf6-afc02303fca6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Flogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Xlogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Vlogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Ulogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[29,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f6c0-4a5d-94bb-377fd73d0a19logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Flogseq____&quot;,29,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Xlogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Vlogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^Ulogseq____&quot;,28,536870916]],[logseq____&quot;^15logseq____&quot;,[30,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ea79-4c58-9a16-5a2c60bf6b05logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^Klogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;abp 959logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^11logseq____&quot;,logseq____&quot;ABP 959logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^Blogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[32,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f3fb-4b93-a953-da1450ea78f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Flogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Xlogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Vlogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Ulogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[33,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0f3d-475c-9015-b01cacb69ebflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Flogseq____&quot;,33,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Xlogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Vlogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^Ulogseq____&quot;,32,536870916]],[logseq____&quot;^15logseq____&quot;,[34,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-28f6-42b0-a2dd-19f3ab34af32logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^Klogseq____&quot;,1691874784529,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;amjevitalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^11logseq____&quot;,logseq____&quot;AMJEVITAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^Blogseq____&quot;,1691874784529,536870916]],[logseq____&quot;^15logseq____&quot;,[36,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e3bc-417e-a4ae-a50caea91e74logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^Klogseq____&quot;,1691874785292,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;monoclonal antibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^11logseq____&quot;,logseq____&quot;Monoclonal Antibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^Blogseq____&quot;,1691874785292,536870916]],[logseq____&quot;^15logseq____&quot;,[37,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-286b-4aeb-81d2-06832d89a12elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^Klogseq____&quot;,1691874785369,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;biosimilarlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^11logseq____&quot;,logseq____&quot;biosimilarlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^Blogseq____&quot;,1691874785369,536870916]],[logseq____&quot;^15logseq____&quot;,[38,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2ef9-4dcd-a34b-cb620929c88alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Flogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[39,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4412-4e74-bf95-b5b4582bbc84logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Flogseq____&quot;,67,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:headinglogseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[40,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4446-4222-98c7-d7ee137db33elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Flogseq____&quot;,39,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[41,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5572-498e-b75e-e23049e9cd1alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# AMJEVITAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Flogseq____&quot;,65,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[42,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-080f-443b-8b2f-9aac550f7d47logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Indicationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Flogseq____&quot;,50,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[43,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b3f2-4367-84ce-c69afbb223bclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Serious infections and malignancy have been reported to occur from AMJEVITA, possibly leading to hospitalization or death.[^1] There have been reports of cancer with TNF blockers including AMJEVITA.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Flogseq____&quot;,66,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[44,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-594f-4db7-b112-f7043fa9a61elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: *DailyMed - AMJEVITA- Adalimumab-Atto Injection*. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c44bd5b-4464-40a4-8933-8680950f00f2. Accessed 22 July 2023.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Flogseq____&quot;,59,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[45,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-319a-40a8-81c1-756be07028a4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Flogseq____&quot;,62,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[46,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6060-48b4-b6b2-ccd16b6ec08blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Flogseq____&quot;,44,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[47,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-82ff-4514-a02f-f70295297daflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Juvenile Idiopathic Arthritis (JIA):** reducing signs and symptoms\\nof moderately to severely active polyarticular JIA in patients 2 years of\\nage and older.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Flogseq____&quot;,54,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[48,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5440-49c2-85cf-e087b6d6dd9elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Ankylosing Spondylitis (AS)**: reducing signs and symptoms in\\nadult patients with active AS.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Flogseq____&quot;,52,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[49,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c46c-4c73-84ba-22e5cb1fa108logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Flogseq____&quot;,46,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[50,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-21bc-4ccd-867d-0d3920869a2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Amjevita.com](https://www.amjevita.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Flogseq____&quot;,40,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[51,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6ad9-4fb7-9321-703d4d459fdelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Psoriatic Arthritis (PsA)**: reducing signs and symptoms, inhibiting\\nthe progression of structural damage, and improving physical function in\\nadult patients with active PsA.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Flogseq____&quot;,48,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[52,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3e11-4461-b8d1-8a225c6c7ce0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Plaque Psoriasis (Ps)**: treatment of adult patients with moderate to\\nsevere chronic plaque psoriasis who are candidates for systemic therapy\\nor phototherapy, and when other systemic therapies are medically less\\nappropriate.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Flogseq____&quot;,70,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[53,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fdf5-4b64-8e13-b9747cbcd479logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Rheumatoid Arthritis (RA):** reducing signs and symptoms,\\ninducing major clinical response, inhibiting the progression of structural\\ndamage, and improving physical function in adult patients with\\nmoderately to severely active RA.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Flogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[54,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-db40-4130-8658-3b7c2e556325logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;AMJEVITA is a tumor necrosis factor (TNF) blocker indicated for:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Flogseq____&quot;,43,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[55,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-da2b-4329-8572-71be9e90527flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Flogseq____&quot;,58,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[56,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a8a6-4c6d-9bbf-b69ece2cb161logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Flogseq____&quot;,56,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[57,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f29d-40b3-8691-670f912d1fe1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Amjevita/amjevita_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Flogseq____&quot;,51,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[58,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2646-4075-aed5-62b057332983logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Flogseq____&quot;,57,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[59,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fb3e-4b05-a4c1-c25f43361763logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Flogseq____&quot;,41,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[60,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3910-4588-b0cd-940a2463778flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Crohn’s Disease (CD):** treatment of moderately to severely active\\nCrohn’s disease in adults and pediatric patients 6 years of age and older.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Flogseq____&quot;,49,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[61,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9d52-4169-a7f6-89941c6c138blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;HUMIRA is a registered trademark of AbbVie Biotechnology Ltd. AMJEVITA is a trademark of Amgen Inc.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Flogseq____&quot;,69,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[62,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7ad6-43bc-a0fe-b1b3031e9d9dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Flogseq____&quot;,45,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[63,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7c99-4b89-8729-fe01ec016f93logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMJEVITA** (**adalimumab-atto**) is a [[biosimilar]] to **HUMIRA** (**adalimumab**), which is a [[Monoclonal Antibody]] that inhibits binding of *TNF-alpha* to cell surface *TNF receptor*.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Flogseq____&quot;,42,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^Hlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[64,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bcc6-448b-a890-7b2bb2b358a6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Flogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[65,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-614a-41f9-96f0-7f088c27f3f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Flogseq____&quot;,60,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[66,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8509-4cce-901e-df5d5b5040ablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Flogseq____&quot;,47,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[67,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bf89-42b2-9cc8-c4cc497ed478logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Hidradenitis Suppurativa (HS)**: treatment of moderate to severe\\nhidradenitis suppurativa in adult patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Flogseq____&quot;,53,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[68,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8e5c-48e4-bee8-43f78e07f5b7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Flogseq____&quot;,64,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Vlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[69,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-af74-4a1d-a3de-504e6292866flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Ulcerative Colitis (UC):** treatment of moderately to severely active\\nulcerative colitis in adult patients.\\nLimitations of Use: Effectiveness has not been established in patients\\nwho have lost response to or were intolerant to TNF-blockers.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Flogseq____&quot;,61,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Xlogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Vlogseq____&quot;,55,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^Ulogseq____&quot;,36,536870916]],[logseq____&quot;^15logseq____&quot;,[70,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4b61-4bb3-bcb5-3c0e0722fbdelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^Klogseq____&quot;,1691874784529,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;aimoviglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^11logseq____&quot;,logseq____&quot;Aimoviglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^Blogseq____&quot;,1691874784529,536870916]],[logseq____&quot;^15logseq____&quot;,[72,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-daed-451c-8ebe-9e341c60485elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^Klogseq____&quot;,1691874784865,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870971]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;amgenlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^11logseq____&quot;,logseq____&quot;Amgenlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^Blogseq____&quot;,1691874784865,536870916]],[logseq____&quot;^15logseq____&quot;,[73,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d7f9-4176-92a7-dd94f35b3d43logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^Klogseq____&quot;,1691874784430,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cytochrome p450logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^11logseq____&quot;,logseq____&quot;cytochrome P450logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^Blogseq____&quot;,1691874784430,536870916]],[logseq____&quot;^15logseq____&quot;,[74,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b979-4b45-8079-2070cfa0897clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Aimovig** (**erenumab-aooe, AMG 334**) is a [[Monoclonal Antibody]] that inhibits *calcitonin gene-related peptide (CGRP)* receptors, which may play a key role in migraines. It is used medically for the prevention of chronic and of episodic migraine in adults and currently in investigation for the prevention of chronic and episodic migraine in pediatric patients. Aimovig was developed by [[Amgen]] and Novartis and approved by the FDA in May 2018.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Flogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Ulogseq____&quot;,73,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^Hlogseq____&quot;,73,536870916]],[logseq____&quot;^15logseq____&quot;,[75,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-833d-4afe-8a64-5ec490949789logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![220px-Aimovig_Autoinjector.jpg](../assets/220px-Aimovig_Autoinjector_1689940343670_0.jpg){:height 150, :width 280}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Flogseq____&quot;,103,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[76,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c38a-4ee6-96b0-889ebc06b59blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^5]: Ref: [\\logseq____&quot;Aimovig: EPAR - Product Information\\logseq____&quot;](https://www.ema.europa.eu/documents/product-information/aimovig-epar-product-information_en.pdf) (PDF). [European Medicines Agency](https://en.wikipedia.org/wiki/European_Medicines_Agency). 8 August 2018. [Archived](https://web.archive.org/web/20181006214554/https://www.ema.europa.eu/documents/product-information/aimovig-epar-product-information_en.pdf) (PDF) from the original on 6 October 2018.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Flogseq____&quot;,97,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[77,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bd0e-4e67-a5c1-5ed8e72d2804logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: Episodic migraine is defined as 4-14 migraine days per month.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Flogseq____&quot;,104,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[78,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-37e3-4668-9dc7-7bd95c00a84flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Flogseq____&quot;,96,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[79,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7512-4b91-a9f6-e5ae87c75fb6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Noteslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Flogseq____&quot;,84,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[80,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eb9f-44a6-b6f1-03f0dbfd280blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Calcitonin gene-related peptide (CGRP) binds to the calcitonin gene-related peptide receptor (CGRPR), which may play a key role in migraines. Aimovig binds to and acts as an antagonist (inhibitor) to CGRPR, so that CGRP cannot bind to and activate it. Aimovig is the first and only preventive migraine treatment that works by blocking CGRPR.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Flogseq____&quot;,105,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[81,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0153-43c8-9e9c-113952ee5ecdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Erenumab (the archetype variant to erenumab-aooe, or Aimovig) has an estimated bioavailability of 82% (subcutaneously). Highest blood plasma concentrations are reached after four to six days and itlogseq____&apos;s elimination half-life is 28 days.[^5] Like other proteins, the substance is degraded by proteolysis to small peptides and amino acids.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Flogseq____&quot;,99,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[82,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2de6-4215-b0d1-66dfa760e825logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Flogseq____&quot;,79,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[83,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c279-426f-a679-5ee835a72465logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Flogseq____&quot;,100,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[84,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6e82-4a2f-9628-c3e44865c24clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Flogseq____&quot;,106,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[85,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-54ae-4607-8cdc-f966086fa735logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing information - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Aimovig/aimovig_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Flogseq____&quot;,101,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[86,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f250-491b-a4a5-35ae052b0edalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Flogseq____&quot;,94,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[87,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-03b2-467b-a7ea-06d925344b82logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Flogseq____&quot;,90,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[88,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ab36-4d47-b00e-3405316e0bb4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;667 People with chronic migraine[^1] taking Aimovig experienced ~7 fewer monthly migraine days on average (vs ~4 for placebo). ~40% of people with chronic migraine taking Aimovig cut their monthly migraine days by 50% or more (vs ~24% for placebo), while providing a similar safety profile to placebo.[^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Flogseq____&quot;,95,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Vlogseq____&quot;,95,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[89,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fc61-4e6f-9fe5-c2a8ad38f16dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Common side effects are constipation, pruritus (itchy skin) , muscle spasms, as well as mild and mostly transient reactions at the injection site. 1.3% of patients discontinued Aimovig due to side effects. Allergic reactions, constipation with serious complications or high blood pressure can also occur.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Flogseq____&quot;,93,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[90,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e0e7-4380-b6d8-c92130527f41logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;955 People with episodic migraine[^2] taking Aimovig experienced 3-4 fewer monthly migraine days on average (vs ~2 for placebo). Up to 50% of people with episodic migraine taking Aimovig cut their monthly migraine days by 50% or more (vs ~27% for placebo). The rates of adverse events were similar between erenumab and placebo.[^4]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Flogseq____&quot;,89,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Vlogseq____&quot;,95,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[91,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-56aa-4c7d-975c-d061c07bffd9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Erenumab is expected to generally have a low potential for interactions because it is not metabolized by [[cytochrome P450]] enzymes, and it was not shown to interact with ethinylestradiol, norgestimate or the well-known migraine drug [sumatriptan](https://en.wikipedia.org/wiki/Sumatriptan).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Flogseq____&quot;,88,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Ulogseq____&quot;,74,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^Hlogseq____&quot;,74,536870916]],[logseq____&quot;^15logseq____&quot;,[92,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-760a-4b6b-83e4-d8cf62b0b1b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Flogseq____&quot;,110,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[93,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e6d7-4b18-86b1-9290d9b99cb4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Flogseq____&quot;,76,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[94,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6d56-4ebb-b242-f4f732af747elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Aimovig was studied in three clinical trials of approximately 2,100 patients. It was proven to help prevent monthly migraine days, and for some, it cut that number in half or more (through months 4-6).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Flogseq____&quot;,85,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[95,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4c3b-4159-a2b3-faa10ca24badlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Flogseq____&quot;,78,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[96,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-da18-4ce6-8707-3cbf57ad2057logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]: Goadsby, Peter J., et al. “A Controlled Trial of Erenumab for Episodic Migraine.” New England Journal of Medicine, vol. 377, no. 22, Nov. 2017, pp. 2123–32. DOI.org (Crossref), https://doi.org/10.1056/NEJMoa1705848.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Flogseq____&quot;,113,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[97,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-71e3-43b6-9578-58ede96b4238logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Flogseq____&quot;,82,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[98,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3073-4c86-9104-b7f2241035e5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Flogseq____&quot;,81,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[99,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ba0a-4314-b608-731ea310b783logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Flogseq____&quot;,86,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[100,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8200-4486-b57c-184293c16deflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Aimovig.com](https://www.aimovig.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Flogseq____&quot;,112,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[101,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-df26-48ea-a34e-3b9c1956ab3blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Flogseq____&quot;,108,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[102,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4bb5-48f1-9b5b-a412737b13f5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Aimovig is an injection for subcutaneous self-administration in the abdomen, thigh, or upper arm. It is administered from a single-dose prefilled SureClick® autoinjector. The recommended dosage is 70mg once a month. Some patients benefit from 140mg once a month.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Flogseq____&quot;,111,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[103,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-195a-4e3d-bf8c-b78d01e889bclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Chronic migraine is defined as 15 or more headache days per month, at least 8 of which were migraine days.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Flogseq____&quot;,80,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[104,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-59ba-4c52-837f-5dcfd9bf863blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Pharmacologylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Flogseq____&quot;,87,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[105,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2350-4c8d-a5d9-e1cf8077b5e2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Flogseq____&quot;,109,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[106,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6779-4fad-a0c0-033636e88165logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A standard 70mg/mL Aimovig autoinjector.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Flogseq____&quot;,76,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Vlogseq____&quot;,76,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[107,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e856-4425-97fa-7cfbd6be702dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Flogseq____&quot;,95,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[108,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ac06-47ef-b76f-97f4c66e9f73logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Flogseq____&quot;,92,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[109,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-361c-4391-83c2-868225fb4e12logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Flogseq____&quot;,98,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[110,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b425-4899-b1ef-ea527266b6c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Flogseq____&quot;,75,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[111,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bd9c-4980-b768-2d47cad2afc5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Flogseq____&quot;,102,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[112,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f2ac-4682-b0a5-fa8c93d3f82dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: Tepper, Stewart, et al. “Safety and Efficacy of Erenumab for Preventive Treatment of Chronic Migraine: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Trial.” *The Lancet Neurology*, vol. 16, no. 6, June 2017, pp. 425–34. *DOI.org (Crossref)*, https://doi.org/10.1016/S1474-4422(17)30083-2.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Flogseq____&quot;,83,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Xlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Vlogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^Ulogseq____&quot;,72,536870916]],[logseq____&quot;^15logseq____&quot;,[113,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eb53-4a22-b8b6-e7768e704f00logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^Klogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;eylealogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^11logseq____&quot;,logseq____&quot;EYLEAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^Blogseq____&quot;,1691874784547,536870916]],[logseq____&quot;^15logseq____&quot;,[115,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-88ef-4633-97ee-b4be6a723073logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^Klogseq____&quot;,1691874785182,536870916]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^11logseq____&quot;,logseq____&quot;Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870958]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^Blogseq____&quot;,1691875048421,536870965]],[logseq____&quot;^15logseq____&quot;,[116,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-30bb-46f7-81c5-081a6ab7d3bflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^Klogseq____&quot;,1691874785243,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;repathalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^11logseq____&quot;,logseq____&quot;Repathalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^Blogseq____&quot;,1691874785243,536870916]],[logseq____&quot;^15logseq____&quot;,[117,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ec6a-4972-b233-8eb6f694f8b0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^Klogseq____&quot;,1691874784548,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;solirislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^11logseq____&quot;,logseq____&quot;SOLIRISlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^Blogseq____&quot;,1691874784548,536870916]],[logseq____&quot;^15logseq____&quot;,[118,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d439-4b48-9fbd-0fbf5a85360clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^Klogseq____&quot;,1691874784534,536870916]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;amgen pipelinelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^11logseq____&quot;,logseq____&quot;Amgen Pipelinelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^Blogseq____&quot;,1691876019757,536871395]],[logseq____&quot;^15logseq____&quot;,[119,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4a1f-4e90-81b7-2c4b60aaf4f7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^Klogseq____&quot;,1691874784791,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;dexamethasonelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^11logseq____&quot;,logseq____&quot;dexamethasonelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^Blogseq____&quot;,1691874784791,536870916]],[logseq____&quot;^15logseq____&quot;,[120,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-308a-4026-b8a9-be1a64519a2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^Klogseq____&quot;,1691874785181,536870916]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^11logseq____&quot;,logseq____&quot;Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870935]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^Blogseq____&quot;,1691875025536,536870935]],[logseq____&quot;^15logseq____&quot;,[121,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-491f-4479-bf75-dfed453ab177logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^Klogseq____&quot;,1691874785270,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;rocatinlimablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^11logseq____&quot;,logseq____&quot;Rocatinlimablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^Blogseq____&quot;,1691874785270,536870916]],[logseq____&quot;^15logseq____&quot;,[122,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0ec5-4d87-83b9-adfe0af31170logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^Klogseq____&quot;,1691874785210,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;prolialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^11logseq____&quot;,logseq____&quot;Prolialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^Blogseq____&quot;,1691874785210,536870916]],[logseq____&quot;^15logseq____&quot;,[123,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bc7a-45a5-94da-2df0c063230flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^Klogseq____&quot;,1691874785090,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;otezlalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^11logseq____&quot;,logseq____&quot;Otezlalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^Blogseq____&quot;,1691874785090,536870916]],[logseq____&quot;^15logseq____&quot;,[124,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2405-4636-9c35-8503624f0907logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^Klogseq____&quot;,1691874785068,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;olpasiranlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^11logseq____&quot;,logseq____&quot;OLPASIRANlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^Blogseq____&quot;,1691874785068,536870916]],[logseq____&quot;^15logseq____&quot;,[125,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-84cd-492b-813e-8babbdb9c39elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^Klogseq____&quot;,1691874784616,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;blincytologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^11logseq____&quot;,logseq____&quot;BLINCYTOlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^Blogseq____&quot;,1691874784616,536870916]],[logseq____&quot;^15logseq____&quot;,[126,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c9b6-40a5-88af-7f496900313dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^Klogseq____&quot;,1691874785149,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;peptibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^11logseq____&quot;,logseq____&quot;Peptibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^Blogseq____&quot;,1691874785149,536870916]],[logseq____&quot;^15logseq____&quot;,[127,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b9b6-4537-a928-a1785605f04elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^Klogseq____&quot;,1691874785292,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;tezspirelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^11logseq____&quot;,logseq____&quot;TEZSPIRElogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^Blogseq____&quot;,1691874785292,536870916]],[logseq____&quot;^15logseq____&quot;,[128,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1b83-422c-ab4e-f122cb1c2b05logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^Klogseq____&quot;,1691874785055,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;nplatelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^11logseq____&quot;,logseq____&quot;Nplatelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^Blogseq____&quot;,1691874785055,536870916]],[logseq____&quot;^15logseq____&quot;,[129,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ae1b-43dc-bef6-511abdab4446logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^Klogseq____&quot;,1691874785382,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;bite moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^11logseq____&quot;,logseq____&quot;BiTE Moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^Blogseq____&quot;,1691874785382,536870916]],[logseq____&quot;^15logseq____&quot;,[130,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f693-46b1-a90d-4d2b8044845elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^Klogseq____&quot;,1691874785498,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;sirnalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^11logseq____&quot;,logseq____&quot;siRNAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^Blogseq____&quot;,1691874785498,536870916]],[logseq____&quot;^15logseq____&quot;,[131,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3e65-40ae-a30d-e763128dca7alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^Klogseq____&quot;,1691874785036,536870916]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;lumakraslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^11logseq____&quot;,logseq____&quot;LUMAKRASlogseq____&quot;,536871574]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871409]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^Blogseq____&quot;,1691877678081,536871778]],[logseq____&quot;^15logseq____&quot;,[132,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bd1e-4543-862d-027b448c83bclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^Klogseq____&quot;,1691874785056,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;fusion proteinlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^11logseq____&quot;,logseq____&quot;Fusion Proteinlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^Blogseq____&quot;,1691874785056,536870916]],[logseq____&quot;^15logseq____&quot;,[133,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4756-4e74-bc62-78b67c6b9277logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^Klogseq____&quot;,1691874784592,536870916]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;bemarituzumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^11logseq____&quot;,logseq____&quot;Bemarituzumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871959]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^Blogseq____&quot;,1691884910663,536871962]],[logseq____&quot;^15logseq____&quot;,[134,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f79b-4b80-a67c-498db178b3e1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^Klogseq____&quot;,1691874785173,536870916]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^11logseq____&quot;,logseq____&quot;Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870942]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^Blogseq____&quot;,1691875035109,536870949]],[logseq____&quot;^15logseq____&quot;,[135,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-feb0-45d9-a0bb-245b444131a5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^Klogseq____&quot;,1691874784791,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;kyprolislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^11logseq____&quot;,logseq____&quot;KYPROLISlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^Blogseq____&quot;,1691874784791,536870916]],[logseq____&quot;^15logseq____&quot;,[136,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d042-4c00-b641-b5425ac12203logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^Klogseq____&quot;,1691874784680,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;evenitylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^11logseq____&quot;,logseq____&quot;EVENITYlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^Blogseq____&quot;,1691874784680,536870916]],[logseq____&quot;^15logseq____&quot;,[137,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-107f-477d-ad4f-7a6d393c48d9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^Klogseq____&quot;,1691874785452,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;osteoporosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^11logseq____&quot;,logseq____&quot;osteoporosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^Blogseq____&quot;,1691874785452,536870916]],[logseq____&quot;^15logseq____&quot;,[138,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a9fa-4127-8b12-feba90ea37d6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^Klogseq____&quot;,1691874785139,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;parsabivlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^11logseq____&quot;,logseq____&quot;Parsabivlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^Blogseq____&quot;,1691874785139,536870916]],[logseq____&quot;^15logseq____&quot;,[139,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a44b-4507-8775-26410bd2a5eflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^Klogseq____&quot;,1691874784546,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;stelaralogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^11logseq____&quot;,logseq____&quot;STELARAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^Blogseq____&quot;,1691874784546,536870916]],[logseq____&quot;^15logseq____&quot;,[140,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ed48-4579-ba68-fbdd38e01014logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^Klogseq____&quot;,1691874785395,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;chemotherapy-induced thrombocytopenialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^11logseq____&quot;,logseq____&quot;chemotherapy-induced thrombocytopenialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^Blogseq____&quot;,1691874785395,536870916]],[logseq____&quot;^15logseq____&quot;,[141,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-aa2a-467d-995e-7077abc948cclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^Klogseq____&quot;,1691874785317,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;tarlatamablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^11logseq____&quot;,logseq____&quot;Tarlatamablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^Blogseq____&quot;,1691874785317,536870916]],[logseq____&quot;^15logseq____&quot;,[142,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-97e7-4c9b-b573-4c960349df2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Flogseq____&quot;,165,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Vlogseq____&quot;,191,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Ulogseq____&quot;,32,536871089]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Ulogseq____&quot;,37,536871089]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Ulogseq____&quot;,119,536871089]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[143,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4c39-4313-a1f5-776fb92b6634logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of advanced colorectal cancer. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Flogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Vlogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Ulogseq____&quot;,121,536871041]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[144,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-83bf-4dd3-9b1d-bf2847652a0dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Parsabiv]]**logseq____&quot;,536871056]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Flogseq____&quot;,265,536870916]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Ulogseq____&quot;,119,536871057]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Ulogseq____&quot;,139,536871057]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871056]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^Hlogseq____&quot;,139,536871056]],[logseq____&quot;^15logseq____&quot;,[145,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7155-49b5-8b89-692521044855logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Under investigation for the treatment of advanced non-small cell lung cancer. (Phase 2) #Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Flogseq____&quot;,144,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Vlogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Ulogseq____&quot;,135,536871041]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[146,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-019b-4462-9e9c-93c96d6b54aclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[BiTE Molecule]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Flogseq____&quot;,262,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Vlogseq____&quot;,221,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Ulogseq____&quot;,119,536871073]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Ulogseq____&quot;,130,536871073]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Ulogseq____&quot;,142,536871073]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^Hlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[147,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-dbfa-4f0c-a3a9-d06975ba4468logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Flogseq____&quot;,188,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Vlogseq____&quot;,209,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Ulogseq____&quot;,37,536871026]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Ulogseq____&quot;,119,536871026]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Ulogseq____&quot;,137,536871026]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[148,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f1cc-44c3-a838-1beb2dcaab65logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Flogseq____&quot;,202,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Vlogseq____&quot;,172,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Ulogseq____&quot;,37,536871065]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Ulogseq____&quot;,117,536871065]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Ulogseq____&quot;,119,536871065]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[149,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8894-49d4-bc63-6eacd21add8clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Flogseq____&quot;,208,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[150,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-dfc2-42d4-b4eb-97a5b7b74ddblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Flogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[151,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-825c-450d-8dba-dc17156ddf0alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Investigational Phase 1 Productslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Flogseq____&quot;,155,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[152,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c81a-4821-bc9d-4fc60f1c068dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Flogseq____&quot;,199,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[153,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f92d-4ad8-973f-42f8d966087blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of male [[osteoporosis]]. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Flogseq____&quot;,209,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Vlogseq____&quot;,209,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Ulogseq____&quot;,119,536871026]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Ulogseq____&quot;,121,536871026]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Ulogseq____&quot;,137,536871026]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Ulogseq____&quot;,138,536871026]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^Hlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[154,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-14ce-4eb8-adae-9ee215b34078logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Flogseq____&quot;,153,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[155,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-005a-49f5-a6c5-50ff17f41f7clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[BLINCYTO]]**logseq____&quot;,536871021]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Flogseq____&quot;,151,536870916]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Ulogseq____&quot;,119,536871022]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Ulogseq____&quot;,126,536871022]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871021]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^Hlogseq____&quot;,126,536871021]],[logseq____&quot;^15logseq____&quot;,[156,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4335-4245-a731-19ac79ff6cc6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Flogseq____&quot;,183,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Vlogseq____&quot;,170,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Ulogseq____&quot;,37,536871061]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Ulogseq____&quot;,119,536871061]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Ulogseq____&quot;,123,536871061]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[158,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3385-48a3-be6d-a3dae41f0d93logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Flogseq____&quot;,251,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Vlogseq____&quot;,246,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Ulogseq____&quot;,37,536871069]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Ulogseq____&quot;,119,536871069]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Ulogseq____&quot;,122,536871069]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[159,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3dcf-4908-bf92-37b5ba0edd8dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[TEZSPIRE]]**logseq____&quot;,536871076]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Flogseq____&quot;,218,536870916]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871076]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^Hlogseq____&quot;,128,536871076]],[logseq____&quot;^15logseq____&quot;,[160,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0dac-457e-a1ae-e3e89e6b9d49logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Otezla]]**logseq____&quot;,536871052]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Flogseq____&quot;,266,536870916]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Ulogseq____&quot;,119,536871053]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Ulogseq____&quot;,124,536871053]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871052]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^Hlogseq____&quot;,124,536871052]],[logseq____&quot;^15logseq____&quot;,[161,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6f11-47fa-99db-f5b4a2e369e0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Flogseq____&quot;,209,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[162,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8881-4411-9778-3641397aa0ablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[KYPROLIS]]**logseq____&quot;,536871029]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Flogseq____&quot;,162,536870916]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Ulogseq____&quot;,119,536871030]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Ulogseq____&quot;,136,536871030]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871029]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^Hlogseq____&quot;,136,536871029]],[logseq____&quot;^15logseq____&quot;,[163,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-be63-46f1-bc4d-261d89cf39d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of chronic obstructive pulmonary disease (COPD). (Phase 2) #Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Flogseq____&quot;,232,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Ulogseq____&quot;,135,536871077]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[164,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3b6b-4d03-9201-0f96890f70b9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigational [[biosimilar]] to [[SOLIRIS]] (eculizumab).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Flogseq____&quot;,191,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Vlogseq____&quot;,191,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Ulogseq____&quot;,32,536871089]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Ulogseq____&quot;,38,536871089]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Ulogseq____&quot;,118,536871089]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Ulogseq____&quot;,119,536871089]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Hlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^Hlogseq____&quot;,118,536870916]],[logseq____&quot;^15logseq____&quot;,[165,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c009-493d-a93b-e7367e409a5dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**ACAPATAMAB**logseq____&quot;,536871156]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Flogseq____&quot;,152,536870916]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^Ulogseq____&quot;,119,536871157]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871156]],[logseq____&quot;^15logseq____&quot;,[166,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c10a-4f0e-b45e-6bff5a7068aalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Flogseq____&quot;,163,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[167,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3451-4761-8309-57b4d4508161logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Peptibody]]/[[Fusion Protein]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Flogseq____&quot;,258,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Vlogseq____&quot;,179,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Ulogseq____&quot;,119,536871045]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Ulogseq____&quot;,127,536871045]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Ulogseq____&quot;,129,536871045]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Ulogseq____&quot;,133,536871045]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Hlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^Hlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[168,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ebc7-442c-924c-fbe9547f6022logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 176**logseq____&quot;,536871132]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Flogseq____&quot;,186,536870916]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^Ulogseq____&quot;,119,536871133]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871132]],[logseq____&quot;^15logseq____&quot;,[169,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cf29-460c-88d6-308b413cfa91logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Prolia]]**logseq____&quot;,536871060]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Flogseq____&quot;,213,536870916]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Ulogseq____&quot;,119,536871061]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Ulogseq____&quot;,123,536871061]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871060]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^Hlogseq____&quot;,123,536871060]],[logseq____&quot;^15logseq____&quot;,[170,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2171-4c52-817d-5d8cff142317logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Peptidelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Flogseq____&quot;,241,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Vlogseq____&quot;,145,536870916]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Ulogseq____&quot;,119,536871057]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^Ulogseq____&quot;,139,536871057]],[logseq____&quot;^15logseq____&quot;,[171,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-81ac-4652-86b9-abc8d82b46a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Repatha]]**logseq____&quot;,536871064]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Flogseq____&quot;,173,536870916]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Ulogseq____&quot;,117,536871065]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Ulogseq____&quot;,119,536871065]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871064]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^Hlogseq____&quot;,117,536871064]],[logseq____&quot;^15logseq____&quot;,[172,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9f0b-48bd-8c0a-fad42ccdffd9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Flogseq____&quot;,170,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[173,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5def-42d8-af2d-b27eefef7cc1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Small moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Flogseq____&quot;,243,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Vlogseq____&quot;,161,536870916]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Ulogseq____&quot;,119,536871053]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^Ulogseq____&quot;,124,536871053]],[logseq____&quot;^15logseq____&quot;,[174,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e6ec-4ffa-947d-c76d1d59abf4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of advanced solid tumors other than advanced squamous non-small cell lung cancer. (Phase 2) #Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Flogseq____&quot;,249,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Vlogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Ulogseq____&quot;,119,536871018]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Ulogseq____&quot;,134,536871018]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Ulogseq____&quot;,135,536871018]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[176,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b775-4420-a09c-e1d43be3ddc2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Also in Phase 1 development being investigated for subcutaneous administration for the treatment of adults with relapsed/refractory Acute Lymphoblastic Leukemia (ALL). (Phase 1) #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Flogseq____&quot;,229,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Vlogseq____&quot;,229,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Ulogseq____&quot;,116,536871022]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Ulogseq____&quot;,119,536871022]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Ulogseq____&quot;,121,536871022]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Ulogseq____&quot;,126,536871022]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[178,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-07c9-4731-9fb4-a984d22ac503logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Nplate]]**logseq____&quot;,536871044]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Flogseq____&quot;,194,536870916]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Ulogseq____&quot;,119,536871045]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Ulogseq____&quot;,129,536871045]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871044]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^Hlogseq____&quot;,129,536871044]],[logseq____&quot;^15logseq____&quot;,[179,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5e20-4148-8ac0-d05bb3885bfblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[OLPASIRAN]]**logseq____&quot;,536871048]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Flogseq____&quot;,222,536870916]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Ulogseq____&quot;,119,536871049]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Ulogseq____&quot;,125,536871049]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871048]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^Hlogseq____&quot;,125,536871048]],[logseq____&quot;^15logseq____&quot;,[180,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-beb2-4f28-9fa3-87ded8bb0eb6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Flogseq____&quot;,198,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Ulogseq____&quot;,37,536871077]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[181,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-096d-4576-aa1d-6cffb1f7749alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Small moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Flogseq____&quot;,204,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Vlogseq____&quot;,163,536870916]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Ulogseq____&quot;,119,536871030]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^Ulogseq____&quot;,136,536871030]],[logseq____&quot;^15logseq____&quot;,[182,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9831-4510-8109-275feeb18371logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of glucocorticoid-induced osteoporosis (GIOP) in pediatric patients. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Flogseq____&quot;,170,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Vlogseq____&quot;,170,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Ulogseq____&quot;,119,536871061]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Ulogseq____&quot;,121,536871061]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Ulogseq____&quot;,123,536871061]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[183,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-86d7-4913-a8bb-c946041c296flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of advanced squamous non-small cell lung cancer. (Phase 1) #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Flogseq____&quot;,176,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Vlogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Ulogseq____&quot;,116,536871018]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Ulogseq____&quot;,119,536871018]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Ulogseq____&quot;,134,536871018]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[184,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1f6f-4248-bf1e-3ce7005ebfeclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 119**logseq____&quot;,536871140]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Flogseq____&quot;,190,536870916]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^Ulogseq____&quot;,119,536871141]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871140]],[logseq____&quot;^15logseq____&quot;,[186,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7723-4fee-bd32-3849ce758e9clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[siRNA]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Flogseq____&quot;,261,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Vlogseq____&quot;,180,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Ulogseq____&quot;,119,536871049]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Ulogseq____&quot;,125,536871049]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Ulogseq____&quot;,131,536871049]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^Hlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[187,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e890-40ed-9465-7c1f18f58a36logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of osteogenesis imperfecta in pediatric patients. (Phase 1) #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Flogseq____&quot;,154,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Vlogseq____&quot;,209,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Ulogseq____&quot;,116,536871026]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Ulogseq____&quot;,119,536871026]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Ulogseq____&quot;,137,536871026]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[188,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-154b-452a-a57f-b3363435d94blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for prevention of chronic and episodic migraine in pediatric patients. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Flogseq____&quot;,236,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Vlogseq____&quot;,236,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Ulogseq____&quot;,72,536871005]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Ulogseq____&quot;,119,536871005]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Ulogseq____&quot;,121,536871005]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[189,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7021-4a04-bf71-95391769d75flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 104**logseq____&quot;,536871144]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Flogseq____&quot;,230,536870916]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^Ulogseq____&quot;,119,536871145]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871144]],[logseq____&quot;^15logseq____&quot;,[190,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ba35-4623-acd6-b31988239d5flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[ABP 959]]**logseq____&quot;,536871088]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Flogseq____&quot;,247,536870916]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Ulogseq____&quot;,32,536871089]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Ulogseq____&quot;,119,536871089]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871088]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^Hlogseq____&quot;,32,536871088]],[logseq____&quot;^15logseq____&quot;,[191,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-07d5-44c9-b00b-e857a0b89172logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigational [[biosimilar]] to [[EYLEA]] (aflibercept).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Flogseq____&quot;,239,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Vlogseq____&quot;,239,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Ulogseq____&quot;,28,536871085]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Ulogseq____&quot;,38,536871085]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Ulogseq____&quot;,115,536871085]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Ulogseq____&quot;,119,536871085]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Hlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^Hlogseq____&quot;,115,536870916]],[logseq____&quot;^15logseq____&quot;,[192,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-39cd-4bf0-a6ef-ba8cc21a35d9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Bemarituzumab]]**logseq____&quot;,536871017]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Flogseq____&quot;,217,536870916]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Ulogseq____&quot;,119,536871018]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Ulogseq____&quot;,134,536871018]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871017]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^Hlogseq____&quot;,134,536871017]],[logseq____&quot;^15logseq____&quot;,[193,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9563-4944-bf80-c15e0af8bb47logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Flogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[194,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8688-4451-978a-1820f24ec6c6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 651**logseq____&quot;,536871105]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Flogseq____&quot;,259,536870916]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^Ulogseq____&quot;,119,536871106]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871105]],[logseq____&quot;^15logseq____&quot;,[195,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b5d0-4baf-95cc-6504f515fc03logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Small moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Flogseq____&quot;,203,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Vlogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[196,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cbb2-4240-8386-386fe0cedccalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the reduction of oral corticosteroid use in adults with oral corticosteroid dependent asthma. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Flogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Ulogseq____&quot;,121,536871077]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[197,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-02f1-44f4-a51d-291ac0be447dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of chronic spontaneous urticaria (CSU). (Phase 2) #Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Flogseq____&quot;,164,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Ulogseq____&quot;,135,536871077]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[198,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0e7a-4684-8b0f-b49e8f34c78flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 133**logseq____&quot;,536871169]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Flogseq____&quot;,228,536870916]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^Ulogseq____&quot;,119,536871170]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871169]],[logseq____&quot;^15logseq____&quot;,[199,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f25-4d7a-bad1-b4328208942clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Flogseq____&quot;,236,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[200,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8252-4678-b493-bc416788738blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Flogseq____&quot;,197,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Ulogseq____&quot;,121,536871077]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[201,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d615-4c25-b4bc-5286089ee1c7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of patients with high-risk cardiovascular disease without prior heart attack or stroke. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Flogseq____&quot;,172,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Vlogseq____&quot;,172,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Ulogseq____&quot;,117,536871065]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Ulogseq____&quot;,119,536871065]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Ulogseq____&quot;,121,536871065]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[202,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6256-4843-ba99-d9cea131ff15logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Under investigation for the treatment of advanced solid tumors other than non-small cell lung cancer or advanced colorectal cancer. (Phase 2) #Phase-2\\nid:: 649b3b6e-590a-4569-a1fa-140d597c26a7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Flogseq____&quot;,146,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Vlogseq____&quot;,240,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Ulogseq____&quot;,135,536871041]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:idlogseq____&quot;,logseq____&quot;649b3b6e-590a-4569-a1fa-140d597c26a7logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b3b6e-590a-4569-a1fa-140d597c26a7logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[203,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u649b3b6e-590a-4569-a1fa-140d597c26a7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of acute lymphoblastic leukemia (ALL) (Phase 2) #Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Flogseq____&quot;,253,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Vlogseq____&quot;,163,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Ulogseq____&quot;,119,536871030]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Ulogseq____&quot;,135,536871030]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Ulogseq____&quot;,136,536871030]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[204,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6222-4665-a058-16e3f83426dblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Flogseq____&quot;,184,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Vlogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Ulogseq____&quot;,37,536871018]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Ulogseq____&quot;,119,536871018]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Ulogseq____&quot;,134,536871018]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[206,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-af66-4d0f-9513-f2f25319b1c6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[AMJEVITA]]**logseq____&quot;,536871011]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Flogseq____&quot;,200,536870916]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Ulogseq____&quot;,36,536871012]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Ulogseq____&quot;,119,536871012]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871011]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^Hlogseq____&quot;,36,536871011]],[logseq____&quot;^15logseq____&quot;,[207,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3532-4b13-891e-2e70fc7c036elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[ABP 654]]**logseq____&quot;,536871080]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Flogseq____&quot;,242,536870916]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Ulogseq____&quot;,24,536871081]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Ulogseq____&quot;,119,536871081]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871080]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^Hlogseq____&quot;,24,536871080]],[logseq____&quot;^15logseq____&quot;,[208,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-925f-435a-b2d9-eeaa175f3b5alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[EVENITY]]**logseq____&quot;,536871025]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Flogseq____&quot;,214,536870916]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Ulogseq____&quot;,119,536871026]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Ulogseq____&quot;,137,536871026]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871025]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^Hlogseq____&quot;,137,536871025]],[logseq____&quot;^15logseq____&quot;,[209,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a63b-4a2c-bccf-623811de23aelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;LUMAKRAS is also in Phase 1 and Phase 2 development for the treatment of NSCLC in combination with other therapies. #Phase-2 #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Flogseq____&quot;,146,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Vlogseq____&quot;,146,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Ulogseq____&quot;,116,536871041]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Ulogseq____&quot;,135,536871041]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[210,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9b0f-47e3-8039-b9686efd4678logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Indicated for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis among others. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Flogseq____&quot;,207,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Vlogseq____&quot;,207,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Ulogseq____&quot;,36,536871012]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Ulogseq____&quot;,119,536871012]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Ulogseq____&quot;,121,536871012]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[211,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-10a1-43a5-8246-ca5e4b888b90logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigational [[biosimilar]] to [[STELARA]] (ustekinumab).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Flogseq____&quot;,208,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Vlogseq____&quot;,208,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Ulogseq____&quot;,24,536871081]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Ulogseq____&quot;,38,536871081]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Ulogseq____&quot;,119,536871081]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Ulogseq____&quot;,140,536871081]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Hlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^Hlogseq____&quot;,140,536870916]],[logseq____&quot;^15logseq____&quot;,[212,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8c69-4f1d-afd8-b9127620c40clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Flogseq____&quot;,145,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[213,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4765-4cf9-ac1b-6403c26e4772logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Flogseq____&quot;,156,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[214,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3762-47e2-a8ee-8fd5f19058a4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 404**logseq____&quot;,536871113]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Flogseq____&quot;,226,536870916]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^Ulogseq____&quot;,119,536871114]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871113]],[logseq____&quot;^15logseq____&quot;,[215,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-329e-426d-905b-a68d9a72db49logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Investigational Phase 3 Productslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Flogseq____&quot;,1388,536871201]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871190]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536871190]],[logseq____&quot;^15logseq____&quot;,[216,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-75f8-4e3d-a115-30772a9c0bfelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Flogseq____&quot;,207,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[217,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7afc-4847-a45d-12f5a634ed79logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Flogseq____&quot;,221,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[218,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-38da-47b4-b0f0-d993d19ed4a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 193**logseq____&quot;,536871128]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Flogseq____&quot;,169,536870916]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^Ulogseq____&quot;,119,536871129]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871128]],[logseq____&quot;^15logseq____&quot;,[219,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9cd6-4c8c-9bdc-8bc8d8bbe603logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[BiTE Molecule]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Flogseq____&quot;,229,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Vlogseq____&quot;,156,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Ulogseq____&quot;,119,536871022]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Ulogseq____&quot;,126,536871022]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Ulogseq____&quot;,130,536871022]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^Hlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[220,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cfc4-465a-aadd-d6f5a3469036logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Tarlatamab]]**logseq____&quot;,536871072]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Flogseq____&quot;,224,536870916]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Ulogseq____&quot;,119,536871073]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Ulogseq____&quot;,142,536871073]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871072]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^Hlogseq____&quot;,142,536871072]],[logseq____&quot;^15logseq____&quot;,[221,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4a49-4866-8916-dfe4583a844flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Flogseq____&quot;,179,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[222,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a74f-4ed9-977d-9a1fa8386556logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 786**logseq____&quot;,536871101]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Flogseq____&quot;,195,536870916]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^Ulogseq____&quot;,119,536871102]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871101]],[logseq____&quot;^15logseq____&quot;,[223,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cb22-4faa-b57d-bd4b6876dbe6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Flogseq____&quot;,246,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[224,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cd4c-4ac6-8fc6-fdb5d116c014logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Bemarituzumab is also in Phase 1 development for the treatment of advanced Gastric and Gastroesophageal cancers in combination with other therapies. #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Flogseq____&quot;,249,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Vlogseq____&quot;,249,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Ulogseq____&quot;,116,536871340]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Ulogseq____&quot;,119,536871340]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Ulogseq____&quot;,121,536871340]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Ulogseq____&quot;,134,536871340]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[225,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9c9a-453a-b0fb-e1056fcc52b8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 340**logseq____&quot;,536871117]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Flogseq____&quot;,252,536870916]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^Ulogseq____&quot;,119,536871118]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871117]],[logseq____&quot;^15logseq____&quot;,[226,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1d02-49cc-9c01-6aad0401b453logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Flogseq____&quot;,189,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Vlogseq____&quot;,236,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Ulogseq____&quot;,37,536871005]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Ulogseq____&quot;,72,536871005]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Ulogseq____&quot;,119,536871005]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[227,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4968-4667-bc18-daf9ed0cd60dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**ORDESEKIMAB**logseq____&quot;,536871173]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Flogseq____&quot;,248,536870916]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^Ulogseq____&quot;,119,536871174]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871173]],[logseq____&quot;^15logseq____&quot;,[228,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0437-44ca-9024-07d27cee3633logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated in newly diagnosed adults age 40 and older with Ph negative B-Cell precursor Acute Lymphoblastic Leukemia (ALL). (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Flogseq____&quot;,156,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Vlogseq____&quot;,156,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Ulogseq____&quot;,119,536871022]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Ulogseq____&quot;,121,536871022]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Ulogseq____&quot;,126,536871022]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[229,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bd59-4413-a3df-74df3ce76d7clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**XALURITAMIG**logseq____&quot;,536871148]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Flogseq____&quot;,238,536870916]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^Ulogseq____&quot;,119,536871149]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871148]],[logseq____&quot;^15logseq____&quot;,[230,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-adc7-48ec-8352-8dd4c6db9381logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 794**logseq____&quot;,536871093]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Flogseq____&quot;,223,536870916]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^Ulogseq____&quot;,119,536871094]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871093]],[logseq____&quot;^15logseq____&quot;,[231,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9030-4c66-85ce-f0772026f9c2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of eosinophilic esophagitis (EoE). (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Flogseq____&quot;,201,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Vlogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Ulogseq____&quot;,119,536871077]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Ulogseq____&quot;,121,536871077]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Ulogseq____&quot;,128,536871077]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[232,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4369-42bb-9358-3ad4b2b48586logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Flogseq____&quot;,212,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Vlogseq____&quot;,208,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Ulogseq____&quot;,24,536871081]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Ulogseq____&quot;,37,536871081]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Ulogseq____&quot;,119,536871081]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[233,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1143-472a-83cf-db184a0cc69blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Investigational Phase 2 Productslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Flogseq____&quot;,264,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[235,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8ad5-4e4a-a1dd-ae70b3632a3flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Aimovig]]**\\nid:: 649b349f-6ea4-494e-972d-99abb4f93bdblogseq____&quot;,536871004]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Flogseq____&quot;,216,536870916]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Ulogseq____&quot;,72,536871005]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Ulogseq____&quot;,119,536871005]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b349f-6ea4-494e-972d-99abb4f93bdblogseq____&quot;],536871004]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[logseq____&quot;^1=logseq____&quot;]],536871004]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b349f-6ea4-494e-972d-99abb4f93bdblogseq____&quot;],536871004]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^Hlogseq____&quot;,72,536871004]],[logseq____&quot;^15logseq____&quot;,[236,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u649b349f-6ea4-494e-972d-99abb4f93bdblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Tarlatamab is also in Phase 2 development for the treatment of SCLC as a monotherapy and in Phase 1 in combination with other therapies. #Phase-2 #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Flogseq____&quot;,254,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Vlogseq____&quot;,254,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ulogseq____&quot;,116,536871073]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ulogseq____&quot;,119,536871073]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ulogseq____&quot;,121,536871073]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ulogseq____&quot;,135,536871073]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Ulogseq____&quot;,142,536871073]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[237,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-73fb-4973-9801-4366c0d7af1elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**LATIKAFUSP**logseq____&quot;,536871152]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Flogseq____&quot;,166,536870916]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^Ulogseq____&quot;,119,536871153]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871152]],[logseq____&quot;^15logseq____&quot;,[238,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7c7f-477f-a34f-ed39151c25dflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[ABP 938]]**logseq____&quot;,536871084]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Flogseq____&quot;,150,536870916]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Ulogseq____&quot;,28,536871085]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Ulogseq____&quot;,119,536871085]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871084]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^Hlogseq____&quot;,28,536871084]],[logseq____&quot;^15logseq____&quot;,[239,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-91ce-452c-b33e-a8faecaf4bb1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[LUMAKRAS]]**logseq____&quot;,536871040]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Flogseq____&quot;,167,536870916]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Ulogseq____&quot;,119,536871041]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Ulogseq____&quot;,132,536871041]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871040]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^Hlogseq____&quot;,132,536871040]],[logseq____&quot;^15logseq____&quot;,[240,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6f0d-4fd4-80c8-1541079c8d90logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease (CKD) receiving hemodialysis. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Flogseq____&quot;,145,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Vlogseq____&quot;,145,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Ulogseq____&quot;,119,536871057]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Ulogseq____&quot;,121,536871057]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Ulogseq____&quot;,139,536871057]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[241,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-02cf-47eb-8e1d-a8a74db98d89logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Flogseq____&quot;,160,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[242,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0827-4481-9785-5db611dc12falogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of moderate to severe plaque psoriasis in pediatric patients. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Flogseq____&quot;,161,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Vlogseq____&quot;,161,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Ulogseq____&quot;,119,536871053]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Ulogseq____&quot;,121,536871053]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Ulogseq____&quot;,124,536871053]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[243,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-615f-4ee4-a9f3-2344ed013dcdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Flogseq____&quot;,149,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Vlogseq____&quot;,172,536870916]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Ulogseq____&quot;,117,536871065]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^Ulogseq____&quot;,119,536871065]],[logseq____&quot;^15logseq____&quot;,[245,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-41c2-4c94-8446-4402892a2e3blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Rocatinlimab]]**logseq____&quot;,536871068]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Flogseq____&quot;,172,536870916]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Ulogseq____&quot;,119,536871069]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Ulogseq____&quot;,122,536871069]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871068]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^Hlogseq____&quot;,122,536871068]],[logseq____&quot;^15logseq____&quot;,[246,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4a5d-4700-abad-46668c05e6a8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Flogseq____&quot;,239,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[247,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9d10-4282-b104-a5b25fb707aclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Efavaleukin alfa**logseq____&quot;,536871181]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Flogseq____&quot;,235,536870916]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^Ulogseq____&quot;,119,536871182]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871181]],[logseq____&quot;^15logseq____&quot;,[248,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-09e2-4d4e-8774-898734165220logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of advanced Gastric and Gastoesophageal Junction (GEJ) Cancers. (Phase 3) #Phase-3logseq____&quot;,536871339]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Flogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Vlogseq____&quot;,193,536870916]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Ulogseq____&quot;,119,536871018]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Ulogseq____&quot;,121,536871018]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Ulogseq____&quot;,134,536871018]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871339]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^Hlogseq____&quot;,121,536871339]],[logseq____&quot;^15logseq____&quot;,[249,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ba3e-41b2-bfa1-efc5b925a120logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Fusion Protein]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Flogseq____&quot;,192,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Vlogseq____&quot;,239,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Ulogseq____&quot;,28,536871085]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Ulogseq____&quot;,119,536871085]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Ulogseq____&quot;,133,536871085]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^Hlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[250,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-746a-4bc2-9e37-304bf7e0de28logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of moderate-to-severe atopic dermatitis. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Flogseq____&quot;,246,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Vlogseq____&quot;,246,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Ulogseq____&quot;,119,536871069]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Ulogseq____&quot;,121,536871069]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Ulogseq____&quot;,122,536871069]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[251,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d3e1-4d77-a079-7235b5113ef6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 199**logseq____&quot;,536871125]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Flogseq____&quot;,219,536870916]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^Ulogseq____&quot;,119,536871122]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871125]],[logseq____&quot;^15logseq____&quot;,[252,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-58ea-40ec-aff9-f0a7e9a1eb61logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for weekly dosing in combination with lenalidomide and [[dexamethasone]] for the treatment of relapsed/refractory multiple myeloma (MM). (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Flogseq____&quot;,163,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Vlogseq____&quot;,163,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Ulogseq____&quot;,119,536871030]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Ulogseq____&quot;,120,536871030]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Ulogseq____&quot;,121,536871030]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Ulogseq____&quot;,136,536871030]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Hlogseq____&quot;,120,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[253,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fb9f-4b67-b53f-4deb07e95573logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of small-cell lung cancer. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Flogseq____&quot;,221,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Vlogseq____&quot;,221,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Ulogseq____&quot;,119,536871073]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Ulogseq____&quot;,121,536871073]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Ulogseq____&quot;,142,536871073]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[254,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1040-44bb-b8dd-581b4c4ad9f4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Flogseq____&quot;,191,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[256,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9012-43bd-9315-4394f956d171logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Monoclonal Antibody]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Flogseq____&quot;,211,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Vlogseq____&quot;,207,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Ulogseq____&quot;,36,536871012]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Ulogseq____&quot;,37,536871012]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Ulogseq____&quot;,119,536871012]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[257,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-251c-47af-b9c6-d4f5864562d6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of [[chemotherapy-induced thrombocytopenia]] (CIT). (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Flogseq____&quot;,179,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Vlogseq____&quot;,179,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Ulogseq____&quot;,119,536871045]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Ulogseq____&quot;,121,536871045]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Ulogseq____&quot;,129,536871045]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Ulogseq____&quot;,141,536871045]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^Hlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[258,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c312-4957-862e-4c873b621dd3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**AMG 609**logseq____&quot;,536871109]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Flogseq____&quot;,215,536870916]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^Ulogseq____&quot;,119,536871110]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871109]],[logseq____&quot;^15logseq____&quot;,[259,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ab6b-451a-9a27-1a23b8c08f8flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of atherosclerotic cardiovascular disease. (Phase 3) #Phase-3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Flogseq____&quot;,180,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Vlogseq____&quot;,180,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Ulogseq____&quot;,119,536871049]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Ulogseq____&quot;,121,536871049]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Ulogseq____&quot;,125,536871049]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^Hlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[261,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a9b5-4944-bd79-e4dce3864aa8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated for the treatment of neuroendocrine prostate cancer. (Phase 1) #Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Flogseq____&quot;,254,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Vlogseq____&quot;,221,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Ulogseq____&quot;,116,536871073]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Ulogseq____&quot;,119,536871073]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Ulogseq____&quot;,142,536871073]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[262,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0f9e-4b79-9bd2-38a31d2c15c7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Flogseq____&quot;,256,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[264,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e4d0-4c82-944d-d637c3e56c4clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Flogseq____&quot;,161,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[265,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4843-4027-87ae-cad764952431logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Flogseq____&quot;,180,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Xlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Vlogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^Ulogseq____&quot;,119,536870916]],[logseq____&quot;^15logseq____&quot;,[266,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-227d-4ffd-aec6-b676f5f30071logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^Klogseq____&quot;,1691874785439,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;minimal residual diseaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^11logseq____&quot;,logseq____&quot;minimal residual diseaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^Blogseq____&quot;,1691874785439,536870916]],[logseq____&quot;^15logseq____&quot;,[268,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2d47-47d9-bf2b-94d0abf43817logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^Klogseq____&quot;,1691874785209,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;corticosteroidlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^11logseq____&quot;,logseq____&quot;corticosteroidlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^Blogseq____&quot;,1691874785209,536870916]],[logseq____&quot;^15logseq____&quot;,[269,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5c7a-4bad-bd4c-1cefe95e3384logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Flogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[270,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a0ff-40e7-aef7-97e23e670a99logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;BLINCYTO has been known to cause serious side effects such as cytokine release syndrome as well as neurological toxicities, which may be fatal. Patients should interrupt or discontinue BLINCYTO in case of these effects, and for the case of CRS medicate with [[corticosteroid]]s.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Flogseq____&quot;,284,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Ulogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^Hlogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[271,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ac34-477d-af63-a5f18d643188logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Flogseq____&quot;,277,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[272,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ee67-4850-87af-9c8388d71398logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Flogseq____&quot;,274,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[273,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0fc8-4486-aef2-af8fc21f2c5flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;BLINCYTO is being investigated in Phase 3 in newly diagnosed adults age 40 and older with *Ph negative B-Cell precursor Acute Lymphoblastic Leukemia (ALL). It is officially indicated for the treatment of adult and pediatric patients with:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Flogseq____&quot;,286,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[274,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4114-4a78-b464-0d45ac04eb67logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Flogseq____&quot;,292,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[275,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1b45-47bd-900e-11994d9345b7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The most common adverse reactions (≥ 20%) are pyrexia, infusion-related reactions, infections (pathogen unspecified), headache, neutropenia, anemia and thrombocytopenia.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Flogseq____&quot;,282,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[276,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f98-436e-a652-b75f52be8f67logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*In a study of 405 adults with ALL, 271 were treated with BLINCYTO® and 134 with chemotherapy. People on BLINCYTO lived nearly twice as long compared to people on chemotherapy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Flogseq____&quot;,280,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[277,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3519-451d-9c93-fd49f6308d20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Flogseq____&quot;,274,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Vlogseq____&quot;,274,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[278,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5dbe-4efc-9265-e4dfd4c3420alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**BLINCYTO** (*blinatumomab*) is an anti-CD19 x anti-CD3 [[BiTE Molecule]] (more specifically, a bispecific CD19-directed CD3 T-cell engager) that used to treat *B-cell precursor acute lymphoblastic leukemia (ALL)* in patients who still have detectable traces of cancer after chemotherapy. ALL is a cancer of the blood in which a particular kind of white blood cell is growing out of control, called lymphoblasts or immature lymphocytes. BLINCYTO is the first and only FDA-approved treatment for people with ALL who test positive for [[minimal residual disease]] (MRD).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Flogseq____&quot;,283,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Ulogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Hlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^Hlogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[279,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-28c3-4bc7-b662-6abb79483ef8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Flogseq____&quot;,289,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[280,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d245-4707-9f0c-e8a9898a57ealogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [BLINCYTO Prescribing Information - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Blincyto/blincyto_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Flogseq____&quot;,293,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[281,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5979-46bf-9593-03877a6423bflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Flogseq____&quot;,271,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[282,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fdb5-416e-b125-b7a16b7cea32logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# BLINCYTOlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Flogseq____&quot;,270,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[283,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-02c6-4951-8ecd-60aaaadb544blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Flogseq____&quot;,275,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[284,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-972c-4cb5-827c-df68b716607flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The drug is intended for intravenous use through injection of 35 mcg of lyophilized powder in a single-dose vial for reconstitution. Initial U.S. Approval of BLINCYTO happened in 2014.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Flogseq____&quot;,273,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[285,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9f09-4cf5-9a80-6650d2b7fc51logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Flogseq____&quot;,279,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[286,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cd24-40d3-a28c-abe07cfbc246logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Flogseq____&quot;,290,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[287,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2807-4e53-bee7-c4a588e7ec5dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Flogseq____&quot;,276,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[288,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f21-4531-8db3-0b9cb14bcffelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Flogseq____&quot;,288,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[289,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7449-464b-a2d1-88812d88957flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Flogseq____&quot;,272,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[290,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3735-4a34-b277-68e8da755d37logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Blincyto.com](https://www.blincyto.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Flogseq____&quot;,287,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[291,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d6cd-4a5e-a019-e042050b7684logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Flogseq____&quot;,285,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[292,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b5b8-4f10-9a1c-69282f3742c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [BLINCYTO Medication Guide - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Blincyto/blincyto_mg_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Flogseq____&quot;,291,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Vlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[293,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9a94-4411-b29b-4d3fe566bff5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Relapsed or refractory CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Flogseq____&quot;,278,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Xlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Vlogseq____&quot;,274,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[294,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0ead-42ad-857d-8fbb4feb5787logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^Klogseq____&quot;,1691874785027,536870916]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;non-small-cell lung cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^11logseq____&quot;,logseq____&quot;Non-Small-Cell Lung Cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871966]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^Blogseq____&quot;,1691884947012,536871976]],[logseq____&quot;^15logseq____&quot;,[296,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-70c2-4169-8e21-fb470469bd70logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Flogseq____&quot;,305,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[298,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-320f-46c5-b583-2fa2862b472clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Bemarituzumab is being developed in Phase 3 in gastric and gastroesophageal junction (GEJ) cancer as a targeted therapy for tumors that overexpress FGFR2b. The company is also evaluating the potential for bemarituzumab in other cancers that overexpress FGFR2b:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Flogseq____&quot;,310,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[299,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-967e-4bd0-bcf0-c0b8c802a5b4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Flogseq____&quot;,308,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[300,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d774-47e2-ae08-2825a4cd06f9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: Shitara K et al. *NEJM*. 2020; 382;25: 2419-30, Wainberg ZA, et al. Presented at: ASCO Gastrointestinal Cancer Symposium; January 15-16, 2021; Online Virtual Scientific Program (Abstract LBA160 and oral presentation).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Flogseq____&quot;,302,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[301,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f212-4c4c-8b28-e33cd4147f3alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Bray F, et al. *CA Cancer J Clin*. 2018;68:394–424, Rawla P, et al. *Prz Gastroenterol*. 2019;14(1):26-38. doi:10.5114/pg.2018.80001.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Flogseq____&quot;,307,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[302,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f98d-46d4-8200-1443f562e600logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated in **Phase 2** for the treatment of advanced solid tumors other than advanced squamous [[Non-Small-Cell Lung Cancer]] .logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Flogseq____&quot;,299,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Vlogseq____&quot;,299,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^Hlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[303,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-74b4-459f-8592-8e7862a2c9d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Bemarituzumab** is a potential first-in-class investigational targeted [[Monoclonal Antibody]] that is designed to block *fibroblast growth factors* (*FGFs*) from binding and activating *FGFR2b* (anti-FGFR2b antibody), inhibiting several downstream pro-tumor signaling pathways and potentially slowing cancer progression.logseq____&quot;,536871962]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Flogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Ulogseq____&quot;,37,536871962]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871962]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^Hlogseq____&quot;,37,536871962]],[logseq____&quot;^15logseq____&quot;,[304,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-64bb-408a-83e6-7e8073ed84aalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for investigational bemarituzumab as first-line treatment for patients with fibroblast growth factor receptor 2b (FGFR2b) overexpressing and human epidermal growth factor receptor 2 (HER2)-negative metastatic and locally advanced gastric and gastroesophageal (GEJ) adenocarcinoma in combination with modified FOLFOX6 (fluoropyrimidine, leucovorin, and oxaliplatin).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Flogseq____&quot;,312,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[305,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-441c-4da5-a9b7-a985601daf5alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Flogseq____&quot;,300,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[306,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a960-484f-a044-41840cd33f41logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Flogseq____&quot;,306,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[307,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0995-456b-802d-0a0554c424a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;More than one million new gastric cancer cases are diagnosed annually, and gastric cancer is particularly prevalent in Asia[^1]. Approximately 80 to 85% of patients with advanced gastric and GEJ cancers are HER2-negative, and approximately 30% of these patients present with FGFR2b overexpression.[^2] In a study, treatment with bemarituzumab (plus chemotherapy) demonstrated clinically significant and substantial improvements in the progression-free survival (PFS) and overall survival (OS) in the patient population, in which at least 10% of tumor cells overexpressed FGFR2b[^3], with additional analysis affirming the activity against this target.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Flogseq____&quot;,311,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[308,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0139-414c-bdad-88ff02a524aclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Flogseq____&quot;,298,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[309,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f7a7-4e89-8610-9884d42def02logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Flogseq____&quot;,304,536871962]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[310,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5411-477c-a38d-3d416e001b4blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;##  Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Flogseq____&quot;,309,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[311,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5d60-47d9-9332-488eecfb1ae7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Flogseq____&quot;,299,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[312,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c05b-4fb6-94a3-6be1f5012377logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: https://pubmed.ncbi.nlm.nih.gov/31094225/logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Flogseq____&quot;,301,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Vlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[313,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8814-415b-8ea3-c6ea5fad49dclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Investigated in **Phase 1** for the treatment of advanced squamous non-small cell lung cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Flogseq____&quot;,303,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Vlogseq____&quot;,299,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[314,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-abac-4ccb-8aae-56997178c08elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Bemarituzumab is also in **Phase 1** development for the treatment of advanced Gastric and Gastroesophageal cancers in combination with other therapies.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Flogseq____&quot;,314,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Xlogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Vlogseq____&quot;,299,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^Ulogseq____&quot;,134,536870916]],[logseq____&quot;^15logseq____&quot;,[315,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8ec2-4ac4-a329-9de60d3ec83clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^Klogseq____&quot;,1691874785381,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;bispecific monoclonal antibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^11logseq____&quot;,logseq____&quot;bispecific monoclonal Antibodylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^Blogseq____&quot;,1691874785381,536870916]],[logseq____&quot;^15logseq____&quot;,[317,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f7b2-4af8-a856-f3a6c6412703logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;BiTEs direct a hostlogseq____&apos;s immune system, more specifically the [T cells](https://en.wikipedia.org/wiki/T_cell)logseq____&apos; cytotoxic activity, against cancer cells. They form a bridge between cancer cells and cytotoxic T cells—white blood cells that can destroy other cells that pose a threat. This link causes T cells to exert cytotoxic activity on tumor cells. It exerts this by releasing proteins ([perforin](https://en.wikipedia.org/wiki/Perforin) and [granzymes](https://en.wikipedia.org/wiki/Granzyme)), which enter tumor cells and initiate the celllogseq____&apos;s apoptosis.\\nid:: 649b5365-834c-477c-966e-4881242819d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Flogseq____&quot;,337,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b5365-834c-477c-966e-4881242819d7logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b5365-834c-477c-966e-4881242819d7logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[318,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u649b5365-834c-477c-966e-4881242819d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Flogseq____&quot;,336,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[319,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0ffe-4a53-97b5-f09df447a5a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Flogseq____&quot;,327,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[320,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-dc69-4447-86c4-3f0a7dad5aablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;BiTEs are [[fusion protein]]s consisting of two single-chain variable fragments (scFvs) of different antibodies, or amino acid sequences from four different genes, on a single peptide chain. One of the scFvs binds to T cells via the [CD3 receptor](https://en.wikipedia.org/wiki/CD3_(immunology)), and the other to a tumor cell via a tumor specific molecule.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Flogseq____&quot;,324,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^Hlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[321,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-94e3-4d60-a46b-f81bf719f3e5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Solitomab**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Flogseq____&quot;,334,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[322,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eca0-4515-b58a-e3d56529a909logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Flogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[323,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8daa-4894-a61f-f81b5314254alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Flogseq____&quot;,325,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[324,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-13b7-441b-87d4-1f6b5a62d354logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Flogseq____&quot;,333,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[325,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-64e4-452f-aa31-d09165ab7ac7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## BiTEs in Clinical Trialslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Flogseq____&quot;,332,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[326,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4977-4dc5-b116-a6b87d3380f8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*BiTE* is a registered trademark of Micromet AG (fully owned subsidiary of Amgen Inc). [^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Flogseq____&quot;,319,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[327,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2f40-4389-a1fd-98dcc88d4fa8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Flogseq____&quot;,335,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[328,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7447-48ce-bb19-ddc67d84327blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [BiTE Molecule - Amgen](https://www.amgen.com/stories/2018/08/the-shape-of-drugs-to-come/bite-molecule)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Flogseq____&quot;,320,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[329,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2f5f-4e22-bff3-dd49f04244a6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# BiTE Moleculelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Flogseq____&quot;,323,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[330,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-437c-42c7-9a5e-c67258dd9955logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Flogseq____&quot;,344,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[331,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8f51-4ee5-9517-5cff320abde6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Flogseq____&quot;,328,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[332,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c0f4-4791-88e0-6edc390da252logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![BiTE-Antibody-Constructs-Fig2_1299x800.webp](../assets/BiTE-Antibody-Constructs-Fig2_1299x800_1687904441950_0.webp)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Flogseq____&quot;,338,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[333,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c6e2-4f54-868c-6944279aa668logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[BLINCYTO]]**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Flogseq____&quot;,340,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Ulogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^Hlogseq____&quot;,126,536870916]],[logseq____&quot;^15logseq____&quot;,[334,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f89a-4a98-a2ed-36161747a0aalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![BiTE-Antibody-Constructs-Fig1_1169x800.webp](../assets/BiTE-Antibody-Constructs-Fig1_1169x800_1687904604411_0.webp){:height 484, :width 727}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Flogseq____&quot;,321,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[335,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1a85-4641-8701-ec74fa6be418logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Bi-specific T-cell engagers (BiTEs) are a class of artificial [[bispecific monoclonal antibody]] that are investigated for use as anti-cancer drugs.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Flogseq____&quot;,330,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Ulogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^Hlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[336,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-df9f-4af8-8417-47b4d8d480dflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Flogseq____&quot;,341,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[337,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6607-4ae7-9d3f-6ab7fbcc7ae3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Flogseq____&quot;,318,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[338,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c974-4970-96ac-6fefd1dcfb11logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1] [\\logseq____&quot;US Trademark registration no. 3,068,856, serial number 78/040,636\\logseq____&quot;](http://tarr.uspto.gov/servlet/tarr?regser=seriallogseq____&amp;entry=78040636). US Patent and Trademark Office.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Flogseq____&quot;,342,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[339,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-998e-4b9b-9dca-2626436ec64dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Tarlatamab]]**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Flogseq____&quot;,326,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^Hlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[340,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fe52-4995-97cc-0247a3915c2elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Flogseq____&quot;,343,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[341,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5c27-487d-b0e9-7be46bc95cd4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Flogseq____&quot;,331,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[342,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9c33-4edf-8888-822d2beef281logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [www.AmgenBiTETechnology.com](https://c212.net/c/link/?t=0logseq____&amp;l=enlogseq____&amp;o=3615468-1logseq____&amp;h=3807296597logseq____&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3466336-1%26h%3D4140778836%26u%3Dhttp%253A%252F%252Fwww.amgenbitetechnology.com%252F%26a%3Dwww.AmgenBiTETechnology.comlogseq____&amp;a=www.AmgenBiTETechnology.com).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Flogseq____&quot;,329,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[343,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b7f5-49d8-bd08-b170dfe87f8flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Kimmtrak**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Flogseq____&quot;,322,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Xlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Vlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[344,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f099-449d-a4e0-81af0130bb6alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^Klogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cancer staginglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^11logseq____&quot;,logseq____&quot;Cancer Staginglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^Blogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[346,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d5f4-49f8-906f-4e472acbf9b8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Itlogseq____&apos;s important to note that the staging of cancer can be complex and may involve a variety of tests and assessments. Itlogseq____&apos;s imperical for treatment to have an accurate stage assessment.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Flogseq____&quot;,355,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[347,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d973-487e-af7b-1c0a065c5081logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In some cancers, the stage of the disease is further specified by adding a letter after the number, such as 1A, 1B, 2A, 2B, etc. The letter provides additional information about the extent of the cancer within the stage, and can be used to help guide treatment decisions. However, not all cancer types use the lettering system, and the exact definition of the letters can vary depending on the cancer type and the staging system used.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Flogseq____&quot;,357,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[348,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7220-4751-9a09-aee1a3b9a179logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cancer is typically classified into four stages:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Flogseq____&quot;,356,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[349,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9e2a-4b3c-8730-0f6b4de04d54logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Flogseq____&quot;,347,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[350,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c5cb-4010-9334-bab9fa4d30b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Flogseq____&quot;,352,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[351,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4101-40d7-a1ee-c0c403954e50logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Flogseq____&quot;,354,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[352,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-85d7-44f7-a47d-4963038797f0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage 1: The cancer is in its early stages and is confined to the primary site where it started. At this stage, the tumor is usually small, and the cancer cells have not spread to nearby tissues or to other parts of the body.\\n\\nStage 2: The cancer has grown beyond its original site and may have spread to nearby lymph nodes or tissues, but it is still contained within the affected area and has not spread to distant parts of the body.\\n\\nStage 3: The cancer has grown further and may have spread to regional lymph nodes or nearby tissues, but it is still considered to be localized and has not spread to distant parts of the body.\\n\\nStage 4: The cancer has spread to other parts of the body and is considered to be advanced or metastatic. At this stage, the cancer cells have traveled through the bloodstream or lymphatic system to reach other organs, such as the liver, lungs, bones, or brain.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Flogseq____&quot;,349,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Vlogseq____&quot;,349,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[353,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e39e-4e02-9738-9399f67f2c68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Flogseq____&quot;,348,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[354,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2055-4415-9171-50614a9d1e6blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Flogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[355,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ea7c-4d38-8c89-ee80b2adaa05logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Stages\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Flogseq____&quot;,350,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[356,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2dc9-4820-9ced-ed0cfeb58beelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Flogseq____&quot;,349,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Xlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Vlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[357,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f338-4349-96bf-7255c7155e0flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^Klogseq____&quot;,1691874784660,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;codebreak_100logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^11logseq____&quot;,logseq____&quot;CodeBreak_100logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^Blogseq____&quot;,1691874784660,536870916]],[logseq____&quot;^15logseq____&quot;,[359,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f027-46b4-909b-05c0e93b80a7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Exposure to Lumakras as a single agent at 960 mg orally once daily in 357 patients with NSCLC (and other solid tumors) with\\nKRAS G12C mutation enrolled in CodeBreaK 100, 28% were exposed for 6 months or longer and 3% were exposedlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Flogseq____&quot;,359,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Xlogseq____&quot;,359,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Vlogseq____&quot;,359,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^Ulogseq____&quot;,359,536870916]],[logseq____&quot;^15logseq____&quot;,[360,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3f99-464a-9b4e-eaefb1f634b7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^Klogseq____&quot;,1691874784866,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;dosage reductions for adverse reactionslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^11logseq____&quot;,logseq____&quot;Dosage reductions for adverse reactionslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^Blogseq____&quot;,1691874784866,536870916]],[logseq____&quot;^15logseq____&quot;,[362,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-082c-499f-b808-fabf2a17cffelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Flogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Xlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Vlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[363,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c1ed-4559-b513-3a355bef07c8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Dosage Modifications\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Flogseq____&quot;,363,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Xlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Vlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[364,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3853-4613-8251-0f074743f1c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![From the official prescribing documentation](dosagemodifications.png)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Flogseq____&quot;,364,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Xlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Vlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[365,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-61f1-4141-a7eb-69f1cf53d2eblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;---logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Flogseq____&quot;,365,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Xlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Vlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[366,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-531b-4932-95c1-6de378a10d87logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Flogseq____&quot;,366,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Xlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Vlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[367,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b763-4e50-84c7-2ee7db611fa7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**EVENITY** (**romosozumab-aqqg**) is a [[Monoclonal Antibody]] and clerostin inhibitor that is being used and investigated in treating osteoporosis (a skeletal condition where bones deteriorate, with low bone mass or bone tissue). Osteoporosis becomes more common with age, with about 15% of Caucasians in their 50s and 70% of those over 80 being affected. EVENITY is currently in Phase 3 development for treating male osteoporosis and in Phase 1 for osteogenesis imperfecta (OI; a group of genetic disorders with underlying problems in connective tissue of poorly formed type I collagen) in pediatric patients. It was approved in the U.S. in 2019.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Flogseq____&quot;,371,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[369,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7fd2-4fce-908d-c14f9502834clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is officially indicated for for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. It is generally only limited to be used for 12 months, after which anti-resorptive agents should be considerd when therapy remains warranted. A combined dose consisting of two times 105 mg (210 mg in total), in pre-filled single-use injections are concurrently administered once every month with EVENITY.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Flogseq____&quot;,376,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[370,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-59e0-4d12-b189-31d4fcea659dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Flogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[371,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4082-4264-8fc0-aaca60bd3244logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Flogseq____&quot;,379,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[372,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5c7a-4740-b412-afbc503ec408logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Flogseq____&quot;,370,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[373,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a7eb-43fa-814f-f73cfa033a89logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[EVENITY Prescribing Information - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Evenity/evenity_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Flogseq____&quot;,377,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[374,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-db51-4eb1-a32b-4bc3aed278felogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Further Readinglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Flogseq____&quot;,372,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[375,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-648f-44e5-8408-7405d8091c56logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Flogseq____&quot;,369,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[376,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-260b-49f1-aa7c-61303ed64971logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Evenity.com](https://www.evenity.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Flogseq____&quot;,375,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[377,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4e3c-48c7-b6e5-fbe8930784a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;EVENITY may increase the risk of myocardial infarction, stroke and cardiovascular death. Patients with a history or cardiac complications should consider whether the benefits outweigh the risk, and EVENITY should be discontinued if these complications arise.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Flogseq____&quot;,373,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[378,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-06c4-4b97-a01e-eefdca78c08clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Flogseq____&quot;,378,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Xlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Vlogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^Ulogseq____&quot;,137,536870916]],[logseq____&quot;^15logseq____&quot;,[379,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d16e-4155-9248-99038c8fa6a1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^Klogseq____&quot;,1691874784694,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;exports guidelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^11logseq____&quot;,logseq____&quot;Exports Guidelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^Blogseq____&quot;,1691874784694,536870916]],[logseq____&quot;^15logseq____&quot;,[381,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-427f-4232-8bbd-60ac4c315696logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`t w`  - Toggle wide modelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Flogseq____&quot;,394,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[382,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7808-40cf-80ed-b2b36a8b74e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Flogseq____&quot;,402,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[383,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d881-4d25-9657-36e267f50ed9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Exports come in several formats:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Flogseq____&quot;,387,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[384,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-121d-4e9f-8a08-f612a0f8ccfelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`t o`  - Toggle open blocks/close blockslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Flogseq____&quot;,397,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[385,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-45cd-406c-9eb5-0632c44af3d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Interactive pages** are a more intricate format of the project, but can be much more easily and efficiently navigated in an interactive fashion very similar as with *Wikipedia*. This is recommended for quick browsing if no individual documents are needed.*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Flogseq____&quot;,389,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[386,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e9c3-49aa-983b-406535298435logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;---logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Flogseq____&quot;,400,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[387,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a405-41e4-9fa9-ab503a625dcblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Flogseq____&quot;,396,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[388,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d570-4bfe-b983-a05b393ce483logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Flogseq____&quot;,384,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[389,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c3f8-4822-b57d-378d1cb6f5bflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`Shift click`  - Open in sidebarlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Flogseq____&quot;,382,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[390,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4c1d-42c4-86ff-1a1978fd96dalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*The **Interactive Pages ***folder contains three files (two folders, and an [index.html](https://index.html) file); it can be downloaded and **extracted** to one place, i.e. Desktop, then open [index.html](https://index.html)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Flogseq____&quot;,386,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[391,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1885-4cfd-b49f-140519d48be0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`g g`  - Go to Graph viewlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Flogseq____&quot;,390,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[392,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-985f-4c76-8c64-1144cc0408fdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Standalone pages** are exports of all relevant pages as individually. In this format, hyperlinks do not work and some elements may be missing. Not recommended for with higher numbers of pages but instead for further sharing of project.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Flogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[393,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a48f-4799-8750-1d1995413a71logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`t d`  - Toggle document (reader) modelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Flogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[394,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cd57-4d74-b4d6-77d9446ba738logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;You can use several shortcuts in the interactive version, such aslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Flogseq____&quot;,391,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[395,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-951d-4a71-816f-c453fbe4e949logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Download this file: https://app.skiff.com/docs/3886b739-88f2-4c79-bb5c-43c6e8364d55#GnJJph9d%2BpnQFyuy6W4u8b77lks0GtRRNqnldeR1h6s%3Dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Flogseq____&quot;,401,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[396,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2232-4a9e-8af7-d5510be4629dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`g h`  - Go to Homelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Flogseq____&quot;,392,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[397,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f26a-4d78-8c54-f290d09eb568logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~`t t`  - Toggle theme.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Flogseq____&quot;,385,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Vlogseq____&quot;,395,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[398,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b4e0-427f-9148-b59285c9e671logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Flogseq____&quot;,393,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[399,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9a21-4918-b48c-2f88d542e0f2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# README (Exports Guide)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Flogseq____&quot;,388,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[400,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f3b-44e6-8e17-6fe65cbda27dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Flogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[401,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-38c3-4dd6-b7a9-2c12ede24d54logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The **EDN format** comes in a single file containing the entire project graph. It can be imported, including on [demo.logseq.com](https://demo.logseq.com) but may unfavorable due to the relatively high effort of navigating to the project homepage.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Flogseq____&quot;,399,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Xlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Vlogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^Ulogseq____&quot;,381,536870916]],[logseq____&quot;^15logseq____&quot;,[402,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-29d4-4c8b-a279-4a5f0cccf5fblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^Klogseq____&quot;,1691874784704,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;fatal adverse reactionslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^11logseq____&quot;,logseq____&quot;Fatal Adverse Reactionslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^Blogseq____&quot;,1691874784704,536870916]],[logseq____&quot;^15logseq____&quot;,[404,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3c37-4a2b-8ff9-7a3119d5815clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Respiratory failure (0.8%), pneumonitis (0.4%), cardiac arrest (0.4%), cardiac failure (0.4%), gastric ulcer (0.4%), pneumonia (0.4%).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Flogseq____&quot;,404,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Xlogseq____&quot;,404,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Vlogseq____&quot;,404,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^Ulogseq____&quot;,404,536870916]],[logseq____&quot;^15logseq____&quot;,[405,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5ac4-43f0-9a29-7248e23e8f46logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Flogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[407,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9db5-4a24-9cf2-a8aa1411916elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Fusion Proteinslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Flogseq____&quot;,407,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[408,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f4d-458a-81d1-246ce2035b0dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Fusion proteins** or **chimeric proteins** (literally, made of parts from different sources) are proteins created through the joining of two or more genes] that originally coded for separate proteins. Translation of this *[fusion gene](https://en.wikipedia.org/wiki/Fusion_gene)* results in a single or multiple [polypeptides](https://en.wikipedia.org/wiki/Polypeptides) with functional properties derived from each of the original proteins. For example, several fusion proteins have been constructed by combining the binding domain of a cell surface receptor with the tail (Fc) portion of an antibody. The receptor portion functions as a decoy binding site to attract and capture molecules that would otherwise contribute to disease. The antibody portion enables the fusion protein to remain in the body much longer than a circulating receptor would last on its own.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Flogseq____&quot;,408,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[409,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-35e2-4e35-939e-df0c1bd58c23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![Fusion-Proteins-Fig1_1169x800.webp](../assets/Fusion-Proteins-Fig1_1169x800_1687905014793_0.webp)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Flogseq____&quot;,409,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[410,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b7e9-4db6-99c3-07d03e14fee8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Flogseq____&quot;,410,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[411,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-94ba-425d-adb3-17084f011057logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Naturally occurring fusion proteins are commonly found in cancer cells.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Flogseq____&quot;,411,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[412,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9a3c-4b28-9361-36c576e2cca8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Flogseq____&quot;,412,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[413,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6094-43d4-8bb0-69ecde14f4f7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Flogseq____&quot;,413,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Xlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Vlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[414,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-86b1-418b-b089-c20c5cbf965clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^Klogseq____&quot;,1691874785036,536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;kras g12clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^11logseq____&quot;,logseq____&quot;KRAS G12Clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^Blogseq____&quot;,1691877657283,536871774]],[logseq____&quot;^15logseq____&quot;,[416,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2a70-4096-bd3f-c55697b02ca6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Flogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[417,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f24e-4984-bc00-4fa88743b494logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Flogseq____&quot;,426,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[418,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c6e8-42f4-b52e-b1eb7723b3b5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**KRAS** ([Kirsten](https://en.wikipedia.org/wiki/Werner_H._Kirsten) rat sarcoma virus) is a gene that provides instructions for making a protein called **K-Ras**, a part of the RAS/MAPK pathway (in [protein dynamics](https://en.wikipedia.org/wiki/Protein_dynamics)). The protein relays signals from outside the cell to the celllogseq____&apos;s nucleus. These signals instruct the cell to grow and divide (proliferate) or to mature and take on specialized functions (differentiate).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Flogseq____&quot;,434,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[419,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5ba3-41e6-ad76-29e6d010e594logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Flogseq____&quot;,421,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[420,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-259d-4980-98d8-c8cac68f9307logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Flogseq____&quot;,437,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[421,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-756a-4a11-8ec6-7a5fce6a2cedlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;One fairly frequent driver mutation is KRAS(G12C). As of 2019, this allowed the development of electrophilic KRAS inhibitors that can form irreversible covalent bonds with nucleophilic sulfur atom of Cys-12 (Cysteine-12) and hence selectively target KRASG12C and leave wild-type KRAS untouched.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Flogseq____&quot;,435,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[422,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c898-4f27-b519-8e81ad1b8ec8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is called *KRAS* because it was first identified as a viral oncogene in the Kirsten rat sarcoma virus.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Flogseq____&quot;,419,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Vlogseq____&quot;,419,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[423,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d074-458e-b82d-5f87ef172beclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A single amino acid substitution, and in particular a single nucleotide substitution, is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, lung cancer or leukemias.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Flogseq____&quot;,418,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[424,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5e79-43af-b10d-7b2a7c03618alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Prevalence of KRAS G12C Mutations\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Flogseq____&quot;,420,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[425,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-53b4-4315-b720-cba9515cab7dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Once it is allosterically activated, it recruits and activates proteins necessary for the propagation of growth factors, as well as other cell signaling receptors.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Flogseq____&quot;,433,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[426,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1310-4fe8-b456-4bc37efccb3alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Flogseq____&quot;,439,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[427,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5363-4dbe-a1e7-abcedc9b7d80logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Flogseq____&quot;,419,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[428,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2f80-45ff-976e-884facfd55f6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Flogseq____&quot;,424,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[429,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7517-447c-bada-8bff5d764050logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The [[KRAS p.G12C]] mutation occurs in approximately 13% of non–small-cell lung cancers. It occurs in roughly 1-3% of colorectal cancers and other solid tumors.logseq____&quot;,536871774]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Flogseq____&quot;,425,536870916]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Ulogseq____&quot;,416,536871775]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Ulogseq____&quot;,441,536871775]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871774]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^Hlogseq____&quot;,441,536871774]],[logseq____&quot;^15logseq____&quot;,[430,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f105-482e-854a-63e7c09aea67logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![image]logseq____&quot;,536871765]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Flogseq____&quot;,436,536870916]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^Ulogseq____&quot;,416,536871758]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871765]],[logseq____&quot;^15logseq____&quot;,[431,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1f0a-4c72-9c07-89e8e5a3f6c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is only able to transmit signals if it is attacked to a GTP molecule and inactivated when it converts the GTP to GDP. When bound to GDP, the protein does not relay signals to the nucleus.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Flogseq____&quot;,433,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Vlogseq____&quot;,433,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[432,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f2b7-4d57-99ad-38d8f408d5a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The K-Ras protein is a GTPase, a class of enzymes which convert the nucleotide guanosine triphosphate (GTP) into guanosine diphosphate (GDP).  In this way the K-Ras protein acts like a switch that is turned on and off by the GTP and GDP molecules.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Flogseq____&quot;,428,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[433,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ac65-4b68-b3ea-831cbb86ad26logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# KRAS\\nheading:: 1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Flogseq____&quot;,417,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[434,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eab1-4d3b-8d3a-e3f8a5017f34logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### G12C Mutation\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Flogseq____&quot;,427,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[435,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-67c3-4330-8cd9-58d89d538b65logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Flogseq____&quot;,422,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[436,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c141-43ab-b358-98d6046338e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Flogseq____&quot;,431,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[437,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7b94-439e-b8ad-2c4460ab3fdclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Surface model of a KRASG12C protein, showing a GDP molecule (orange) and sotorasib occupying an adjacent \\logseq____&quot;cryptic\\logseq____&quot; binding pocket. Sotorasib forms an irreversible bond with a cysteine residue and disrupts function of the mutated protein.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Flogseq____&quot;,431,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Vlogseq____&quot;,431,536870916]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^Ulogseq____&quot;,416,536871766]],[logseq____&quot;^15logseq____&quot;,[438,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-12ba-48b9-9b7e-0e933b346150logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Flogseq____&quot;,429,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Xlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Vlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[439,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5032-4d17-8b7a-6f707c754c41logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^Klogseq____&quot;,1691874784771,536870916]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;kras p.g12clogseq____&quot;,536871769]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^11logseq____&quot;,logseq____&quot;KRAS p.G12Clogseq____&quot;,536871769]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871705]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^Blogseq____&quot;,1691877359168,536871705]],[logseq____&quot;^15logseq____&quot;,[441,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8b6b-400a-8041-5b693b9721fdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Specific mutation of [[KRAS G12C]].logseq____&quot;,536871705]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Flogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Xlogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Vlogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Ulogseq____&quot;,416,536871702]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Ulogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871705]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^Hlogseq____&quot;,416,536871705]],[logseq____&quot;^15logseq____&quot;,[443,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c7ec-46a0-8bab-fd09de780d69logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Flogseq____&quot;,443,536871702]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Xlogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Vlogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^Ulogseq____&quot;,441,536870916]],[logseq____&quot;^15logseq____&quot;,[445,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f0af-4e9a-a677-bf31012abf4dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# KYPROLISlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Flogseq____&quot;,458,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[447,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1842-4d14-9e99-346457813700logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Several clinically significant adverse reactions are described, including cardiac toxicity, acute renal failue, tumor lysis syndrome, pulmonary toxicity, hepatic toxicity, thrombotic events, blood-related problems, posterior reversible encephalopathy syndrome or progressive multifocal leukoencephalopathy among others. It is also strongly noted that proper hydration should be ensured in order to avoid renal complications.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Flogseq____&quot;,449,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[448,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9fe8-4b39-971f-cba84932e19clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Flogseq____&quot;,454,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[449,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e149-4ab6-88e2-e2d252389514logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Flogseq____&quot;,451,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[450,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9313-4bc8-856f-fdaf8ce8886flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Flogseq____&quot;,457,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[451,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a1a0-46ed-bbd2-63b585af93delogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Flogseq____&quot;,456,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[452,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f47-4051-92bf-51985e7ce270logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Prescribing Information - PDF](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/kyprolis/kyprolis_pi.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Flogseq____&quot;,455,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[453,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4bfa-4832-b1ee-d42b35054ec7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Officially, it is indicated for adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with certain other agents or as a single agent in patients who have received one or more lines of therapy. It comes in 10 mg, 30 mg or 60 mg of lyophilized powder in single-dose vials for reconstitution for injection as a continuous intravenous infusion. Depending on the combination that is used when KYPROLIS prescribed, which include Dexamethasone, intravenous or subcutaneous Daratumurab, Isatuximab, hyaluronidase-fihj or when none are used, administration is performed once or a week for a duration of 10 or 30 minutes in various strengths. In the case of Kyprolis, Lenalidomide and Dexamethasone (termed *\\logseq____&quot;KRd\\logseq____&quot;*), twice weekly for 10 minutes.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Flogseq____&quot;,452,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[454,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c187-4f50-8eb1-2cc5c6b96cdclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Krypolis.com](https://www.kyprolis.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Flogseq____&quot;,450,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[455,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-66ae-4c12-83b8-1ecd8d476fd0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;***KYPROLIS*** (*carfilzomib*) is a small molecule proteasome inhibitor (PI) that is in Phase 3 development in a combination with lenalidomide (an immunomodulator) and [[dexamethasone]] (a [[corticosteroid]], specifically glucocorticoid) for the treatment of relapsed/refractory multiple myeloma (MM; a type of cancer involving a certain type of white blood cells called plasma cells, which affects an estimated 175,000 people and results in around 117logseq____&apos;000 deaths per year, globally) and in Phase 2 for the treatment of acute lymphoblastic leukemia (ALL) in pediatric patients. It was approved by the FDA in 2012.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Flogseq____&quot;,447,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Ulogseq____&quot;,120,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Ulogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Hlogseq____&quot;,120,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^Hlogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[456,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2b72-422c-b27d-fa980308aee7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Flogseq____&quot;,448,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[457,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7d7c-47e5-863f-21d7dd7c0908logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Flogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Xlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Vlogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Ulogseq____&quot;,136,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[458,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-64f1-412f-9a00-1d014432ded2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^Klogseq____&quot;,1691874784888,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;lumakras alternative administrationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^11logseq____&quot;,logseq____&quot;Lumakras Alternative Administrationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^Blogseq____&quot;,1691874784888,536870916]],[logseq____&quot;^15logseq____&quot;,[460,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5948-44af-ac4b-783dacb367e6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Information on LUMAKRAS (Product)\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Flogseq____&quot;,468,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[461,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9fe5-448f-be0d-275b8ee71ee9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Pharmacology\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Flogseq____&quot;,568,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[462,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-dd35-42b3-934d-8607e454af1dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;55% of patients were female.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Flogseq____&quot;,498,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[463,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d515-4f11-adde-59698af1ae6elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Serious adverse reactions** were observed in 50% of patients, including:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Flogseq____&quot;,508,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[464,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5082-4446-8e36-bf88afd8cb23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lumakras is approved by the FDA to treat KRAS G12C mutation-driven non-small-cell lung cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Flogseq____&quot;,543,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[465,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-71fc-4151-a96e-3899b049d875logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Flogseq____&quot;,526,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Vlogseq____&quot;,503,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[466,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b467-4e24-ab7d-c921ff3d7ed4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Further reading: Sotorasib Clinical Study (NEJM) - https://www.nejm.org/doi/10.1056/NEJMoa1917239)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Flogseq____&quot;,518,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[467,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-733e-4268-9852-ffe28d032716logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Flogseq____&quot;,484,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[468,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f9e6-46ae-a9d1-ea1244043f1alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Flogseq____&quot;,504,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[469,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-73a9-48d6-a5c5-1954c23d20b0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;0.6% had Grade 4 ALT/AST elevation.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Flogseq____&quot;,574,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Vlogseq____&quot;,515,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[470,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2eb4-4b1b-83f0-64abbcc12163logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Musculoskeletal pain (3.9%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Flogseq____&quot;,489,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Vlogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[471,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-702b-4981-87c6-0d71ead16905logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Flogseq____&quot;,536,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[472,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b7eb-4654-abe7-0b59f7e511a6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Co-administration with **breast cancer resistance protein (BCRP) substrates** should also be avoided, as sotorasib is a BCRP-inhibitor, which increases its plasma concentrations. If co-administration is necessary, patients should be monitored for adverse effects, and the BCRP substrate dosage should be decreased.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Flogseq____&quot;,598,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[473,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f440-41c3-a2be-4cc942fb185alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Fatal adverse reactions** occurred in 3.4% of patients, with various causes.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Flogseq____&quot;,464,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[474,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b67c-4a6c-8d3e-640661b94181logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; *[Prescribing Information (PDF)](https://www.pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf)*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Flogseq____&quot;,473,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[475,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-96d1-43cf-9e07-f7fbce857fd4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;7% of patients had a dose interruption or reduction.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Flogseq____&quot;,493,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[476,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ebfd-4ed8-b9a0-60600b445c6blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Hepatotoxicity (11%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Flogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Vlogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[477,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6836-4027-ad88-c680c006e56clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![](https://www.lumakrashcp.com/-/media/Themes/Amgen/Lumakrashcp-com/Lumakrashcp-com/images/8-120-pill.png?la=enlogseq____&amp;hash=73D2DEDBE8D1F1880E2DC7750D8C19C7){:height 126, :width 221} ![](https://5.imimg.com/data5/SELLER/Default/2022/4/JT/IE/OT/142062645/lumakras-sotorasib-120mg-500x500.png){:height 182, :width 178}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Flogseq____&quot;,565,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[478,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b4e6-4125-bba3-21cd60751324logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Dose reductions** due to adverse reactions were reported in 5% of patients, primarily due to increased levels of ALT (2.9%) and AST (2.5%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Flogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[479,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d88f-41d0-89fe-96fd32d82356logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**0.8% of patients developed ILD/pneumonitis**. All cases were Grade 3 or 4 at onset; and 1 case was fatal.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Flogseq____&quot;,596,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Vlogseq____&quot;,596,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[480,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-006e-4425-8f8b-a0c57b36389dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;LUMAKRAS® is a trademark of [[Amgen]] Inc.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Flogseq____&quot;,465,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Ulogseq____&quot;,73,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^Hlogseq____&quot;,73,536870916]],[logseq____&quot;^15logseq____&quot;,[481,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9850-4384-bc46-c710b2a181bclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Flogseq____&quot;,488,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[482,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ef02-4133-b661-3b8fb8b63aaelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Flogseq____&quot;,472,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[483,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-23e0-46c5-bf31-c48f3a0da913logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Flogseq____&quot;,593,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[484,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d5af-4b2d-bf67-1b65128d98f9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Efficacy\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Flogseq____&quot;,564,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[485,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7745-4d14-b468-99f9de8a78fblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Patients should be monitored for new or worsening pulmonary symptoms indicative of the disease. Patients with suspected ILD/pneumonitis should immediately withhold and permanently discontinue Lumakras, if no other potential causes for ILD/pneumonitis are identified.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Flogseq____&quot;,596,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[486,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-97e0-4439-95cc-bbf9addd65c6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Flogseq____&quot;,475,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[488,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-782c-4e5d-ad3c-0b3a219a4a0clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Diarrhea (8%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Flogseq____&quot;,477,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Vlogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[489,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e48e-4eae-b6bd-d534a8df88c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lumakras should not be co-administered with **antacids** (proton pump inhibitors (PPIs) / H2 receptor antagonists) due to the pH-dependent solubility of sotorasib, which reduces its efficacy. If co-administration is necessary, Lumakras should be taken either 4 hours before or 10 hours after the antacid.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Flogseq____&quot;,521,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[490,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6cd8-4fe3-9626-66e5974ec100logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;3. and **the patient has undergone at least one prior systemic treatment** for their cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Flogseq____&quot;,523,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Vlogseq____&quot;,517,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[491,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-00c2-462c-ad37-2d35021e9300logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;80% were White, 15% were Asian, and 3% were Black.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Flogseq____&quot;,463,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[492,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3fe0-4181-8fb8-8c917a29c7aclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The median time to first onset of hepatotoxicity was 9 weeks (range: 0.3 - 42).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Flogseq____&quot;,515,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[493,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-da37-47a0-8fbb-935dfc733c66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In summary, **sotorasib targets tumors that are driven by the [[KRAS p.G12C]] mutation and inhibiting the mutated gene, in turn preventing KRAS p.G12C-expressing tumor cells from proliferating, while leaving KRAS in healthy cells unaffected.**logseq____&quot;,536871778]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Flogseq____&quot;,503,536870916]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Ulogseq____&quot;,132,536871779]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Ulogseq____&quot;,441,536871779]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871778]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^Hlogseq____&quot;,441,536871778]],[logseq____&quot;^15logseq____&quot;,[495,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-37c4-481f-872f-aa467cbf4d9elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;No overall differences in safety or effectiveness were observed between older and younger patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Flogseq____&quot;,514,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[496,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3e92-49ac-b454-241bdbc8af61logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There is an indicated technique for liquid dispersion, if the patient has difficulties swallowing: Patients must disperse tablets in non-carbonated, room-temperature water, stir for 3 min., swallow dispersion without chewing, then rinse with more water. -logseq____&gt; [[Lumakras Alternative Administration]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Flogseq____&quot;,597,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Vlogseq____&quot;,597,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^Hlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[497,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-934b-4ffc-9a57-68aee97adc9flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The median age of patients was 66 years (range: 37 - 86)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Flogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[498,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3af9-40b5-bde1-f97bb1968666logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*Grades are defined by the National Cancer Institute Common Terminology Criteria for Adverse Events (NCICTCAE) version 5.0*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Flogseq____&quot;,537,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[499,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-106b-40bf-9405-f6eae7d61f8blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Sotorasib is an anti-cancer medication. It is classified as an *inhibitor of the RAS GTPase family*, or *KRAS inhibitor*, and is the first compound of its class to reach the market.logseq____&quot;,536871675]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Flogseq____&quot;,535,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871675]],[logseq____&quot;^15logseq____&quot;,[500,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c796-4640-9ce3-64b32b7ee2ablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;2% of patients discontinued treatment.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Flogseq____&quot;,476,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[501,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4c7e-4951-ac3d-b94f89bbd9celogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Information on FDA-approved tests for the detection of KRAS G12C mutations - http://www.fda.gov/CompanionDiagnosticslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Flogseq____&quot;,594,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[502,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e078-4825-b268-ba75ac3c50b0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It targets a specific mutation, the *G12C mutation*, in the protein *K-Ras* encoded by the gene *KRAS*. It locks the protein in its inactive state by irreversibly bonding to it, preventing tumor cell signaling through the *KRAS p.G12C* mutant and inhibits growth of *KRAS p.G12C*-expressing tumor cells. It also promotes *apoptosis* (programmed cell death). Sotorasib only targets the G12C mutant and ignores non-mutated KRAS genes within healthy cells.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Flogseq____&quot;,462,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[503,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8ab8-436a-af94-36d2eda233d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Flogseq____&quot;,529,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[504,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f63-464a-a561-138009a21589logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;No overall differences in safety or effectiveness were observed between older and younger patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Flogseq____&quot;,541,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[505,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2dcf-4430-a44e-1198e5971be0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Co-administration with strong **CYP3A4 substrates** should also be avoided, as this may increase or decrease the plasma concentration of a substrate drug. If co-administration is necessary, substrate dosages need to be adjusted to avoid the risk of treatment failure.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Flogseq____&quot;,553,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[506,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-513a-41a3-992b-0cf8a51f33d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Liver function tests (ALT, AST, and total bilirubin) should be monitored prior to the start of Lumakras, every 3 weeks for the first 3 months of treatment, then once a month or as clinically indicated, with more frequent testing in patients who develop these elevations.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Flogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[507,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-40d3-4a00-96ad-2f831ba3d589logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;39% of patients were exposed for 6 months or longer, 3% were exposed for greater than one year.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Flogseq____&quot;,492,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[508,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-66b3-4527-ada4-6fff7a9296d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Median time to first onset was 2 weeks (range: 2 - 18 weeks).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Flogseq____&quot;,480,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Vlogseq____&quot;,596,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[509,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-59f9-4d44-bdad-f78e07d90ac3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Flogseq____&quot;,550,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[511,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ee1e-40de-9bce-102b9014f7belogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Lumakras has the potential to cause Interstitial Lung Disease (ILD)/Pneumonitis, which is a severe condition and can be fatal.**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Flogseq____&quot;,585,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[513,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d522-47b5-a737-6ea87ca42b2dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Flogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[514,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0b67-437f-a071-79a1095c9064logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;18% of patients had increased ALT/AST levels:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Flogseq____&quot;,567,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[515,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e5b1-420c-8dd3-6623d7e26640logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Diarrhea (2%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Flogseq____&quot;,528,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Vlogseq____&quot;,464,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[516,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c037-4acf-a969-cac9c66c43fdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lumakras is approved for use in **_adults_ with non-small-cell lung cancer**, if they fit the following criteria:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Flogseq____&quot;,531,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[517,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-552d-447c-ad91-e2936c3aeac5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ref: NCI Drug Dictonary: Sotorasib - https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotorasiblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Flogseq____&quot;,555,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[518,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-58b8-44c0-b69a-cc08dbff9d5clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Permanent discontinuation** due to adverse reactions was necessary in 9% of patients, with the primary reason being hepatotoxicity (4.9%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Flogseq____&quot;,474,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[519,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d405-4b18-a79b-8d995bf3e3ealogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Pharmacokinetics\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Flogseq____&quot;,527,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[520,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-563a-430c-a6ae-d117a881eb17logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Interactions\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Flogseq____&quot;,469,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[521,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6924-44df-acb6-2b19937bb300logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Important: *Because clinical trials are conducted under widely varying conditions, adverse reaction rates cannot be directly compared to rates of another drug, and may not reflect the rates observed in practice*.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Flogseq____&quot;,600,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[522,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-54cf-4491-b573-bb4d232c8018logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;2. the cancer **is locally advanced or has metastasized**, or **cannot be removed by surgery.**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Flogseq____&quot;,601,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Vlogseq____&quot;,517,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[523,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-646c-4542-9677-b0a23b366c14logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Flogseq____&quot;,1399,536871506]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[524,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-91e6-4467-9a11-c606c0ac36d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; *Further reading: [Sotorasib Clinical Study (NEJM)](https://www.nejm.org/doi/10.1056/NEJMoa1917239)*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Flogseq____&quot;,546,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Vlogseq____&quot;,503,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[526,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4690-4ec0-861c-e51ca22df3dalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Flogseq____&quot;,495,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[527,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7772-4305-ac9e-713f9f4f5245logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Hepatotoxicity (3.4%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Flogseq____&quot;,575,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Vlogseq____&quot;,464,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[528,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-126f-4e47-8078-8336e6ed55edlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Flogseq____&quot;,602,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[529,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d736-43bb-a790-eceeb2d9b1d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Flogseq____&quot;,505,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[530,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b644-454e-9981-dd43aa102f16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; *[Patient Information](https://www.pi.amgen.com/united_states/lumakras/lumakras_ppi_pt_english.pdf)*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Flogseq____&quot;,581,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[531,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6874-49b0-893a-03461af11691logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Flogseq____&quot;,482,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[532,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-03cc-4036-8e6c-c2f413f78779logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[*Product Website | Lumakras.com*](https://lumakras.com)logseq____&quot;,536871611]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Flogseq____&quot;,481,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871611]],[logseq____&quot;^15logseq____&quot;,[533,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4708-4fec-808e-c18327f37245logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;2% were *complete response* (*CR*; complete disappearance of all tumor lesions).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Flogseq____&quot;,576,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Vlogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[534,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9988-4586-8867-549144681d70logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In the field of molecular biology in drugs, sotorasib is termed a [[small molecule]] .logseq____&quot;,536871631]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Flogseq____&quot;,548,536870916]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Ulogseq____&quot;,132,536871632]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Ulogseq____&quot;,1398,536871632]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871631]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^Hlogseq____&quot;,1398,536871631]],[logseq____&quot;^15logseq____&quot;,[535,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b5cd-4616-ae74-849878f1d728logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Flogseq____&quot;,522,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[536,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4154-43a2-89ac-f1b12df8687elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Toxicity of LUMAKRAS\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Flogseq____&quot;,588,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[537,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-18b6-4f09-af82-2ff78fddbc40logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Flogseq____&quot;,542,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[539,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-919c-4fe5-8c5a-2f861a14e32elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Flogseq____&quot;,557,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[540,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8338-4168-9640-9b5dbf80de09logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Flogseq____&quot;,486,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[541,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-941c-4ecc-9785-bf53752b88eclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Flogseq____&quot;,556,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[542,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f2ed-471b-87a5-bf32b7a12fc3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### Current Status of Lumakras\\nheading:: 4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Flogseq____&quot;,524,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[543,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c47a-4121-bda1-fcbc44a9f204logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**1.7% of patients experienced hepatotoxicity** (all grades)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Flogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[544,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-203a-4932-bbd6-22936e1bf19dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Flogseq____&quot;,530,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[545,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fe92-486c-b1b7-a28411b42464logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; See [[KRAS G12C]]\\n-logseq____&gt; Ref: [NCI Drug Dictonary: Sotorasib](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotorasib)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Flogseq____&quot;,503,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Vlogseq____&quot;,503,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^Hlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[546,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f996-41e3-b468-b81a1e365c66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**LUMAKRAS** (**sotorasib, AMG 510**) is a [[small molecule]] anti-cancer drug used for adults with [[non-small-cell lung cancer]] (NSCLC) who have cancer locally advanced or metastasized, or that cannot be eliminated through surgery, and who have previously received at least one other systemic treatment. **It is specifically used in patients the harbor the [[KRAS G12C]] gene mutation, which 10-15% of patients with NSCLC harbor**.logseq____&quot;,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Flogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Ulogseq____&quot;,296,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Ulogseq____&quot;,416,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Ulogseq____&quot;,1398,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Hlogseq____&quot;,296,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Hlogseq____&quot;,416,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^Hlogseq____&quot;,1398,536871608]],[logseq____&quot;^15logseq____&quot;,[547,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5706-4feb-8062-25b43f6381fflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Properties of Sotorasib\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Flogseq____&quot;,511,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[548,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9971-4a50-9692-259dfad4e13blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The safety of LUMAKRAS was evaluated in a *subset* of patients with KRAS G12C-mutated locally advanced or metastatic NSCLC in CodeBreak_100.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Flogseq____&quot;,582,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[549,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9cd7-4f4f-aa01-9bd001b46dbdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Flogseq____&quot;,551,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[550,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d1fd-495d-9307-54eb970db9aalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Flogseq____&quot;,533,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[551,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ebfa-4854-a7a7-a7d96e4d0ebblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The *objective response rate* (*ORR*; percentage of patients who experience tumor shrinkage) was 36% among patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Flogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Vlogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[552,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-897d-4da2-906f-558c960e25c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Co-administration with strong **CYP3A4 inducers** should be avoided, as this combination increases the metabolism of sotorasib, is a CYPA34 substrate. As a result, this combination reduces its efficacy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Flogseq____&quot;,490,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[553,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a2e6-4deb-b0e6-c7df15c064d2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prescribing Information (PDF) - https://www.pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Flogseq____&quot;,467,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[554,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-123a-40ec-b0ac-7e7b4dc4fda3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Product Website - https://lumakras.comlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Flogseq____&quot;,559,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[555,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0918-4075-8643-8c7eef09b841logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Although uncommon, serious side effects can be fatal and include **hepatotoxicity** with symptoms such as jaundice, dark urine, light-colored stools, tiredness, weakness, bleeding, bruising, appetite loss, and musculoskeletal pain. Additionally, this medication may cause **Interstitial Lung Disease (ILD)/Pneumonitis**, with symptoms such as shortness of breath, cough, and fever. It is important to monitor for any concerning symptoms and report them to a healthcare provider promptly. Routine laboratory monitoring is recommended to detect any changes in liver or blood tests.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Flogseq____&quot;,540,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[556,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2df0-404c-ad42-e2be729d149blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Common side effects include diarrhea, muscle or bone pain, nausea, tiredness, hepatotoxicity, cough, changes in liver and certain blood tests, among others.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Flogseq____&quot;,577,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[557,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8473-46ba-96ae-c53d5de115d3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Another subset of the study (n = 124 patients) evaluated Lumakraslogseq____&apos; efficacy and concluded:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Flogseq____&quot;,485,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[558,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-83d7-41d2-a756-1f14414860e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Links\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Flogseq____&quot;,483,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[559,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4e5a-4026-a72a-bf975bf7b080logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Flogseq____&quot;,517,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[560,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-de67-42e4-80c8-a665fcce9bfflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Lumakras is known to cause hepatotoxicity**, which may lead to drug-induced liver injury and hepatitis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Flogseq____&quot;,589,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[561,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-11b0-462c-9736-70cd7f70f4e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Flogseq____&quot;,497,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Vlogseq____&quot;,597,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[562,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1725-44cc-8ea5-c900adcc7c8elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Flogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[564,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9009-4d2d-974d-31f55afc850flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Formulation\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Flogseq____&quot;,1402,536871621]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[565,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d1f7-4448-9518-2bd59019c98dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;1.4% of patients had Grade 3 hepatotoxicity.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Flogseq____&quot;,544,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Vlogseq____&quot;,587,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[567,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b08d-4e8a-b9f5-6c7304ca5539logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Flogseq____&quot;,1403,536871641]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[568,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d486-4453-b251-a20fe805aee7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Flogseq____&quot;,603,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[569,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7faa-4b29-a95a-ad107715e99alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Flogseq____&quot;,502,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[572,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3c26-424c-93e1-a363e433d567logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Pneumonia (2.5%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Flogseq____&quot;,592,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Vlogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[573,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-07a2-4628-9ffd-3a4d7973df85logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;6% of these were Grade 3 ALT/AST elevation.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Flogseq____&quot;,515,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Vlogseq____&quot;,515,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[574,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2c20-474a-b2cd-4652719f9ba9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Pneumonia (8%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Flogseq____&quot;,464,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Vlogseq____&quot;,464,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[575,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d619-49c3-86a6-1870bd1beff6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;35% were *partial response* (*PR*; reduction in tumor size by at least 30%).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Flogseq____&quot;,552,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Vlogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[576,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8191-4d5d-8989-3b0e4d9816c5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## What Are The Side Effects?\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Flogseq____&quot;,569,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[577,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b45f-4c67-b3e5-c5f94ffb4418logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**It is not known if Lumakras is safe for children or during pregnancy**, since there is no human data available and should not be used in these patients. Animal models may suggest that toxicity in pregnant subjects may not be clinically significant at the recommended dosage. **It is also not known, if lactation (breast feeding) if safe on Lumakras**, and should be avoided for one week after treatment.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Flogseq____&quot;,560,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[579,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0691-4030-80b4-09027ba4e229logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Dosage interruptions** due to adverse reactions were reported in 34% of patients, with the most common reasons being:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Flogseq____&quot;,519,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Vlogseq____&quot;,586,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[580,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-be42-4644-a329-f51523825959logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Who Receives This Treatment?\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Flogseq____&quot;,532,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[581,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e02d-44fc-9ce6-d5734186d3aflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Safety\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Flogseq____&quot;,584,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[582,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-482e-4d10-9c18-a60e3d488ab3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;58% of patients in that subset had a duration of response of 6 months or longer, with the median being 10.0 months.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Flogseq____&quot;,534,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Vlogseq____&quot;,558,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[583,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-cefc-4362-ab52-04a39b1f5824logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Safety and Efficacy of LUMAKRAS\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Flogseq____&quot;,545,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[584,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c5b3-42b6-be40-f13286dbb357logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Interstitial Lung Disease\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Flogseq____&quot;,599,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[585,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b8e4-42f5-ba80-be9e82be5aa5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Among 204 patients who have received Lumakras at 960mg orally once daily until \\logseq____&quot;disease progression or unacceptable toxicity\\logseq____&quot;:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Flogseq____&quot;,549,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[586,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-72b7-4ca7-91ed-65cc345a9ddalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a clinical study involving 357 patients:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Flogseq____&quot;,561,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[587,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-07a0-4654-bcee-5ca3b31b899dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Flogseq____&quot;,539,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[588,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-45c0-4dec-a7e1-04d3ab983471logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Liver Toxicity\\nheading:: 3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Flogseq____&quot;,595,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[589,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-87f1-4342-b9d3-99d67975693elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;0.6% had discontinued Lumakras.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Flogseq____&quot;,509,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Vlogseq____&quot;,596,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[590,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-79d1-416f-b1de-43e00e4dea3blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Information on FDA-approved tests for the detection of KRAS G12C mutations](http://www.fda.gov/CompanionDiagnostics)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Flogseq____&quot;,601,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Vlogseq____&quot;,601,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[591,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5726-4b93-89e4-226b7e2e08aelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nausea (2.9%)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Flogseq____&quot;,471,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Vlogseq____&quot;,580,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[592,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ed09-48ea-add3-fc5281d34539logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Peak plasma concentration is reached in 1 hour. High-fat, high-calorie meals increase AUC0-24h by 24% compared to fasted administration. The terminal half-life is 5 hours (standard deviation (SD) ±2).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Flogseq____&quot;,520,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[593,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3f69-4cec-87c8-68cbf31c7df9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Patient Information - https://www.pi.amgen.com/united_states/lumakras/lumakras_ppi_pt_english.pdflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Flogseq____&quot;,554,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[594,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ef5d-4f01-b80d-57c08b35862alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Flogseq____&quot;,499,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[595,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0de3-42c4-be2a-0c0776a6e781logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a clinical study, involving 357 patients:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Flogseq____&quot;,513,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[596,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fc32-4c2e-bb7f-fc71fa168813logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lumakras (sotorasib) comes in tablets of **120mg** or **320mg**. The recommended dose is **960mg taken once daily** (3 or 8 tablets). It is intended to be taken by mouth, with or without food and for a duration a\\logseq____&quot;until disease progression or unacceptable toxicity\\logseq____&quot;.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Flogseq____&quot;,478,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[597,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-95f2-486c-9a6c-f60aadba1a04logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Co-administration with **P-gt substrates** should be avoided, and if not possible, substrate dosages need to be adjusted to minimize the risk of treatment failure.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Flogseq____&quot;,506,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[598,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-907b-4cab-9100-336efe37274blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Flogseq____&quot;,507,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[599,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-428f-4f42-a7da-08c3b62b789blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Flogseq____&quot;,496,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[600,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a4f5-4c10-b9a7-894e2103d3d3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;1. **Have the KRAS G12C gene mutation**  (in tumor or plasma specimens).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Flogseq____&quot;,517,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Vlogseq____&quot;,517,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[601,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1fa5-47aa-8ad5-a5908c27e4dflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Dosage reductions for adverse reactions]]: Dosage reductions should be limited to a maximum of two dosage reductions. Lumakras is to be discontinued if the patient does not tolerate the minimum dosage of 240mg.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Flogseq____&quot;,597,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Ulogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^Hlogseq____&quot;,362,536870916]],[logseq____&quot;^15logseq____&quot;,[602,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f542-486c-90e8-73b68d454f1dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Flogseq____&quot;,579,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Xlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Vlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[603,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-75c7-4ff2-af63-a4a269d1ab19logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^Klogseq____&quot;,1691874785025,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;large cell carcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^11logseq____&quot;,logseq____&quot;Large cell carcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^Blogseq____&quot;,1691874785025,536870916]],[logseq____&quot;^15logseq____&quot;,[605,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e9ee-4089-a137-0908a5e10824logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^Klogseq____&quot;,1691874785276,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;squamous cell carcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^11logseq____&quot;,logseq____&quot;Squamous Cell Carcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^Blogseq____&quot;,1691874785276,536870916]],[logseq____&quot;^15logseq____&quot;,[606,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8150-457e-ad9e-1b137351eef7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Flogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[607,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-04aa-4d3a-83d5-9da66184358clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Flogseq____&quot;,607,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[608,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a91f-45c4-9f60-32ab448f9316logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Large Cell Lung Carcinoma\\nheading:: 1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Flogseq____&quot;,608,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[609,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-30d6-4f07-abc1-44085c9c4eb2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Flogseq____&quot;,609,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[610,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e19d-4f8b-88c8-60f66c422597logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Large cell lung carcinoma** (LCLC) is a rare form of NSCLC, accounting for only 10 to 15 percent of all diagnoses. It can occur anywhere in the lung and tends to be aggressive. It affects almost entirely smokers, similar to [[Squamous Cell Carcinoma]].logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Flogseq____&quot;,610,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^Hlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[611,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8248-401f-a0d1-b6844ae640aclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Flogseq____&quot;,611,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[612,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-744d-42d9-90cd-6cda9ad7fe91logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Flogseq____&quot;,612,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[613,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-480f-430d-ada9-478df461aea0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Flogseq____&quot;,613,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Xlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Vlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[614,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-83e5-43ff-917b-9a70d91652cdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Flogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Vlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[616,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-42e4-4a6e-8366-9f6a769e7098logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### Administration to Patients Who Have Difficulty Swallowing Solids\\nheading:: 4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Flogseq____&quot;,616,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Vlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[617,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-90b4-4043-ad33-f3c0d571b258logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*Excerpt from patient information:*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Flogseq____&quot;,617,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Vlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[618,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6b49-487a-9bbf-99bcb491e12elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; Disperse tablets in 120 mL (4 ounces) of non-carbonated, room-temperature water without crushing. No other liquids should be used. Stir or swirl the cup for approximately 3 minutes until tablets are dispersed into small pieces (the tablets will not completely dissolve) and drink immediately or within 2 hours. The appearance of the mixture may range from pale yellow to bright yellow. Swallow the tablet dispersion. Do not chew pieces of the tablet. Rinse the container with an additional 120 mL (4 ounces) of water and drink. If the mixture is not consumed immediately, stir the mixture again to ensure that tablets are dispersed.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Flogseq____&quot;,618,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Vlogseq____&quot;,618,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[619,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d90d-464d-9aa0-a0af3f20875clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Flogseq____&quot;,618,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Vlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[620,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8e86-49d7-a0c4-381f515e70d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Patients must disperse tablets in non-carbonated, room-temperature water, stir for 3 min., swallow dispersion without chewing, then rinse with more water.\\nid:: 63f922bc-86fe-4bf3-bdfd-bde6869e1e0alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Flogseq____&quot;,620,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Xlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Vlogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Ulogseq____&quot;,460,536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f922bc-86fe-4bf3-bdfd-bde6869e1e0alogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f922bc-86fe-4bf3-bdfd-bde6869e1e0alogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[621,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63f922bc-86fe-4bf3-bdfd-bde6869e1e0alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^Klogseq____&quot;,1691874785036,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;lung cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^11logseq____&quot;,logseq____&quot;Lung Cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^Blogseq____&quot;,1691874785036,536870916]],[logseq____&quot;^15logseq____&quot;,[623,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ecc5-47d1-9173-d44c411f4639logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^Klogseq____&quot;,1691874785318,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;small cell lung cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^11logseq____&quot;,logseq____&quot;small cell lung cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^Blogseq____&quot;,1691874785318,536870916]],[logseq____&quot;^15logseq____&quot;,[624,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8d69-4f05-b9ff-8361e80e4136logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Flogseq____&quot;,647,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[625,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6700-4b8a-b21a-082a0224e45alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lung cancer is a type of cancer that originates in the lung tissue.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Flogseq____&quot;,644,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[626,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3863-4fd0-928a-6a629ff04ba0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Many people with lung cancer do not experience any symptoms in the early stages of the disease, and they worsen as the disease progresses. --logseq____&gt; [(MedicinePlus)](https://medlineplus.gov/ency/article/007194.htm)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Flogseq____&quot;,635,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[627,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6a53-4473-811c-6df9fde0a325logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Treatment: Treatment options for lung cancer may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The specific treatment plan depends on the stage and type of the cancer, as well as the patientlogseq____&apos;s age, overall health, stage of the cancer and side effects of the treatments.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Flogseq____&quot;,649,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[628,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4aa3-4e85-a820-13fda96b1f57logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Flogseq____&quot;,627,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[629,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eead-41d5-9c40-66d835122d37logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Flogseq____&quot;,628,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[630,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f657-4813-aacf-c516408f9ad2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;This page is a short summary of the most basic aspects of lung cancer, and is by no means complete.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Flogseq____&quot;,642,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[631,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0072-47ec-84f4-3553a2013d25logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Flogseq____&quot;,626,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[632,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c7cf-4725-8180-2b1fdcdc67e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Smoking is the leading cause of lung cancer**. Other risk factors include exposure to secondhand smoke, exposure to radon, asbestos and other carcinogens, including air pollution, and a family history of lung cancer or previous HIV infection. Genetics can also play a role. In general, DNA damage appears to be the primary underlying cause of cancer.\\nid:: d303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Flogseq____&quot;,634,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;d303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;d303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[633,logseq____&quot;^;logseq____&quot;,logseq____&quot;~ud303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Flogseq____&quot;,638,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[634,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-36bd-4ee8-a13c-03979e4ffb23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Common symptoms of lung cancer may include a persistent cough, chest pain, shortness of breath, wheezing, hoarseness, blood in mucus or sputum, lung infections (bronchitis or pneumonias), fatigue, weight loss, appetite loss, feeling weak, being very tired, having trouble swallowing, swelling in the face or neck among others.\\nid:: 63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Flogseq____&quot;,645,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[635,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The ***incidence*** of lung cancer varies by country and demographic. Globally, lung cancer is the most common cancer found in men and 5th most common cancer in women, and a leading cause of cancer deaths. In 2020, about **2.1 million cases** of lung cancer were diagnosed worldwide, and caused **1.8 million deaths**. 228,820 new cases of lung cancer were reported in the United States and estimated that about 135,720 people in the United States would die from lung cancer.\\nid:: 63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Flogseq____&quot;,648,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[636,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;As for diagnosis, many cases are not detected until they have spread (metastasized) to other areas of the body. *Early detection is important, as treatment is most effective when the cancer is in its early stages.* Lung cancer is usually diagnosed using a combination of imaging tests (such as CT scans or X-rays) and biopsy procedures.\\nid:: 63f33c7c-d11c-41d4-a8ce-45ef9a4501aelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Flogseq____&quot;,629,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f33c7c-d11c-41d4-a8ce-45ef9a4501aelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63f33c7c-d11c-41d4-a8ce-45ef9a4501aelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[637,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63f33c7c-d11c-41d4-a8ce-45ef9a4501aelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*Due to its high incidence and mortality rate, lung cancer is a major public health concern, and ongoing efforts are focused on improving early detection and treatment options.*\\nid:: 63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Flogseq____&quot;,639,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[638,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The **prevalence** of lung cancer is difficult to determine because many cases of lung cancer go undiagnosed until the disease is advanced.\\nid:: 63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Flogseq____&quot;,636,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[639,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Itlogseq____&apos;s important to note that lung cancer can be a complex and serious disease, and early detection and prompt treatment are important for improving outcomes.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Flogseq____&quot;,625,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[640,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f11f-488b-ab7b-2169c8afca43logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Flogseq____&quot;,643,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[641,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-37f9-4e2d-87b2-8d0e4244c6a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Flogseq____&quot;,646,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[642,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a302-48a3-b92c-4ca73759be4clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There are two main types of lung cancer: [[Small Cell Lung Cancer]] (SCLC) and [[Non-Small-Cell Lung Cancer]] (NSCLC).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Flogseq____&quot;,632,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Ulogseq____&quot;,624,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Hlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^Hlogseq____&quot;,624,536870916]],[logseq____&quot;^15logseq____&quot;,[643,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-19a1-4cc5-9316-64189829a5c9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Lung Cancer\\nheading:: 1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Flogseq____&quot;,631,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[644,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bcca-47e8-821e-5a272bc3261elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Flogseq____&quot;,633,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[645,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3973-4c0a-a1ed-f99cc491043blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Flogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[646,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f83c-4147-afed-1151c8cf0932logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prognosis: The prognosis for lung cancer depends on the stage of the disease at the time of diagnosis, as well as other factors such as the patientlogseq____&apos;s age and overall health. In general, earlier stage lung cancer has better prognosis than later stage disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Flogseq____&quot;,630,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[647,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-257b-4ea2-9dc7-4a16835d56ealogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lung cancer is by far the leading cause of cancer deaths in the US, accounting for about 1 in 5 of all cancer deaths.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Flogseq____&quot;,641,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[648,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-aa13-44c7-ae24-567de13246felogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Flogseq____&quot;,637,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Xlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Vlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[649,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5d64-461c-98d0-78f0ae82200alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;MAbs approved by the FDA for cancer include:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Flogseq____&quot;,665,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[651,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-93d8-4e98-8e4b-44a19c953a76logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Rituximablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Flogseq____&quot;,687,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[652,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-64e2-48cd-8769-5e7feac52ffdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Flogseq____&quot;,659,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[653,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-dce9-4a8e-9e2e-4e7a64d0f985logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Flogseq____&quot;,682,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[654,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-edd9-4582-a961-54b75fc97ca1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.cell.com/trends/pharmacological-sciences/comments/S0165-6147(99)01382-6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Flogseq____&quot;,674,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[655,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6d54-4a45-912b-0de3e92c7ecalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Flogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[656,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-675a-4584-905b-f4ebd7faf989logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Alemtuzumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Flogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[657,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0985-46bc-91eb-83469230d276logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Monoclonal](https://en.wikipedia.org/wiki/Monoclonal) antibodies can have monovalent affinity, binding only to the same [epitope](https://en.wikipedia.org/wiki/Epitope) (the part of an [antigen](https://en.wikipedia.org/wiki/Antigen) that is recognized by the antibody). In contrast, [polyclonal antibodies](https://en.wikipedia.org/wiki/Polyclonal_antibodies) bind to multiple epitopes and are usually made by several different antibody-secreting [plasma cell](https://en.wikipedia.org/wiki/Plasma_cell) lineages. [Bispecific monoclonal antibodies](https://en.wikipedia.org/wiki/Bispecific_monoclonal_antibodies) can also be engineered, by increasing the therapeutic targets of one monoclonal antibody to two epitopes.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Flogseq____&quot;,653,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[658,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-df33-4407-bcc9-f5ea6d191835logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Flogseq____&quot;,683,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[659,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-19b5-41f8-93e4-53ca645eb6c9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;One possible treatment for cancer involves monoclonal antibodies that bind only to cancer-cell-specific antigens and induce an immune response against the target cancer cell. Such mAbs can be modified for delivery of a toxin, radioisotope, cytokine or other active conjugate, or to design bispecific antibodies that can bind with their Fab regions both to target antigen and to a conjugate or effector cell.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Flogseq____&quot;,670,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[660,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6be1-47d0-909a-ebf91a1031c5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Gemtuzumab ozogamicinlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Flogseq____&quot;,686,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[661,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f8e1-44d8-a58b-454dee8de0f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Flogseq____&quot;,660,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[662,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ceac-4ad0-929a-3366492971f5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nivolumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Flogseq____&quot;,672,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[663,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0aa8-439e-8c9f-b87b009c05e3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Flogseq____&quot;,662,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[664,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ebfa-4163-ba30-6f795f86f131logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Approved Monoclonal Antibody Drugs for Cancerlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Flogseq____&quot;,664,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[665,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7102-4062-8bde-d2e505d01cdelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Monoclonal antibodies - Wikipedia](https://en.wikipedia.org/wiki/Monoclonal_antibody)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Flogseq____&quot;,677,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[666,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-73e0-46df-a8cf-5f7a5b4f22a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Flogseq____&quot;,656,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[667,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-05db-4551-a3e5-62c471501b0clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Panitumumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Flogseq____&quot;,676,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[668,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6bd1-4853-89b5-a930fa95e5c8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Trastuzumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Flogseq____&quot;,652,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[669,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5701-47ba-9a2c-f5c01cd2532dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Flogseq____&quot;,658,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[670,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e206-4a2f-85ab-3da8a53b4cc7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Pembrolizumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Flogseq____&quot;,668,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[671,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8894-437c-a022-617c094a5cd6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ipilimumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Flogseq____&quot;,661,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[672,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b351-40a0-9548-f4ed1f41cb6elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Like natural antibodies, they are potent and highly selective in terms of the targets they engage. They also tend to stay in the body longer than most other medicines, so in general, they need to be dosed less frequently. Antibody drugs can be used against targets that are outside cells or on the cell surface, but because of their size, they generally can’t reach targets inside cells. It is possible to produce monoclonal antibodies that specifically bind to almost any suitable substance; they can then serve to detect or purify it. This capability has become an investigative tool in [biochemistry](https://en.wikipedia.org/wiki/Biochemistry), [molecular biology](https://en.wikipedia.org/wiki/Molecular_biology), and [medicine](https://en.wikipedia.org/wiki/Medicine). Monoclonal antibodies are being used on a clinical level for both the diagnosis and therapy of several diseases.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Flogseq____&quot;,654,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[673,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6f81-48b7-939a-14eb74e9f436logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Flogseq____&quot;,675,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[674,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2123-4f69-930b-2eb903f6af66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Flogseq____&quot;,667,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[675,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3c63-4684-a481-a53115e1480dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ofatumumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Flogseq____&quot;,663,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[676,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6db8-43a3-a857-f920558cf7e3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Monoclonal Antibodieslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Flogseq____&quot;,685,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[677,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b816-46a5-867e-f88f624a3757logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Monoclonal Antibodies  Amgen](https://www.amgen.com/stories/2018/08/the-shape-of-drugs-to-come/monoclonal-antibody)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Flogseq____&quot;,666,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[678,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6e4c-4ab1-8ea4-cde2ce08efb6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Representation of the method used to produce monoclonal antibodies. [^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Flogseq____&quot;,682,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Vlogseq____&quot;,682,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[679,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6139-4d10-a423-d91cdfc43ef7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A **monoclonal antibody** (**mAb**, more rarely called **moAb**) is an [antibody](https://en.wikipedia.org/wiki/Antibody) produced from a [cell lineage](https://en.wikipedia.org/wiki/Lineage_(evolution)) made by [cloning](https://en.wikipedia.org/wiki/Cloning) a unique [white blood cell](https://en.wikipedia.org/wiki/White_blood_cell). All subsequent antibodies derived this way trace back to a unique parent cell. Monoclonal antibodies are potent and highly selective bioengineered molecules that are designed to target specific proteins involved in disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Flogseq____&quot;,678,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[680,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ab73-40e1-8075-dbae5af13225logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cetuximablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Flogseq____&quot;,684,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[681,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9371-429b-8f19-0708e5d76256logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![300px-Monoclonals.png](../assets/300px-Monoclonals_1687903347411_0.png)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Flogseq____&quot;,680,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[682,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-59ec-461c-b87e-66fa56a9063blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Flogseq____&quot;,673,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[683,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-989c-4ff3-8fc7-164bff827f74logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Bevacizumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Flogseq____&quot;,657,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[684,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1037-45d7-a183-8285aca00b19logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Flogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Vlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[685,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eeee-413f-8609-8a4042c93937logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Dostarlimablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Flogseq____&quot;,681,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[686,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0d82-4533-b807-d9c93d1fee28logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ranibizumablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Flogseq____&quot;,671,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Xlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Vlogseq____&quot;,651,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[687,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6c83-4fec-97ef-286dc796130elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^Klogseq____&quot;,1691874784940,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;most common laboratory resultslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^11logseq____&quot;,logseq____&quot;Most common laboratory resultslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^Blogseq____&quot;,1691874784940,536870916]],[logseq____&quot;^15logseq____&quot;,[689,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9847-4e9c-a69f-bbbb77902891logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;he most common laboratory abnormalities (≥ 25%) were decreased lymphocytes, decreased\\nhemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, decreased calcium, increased alkaline phosphatase, increased urine protein, and decreased sodium.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Flogseq____&quot;,689,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Xlogseq____&quot;,689,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Vlogseq____&quot;,689,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^Ulogseq____&quot;,689,536870916]],[logseq____&quot;^15logseq____&quot;,[690,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3d38-4feb-b2e6-10803b5023e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^Klogseq____&quot;,1691874785419,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;epithelial tissuelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^11logseq____&quot;,logseq____&quot;epithelial tissuelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^Blogseq____&quot;,1691874785419,536870916]],[logseq____&quot;^15logseq____&quot;,[692,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-81b2-4577-ac19-c8111f444941logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^Klogseq____&quot;,1691874785034,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cancer vaccineslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^11logseq____&quot;,logseq____&quot;Cancer vaccineslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^Blogseq____&quot;,1691874785034,536870916]],[logseq____&quot;^15logseq____&quot;,[693,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-19dc-4b99-a037-60796ab70e92logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^Klogseq____&quot;,1691874785027,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^11logseq____&quot;,logseq____&quot;63ee5069-a285-4e6d-a129-86328721a5d8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^Blogseq____&quot;,1691874785027,536870916]],[logseq____&quot;^15logseq____&quot;,[694,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-496e-4fca-9fef-24994bcef805logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^Klogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;neuron-specific enolaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^11logseq____&quot;,logseq____&quot;neuron-specific enolaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^Blogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[695,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0c5a-4cd4-86a2-f2a7e3e6d96blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^Klogseq____&quot;,1691874785034,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;adoptive cell transferlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^11logseq____&quot;,logseq____&quot;Adoptive Cell Transferlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^Blogseq____&quot;,1691874785034,536870916]],[logseq____&quot;^15logseq____&quot;,[696,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-33af-4313-997a-eef3fb5e497flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^Klogseq____&quot;,1691874785033,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cytokineslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^11logseq____&quot;,logseq____&quot;Cytokineslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^Blogseq____&quot;,1691874785033,536870916]],[logseq____&quot;^15logseq____&quot;,[697,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ea71-47a1-b430-ba74cf075e16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^Klogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;surgerylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^11logseq____&quot;,logseq____&quot;Surgerylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^Blogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[698,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-118c-497f-bfaa-198f6e383326logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^Klogseq____&quot;,1691874785025,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;carcinomaslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^11logseq____&quot;,logseq____&quot;carcinomaslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^Blogseq____&quot;,1691874785025,536870916]],[logseq____&quot;^15logseq____&quot;,[699,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1d59-45db-96f4-180acd6b4031logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^Klogseq____&quot;,1691874785032,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;immunotherapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^11logseq____&quot;,logseq____&quot;Immunotherapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^Blogseq____&quot;,1691874785032,536870916]],[logseq____&quot;^15logseq____&quot;,[700,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7a9b-4862-ba62-c48d519a1224logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^Klogseq____&quot;,1691874785035,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;targeted therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^11logseq____&quot;,logseq____&quot;Targeted therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^Blogseq____&quot;,1691874785035,536870916]],[logseq____&quot;^15logseq____&quot;,[701,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-45fa-4996-b9ae-6dd1676caa06logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^Klogseq____&quot;,1691874785028,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^11logseq____&quot;,logseq____&quot;63f33c7c-1efd-4dfe-860b-63b02b326879logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^Blogseq____&quot;,1691874785028,536870916]],[logseq____&quot;^15logseq____&quot;,[702,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-087f-43db-bc4e-04fb0c5956eelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^Klogseq____&quot;,1691874785325,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;adenocarcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^11logseq____&quot;,logseq____&quot;adenocarcinomalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^Blogseq____&quot;,1691874785325,536870916]],[logseq____&quot;^15logseq____&quot;,[703,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b4a9-4898-b578-bbdcf35fc866logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^Klogseq____&quot;,1691874785033,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;ablationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^11logseq____&quot;,logseq____&quot;ablationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^Blogseq____&quot;,1691874785033,536870916]],[logseq____&quot;^15logseq____&quot;,[704,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-221f-4f44-8017-3487ca7bcef7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^Klogseq____&quot;,1691874785115,536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;outlinelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^11logseq____&quot;,logseq____&quot;Outlinelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^Blogseq____&quot;,1691884799836,536871954]],[logseq____&quot;^15logseq____&quot;,[705,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e43a-43ed-8b4c-8b0877bd0f35logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^Klogseq____&quot;,1691874785026,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^11logseq____&quot;,logseq____&quot;63ee4fb3-56e1-4735-bbd4-bb5c4c18d31clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^Blogseq____&quot;,1691874785026,536870916]],[logseq____&quot;^15logseq____&quot;,[706,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4032-4386-b5dd-7a2a862f7a86logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^Klogseq____&quot;,1691874785027,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^11logseq____&quot;,logseq____&quot;63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^Blogseq____&quot;,1691874785027,536870916]],[logseq____&quot;^15logseq____&quot;,[707,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a786-40f8-bac8-460d64578726logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^Klogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;carcinoembryonic antigenlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^11logseq____&quot;,logseq____&quot;carcinoembryonic antigenlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^Blogseq____&quot;,1691874785029,536870916]],[logseq____&quot;^15logseq____&quot;,[708,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d72c-4aba-96c5-4f4526d3f498logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^Klogseq____&quot;,1691874785032,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;immune checkpoint inhibitorslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^11logseq____&quot;,logseq____&quot;Immune checkpoint inhibitorslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^Blogseq____&quot;,1691874785032,536870916]],[logseq____&quot;^15logseq____&quot;,[709,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dac8-4252-ac1d-51cc777e0fbblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^Klogseq____&quot;,1691874785030,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;ajcc letter classification systemlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^11logseq____&quot;,logseq____&quot;AJCC letter classification systemlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^Blogseq____&quot;,1691874785030,536870916]],[logseq____&quot;^15logseq____&quot;,[710,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-63b7-42fc-8b9d-ce2d1cf99309logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^Klogseq____&quot;,1691874785035,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;immunotherapieslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^11logseq____&quot;,logseq____&quot;Immunotherapieslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^Blogseq____&quot;,1691874785035,536870916]],[logseq____&quot;^15logseq____&quot;,[711,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-64cb-479f-b6ef-7ed3992350e0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^Klogseq____&quot;,1691874785300,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;tnm classification systemlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^11logseq____&quot;,logseq____&quot;TNM classification systemlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^Blogseq____&quot;,1691874785300,536870916]],[logseq____&quot;^15logseq____&quot;,[712,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d3e2-4303-ad6e-ef3c6ebfae6blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^Klogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;radiation therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^11logseq____&quot;,logseq____&quot;Radiation therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^Blogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[713,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-baec-47f7-9e20-1dbab29804b2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^Klogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;chemotherapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^11logseq____&quot;,logseq____&quot;Chemotherapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^Blogseq____&quot;,1691874785031,536870916]],[logseq____&quot;^15logseq____&quot;,[714,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-46ac-4913-80c0-54f6556f00dblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^Klogseq____&quot;,1691874785026,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;d303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^11logseq____&quot;,logseq____&quot;d303baa3-296a-48d9-941a-bfcab5be4e20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^Blogseq____&quot;,1691874785026,536870916]],[logseq____&quot;^15logseq____&quot;,[715,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4995-4a70-9e87-ae421f55d555logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Physical Examination**: Listening to the chest with a stethoscope and checking for abnormalities.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Flogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[716,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4ac9-4d2d-944d-03c3c5e7e0a0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Flogseq____&quot;,742,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[717,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2f31-4755-b70d-bee2fd646be6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Flogseq____&quot;,815,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[718,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c987-4e6e-b1d8-f060948f7c19logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Symptoms\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Flogseq____&quot;,790,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[719,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8e3d-481f-8e2b-f0b101378beelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Flogseq____&quot;,789,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[720,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e605-4591-8346-92e851975a36logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Description and Analogy\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Flogseq____&quot;,752,536871969]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871969]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;]],536871969]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871969]],[logseq____&quot;^15logseq____&quot;,[721,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5138-486b-91d0-6b9212a28daflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Pie Chart of NSCLC Types, SCLC (small-cell carcinoma) and their respective ratio of smokers to non-smokers.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Flogseq____&quot;,770,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Vlogseq____&quot;,770,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[722,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fe5f-40c1-b9a1-7652cd83d5e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLC accounts for about 85%  (±5% depending on source) of all lung cancers worldwide, the percentage is 84% for the United States.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Flogseq____&quot;,777,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[723,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9756-4ba9-a6ac-59ef9fb4b901logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Flogseq____&quot;,767,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[724,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-c06c-4455-a308-4cb5c3200751logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Stage I**: The cancer is limited to the lung and has not spread to any other parts of the body.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Flogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Vlogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Ulogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[725,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d824-4fdf-adf7-8bb8b94b2477logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLC typically progresses more slowly than SCLC does.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Flogseq____&quot;,765,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[726,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f03f-4a91-b2db-c9e2c0712e4flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Stage III**: The cancer has spread to nearby lymph nodes and tissues, but is still confined to one lung and the surrounding area.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Flogseq____&quot;,782,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Vlogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Ulogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[727,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8af1-44ff-a956-50187e2de04dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Surgery]]**: Removal of cancerous tissue from the lungs. **In early stages, this is the primary and preferred treatment option**, though it is still used in later stages as well.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Flogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Vlogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Ulogseq____&quot;,698,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^Hlogseq____&quot;,698,536870916]],[logseq____&quot;^15logseq____&quot;,[728,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-39a2-4928-9173-c500eefa2eb4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Blood tests**: Certain proteins may be elevated in people with lung cancer, such as [[carcinoembryonic antigen]] (CEA) or[[neuron-specific enolase]] (NSE).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Flogseq____&quot;,816,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Ulogseq____&quot;,695,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Ulogseq____&quot;,708,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Hlogseq____&quot;,695,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^Hlogseq____&quot;,708,536870916]],[logseq____&quot;^15logseq____&quot;,[729,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f0f8-476a-9fd2-136045bb1daflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The treatment approach for people who have advanced NSCLC is first aimed at relieving pain and distress (palliative). Two genetic markers are routinely profiled in NSCLC tumors to guide further treatment decision-making - mutations within epidermal growth factor (EGFR) and anaplastic lymphoma kinase. Also, a number of additional genetic markers are known to be mutated within NSCLC and may impact treatment in the future, including BRAF, HER2/neu, and KRAS ([[KRAS G12C]]). Roughly 10–35% of people (percentage varies significantly by race), who have NSCLC will have drug-sensitizing mutations of the EGFR. Up to 7% of NSCLC patients have EML4-ALK translocations or mutations in ROS1 and may benefit from ALK inhibitors. NSCLC most frequently harbors alterations in TP53, KRAS ([[KRAS G12C]]), EGFR, CDKN2A, and STK11.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Flogseq____&quot;,829,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^Hlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[730,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2b23-46a0-b63a-40f0d3ea745dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Flogseq____&quot;,799,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[731,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5e80-4c6e-b8e2-1f7257f7118flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Flogseq____&quot;,724,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[732,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8202-434f-873d-d6db37f261edlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Epigenetic therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Flogseq____&quot;,830,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[733,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fa96-4051-a1f8-557d2c34b388logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Targeted therapy]]**: Targets specific molecules or genes involved in the growth or spread of cancer cells. Can be used alone or in combination with other treatments. Patients with specific genetic mutations in their cancer cells may be candidates for targeted therapies, for example patients with the [[KRAS G12C]] mutation, who care candidates for [[LUMAKRAS]].logseq____&quot;,536871576]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Flogseq____&quot;,792,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Vlogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Ulogseq____&quot;,701,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Hlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Hlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^Hlogseq____&quot;,701,536870916]],[logseq____&quot;^15logseq____&quot;,[734,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-391b-4872-8d90-68f97e4abf86logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Flogseq____&quot;,726,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[735,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-30df-468a-892c-54738a2b1aa4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage III: Radiation + chemotherapy/surgery, 10-15%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Flogseq____&quot;,811,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Vlogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[736,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7af0-46f5-92bb-764b21e4c7f3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Current Treatment Limitations\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Flogseq____&quot;,781,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[737,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-94ee-4540-8dd8-6fac4ea3f9b8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;For NSCLC, the five-year survival rate is 24%. The rate decreases significantly with each stage. For stage I, it is 47%, stage II is 30%, stage III is 10%, and stage IV is 1%. [(Ref: cancer.org)](https://www.cancer.org/cancer/non-small-cell-lung-cancer/detection-diagnosis-staging/survival-rates.html)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Flogseq____&quot;,779,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[738,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-73c6-44a9-8eb5-724700ec3b06logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage III: Surgery + chemotherapy, 20-30%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Flogseq____&quot;,826,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Vlogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[739,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b526-4ec1-8bf7-7318718be4ealogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{embed ((63ee5069-a285-4e6d-a129-86328721a5d8))}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Flogseq____&quot;,786,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Slogseq____&quot;,852,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Ulogseq____&quot;,694,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Hlogseq____&quot;,639,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^Hlogseq____&quot;,694,536870916]],[logseq____&quot;^15logseq____&quot;,[740,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-16bf-4da4-8890-fd0d2689e83clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Radiation therapy]]**: Uses high-energy beams to kill cancer cells and shrink tumors. Can be used as a primary treatment or in combination. **NSCLCs are *not* very sensitive to radiotherapy.** New methods of giving radiation treatment allow doctors to be more accurate, however, it is still not commonly used in early stages, unless they present a small, inoperable tumor.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Flogseq____&quot;,728,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Vlogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Ulogseq____&quot;,713,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^Hlogseq____&quot;,713,536870916]],[logseq____&quot;^15logseq____&quot;,[741,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8bc8-416d-b00d-e4577575720flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; *Detailed Statistics can be found via the ACS and the SEER database.*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Flogseq____&quot;,776,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[742,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-71d7-4edc-baf8-19d9cc412796logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Flogseq____&quot;,783,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[743,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a510-4dbe-9e2c-83a636b442celogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ref: Cancer.org Staging - https://www.cancer.org/cancer/non-small-cell-lung-cancer/detection-diagnosis-staging/survival-rates.htmllogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Flogseq____&quot;,835,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[744,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d8b0-40f2-97f6-f49ba48397b3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Flogseq____&quot;,838,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[745,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2321-4b9b-97a8-3e89aab56152logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**The most typical treatments involve a *combination* of surgery, chemotherapy, and radiation therapy**.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Flogseq____&quot;,825,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[746,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9c6a-4716-9331-e492c28d6c1elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Flogseq____&quot;,787,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[747,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ee10-4ffc-8e25-5e3e52d55612logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Flogseq____&quot;,832,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[748,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-146a-4d77-8a10-7b03bee1b280logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Links\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Flogseq____&quot;,817,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[749,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2026-4b50-9764-507bac0561felogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Flogseq____&quot;,758,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[750,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-4000-4224-ba9d-6364fc30125blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Surgery**: *Complete tumor removal* during surgery is associated with the highest success rates for early-stage, typically in the range of 60-80%. *Partial resection* is associated with lower success rates, with estimated five-year survival rates in the range of 30-50%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Flogseq____&quot;,845,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[751,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d5f0-4e53-8dd3-687d5a094f07logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Non-Small-Cell Lung Cancerlogseq____&quot;,536871969]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Flogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536871969]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536871969]],[logseq____&quot;^15logseq____&quot;,[752,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-93eb-4189-88a1-e325b26ecb91logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Flogseq____&quot;,717,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[753,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fb74-44e2-b05a-6fef79cc4c2clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Chemotherapy**: *Complete* or *partial response* to chemotherapy is associated with estimated five-year survival rates typically in the range of 5-15%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Flogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[754,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-fb8c-461f-9351-bb158ffa8530logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Types\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Flogseq____&quot;,720,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[755,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b5f7-4ad8-8e3f-379365dc739clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Both the [[TNM classification system]] and the [[AJCC letter classification system]] are important tools for staging NSCLC. -logseq____&gt; *See [[Cancer Staging]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Flogseq____&quot;,813,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Ulogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Hlogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Hlogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^Hlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[756,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f876-4151-834d-3f4ce8e0e93alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Flogseq____&quot;,745,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[757,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5881-416d-928b-382db36dcbb9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Angiogenesis inhibitorslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Flogseq____&quot;,733,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[758,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8a1c-4558-8f96-38d82eabf405logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Chest X-Ray**: A chest x-ray is a common first test to identify changes or abnormalities in lung tissue.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Flogseq____&quot;,716,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[759,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1566-4a3a-9c3e-a39550631dfblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Radiation therapy** may be further limited where the tumor is located near vital organs, such as near the heart. Radiation therapy is also associated with side effects such as fatigue.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Flogseq____&quot;,843,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[760,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1a55-409b-afeb-3fca8d119377logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Flogseq____&quot;,791,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[761,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e12c-4ab3-b303-bb73de106956logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{embed ((63f33c7c-1efd-4dfe-860b-63b02b326879))}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Flogseq____&quot;,778,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Slogseq____&quot;,854,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Ulogseq____&quot;,702,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Hlogseq____&quot;,635,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^Hlogseq____&quot;,702,536870916]],[logseq____&quot;^15logseq____&quot;,[762,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-983c-4173-a4c9-29c7dace3c0dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage I: Chemotherapy + surgery, 45%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Flogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Vlogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[763,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a0f8-4ba3-b44b-87b52368e47elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[LUMAKRAS]]logseq____&quot;,536871576]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Flogseq____&quot;,808,536871976]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^Hlogseq____&quot;,132,536871976]],[logseq____&quot;^15logseq____&quot;,[764,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-aba8-4ff9-8968-2edfa28cbee6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLCs are [[carcinomas]], which are cancers of the cells lining the surface of the organs ([[epithelial tissue]]). Consequently, NSCLC affects the lung airways. These include the bronchi, bronchioles, and alveoli.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Flogseq____&quot;,803,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Ulogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Ulogseq____&quot;,699,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Hlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^Hlogseq____&quot;,699,536870916]],[logseq____&quot;^15logseq____&quot;,[765,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-234c-4740-962e-eedce3df136flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**PET Scan** (*positron emission tomography scan*; uses a small amount of radioactive material to produce detailed images of tissues): Can help determine if a suspicious area seen on a CT scan is cancerous and if the cancer has spread to other parts of the body.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Flogseq____&quot;,848,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[766,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-84f2-4885-a76d-48117b558549logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Immunotherapy** may be less effective in patients with certain genetic mutations or with low levels of tumor-infiltrating lymphocytes.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Flogseq____&quot;,812,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[767,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2b1c-41ef-b4f5-9bd692710793logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage IV: No curative intentlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Flogseq____&quot;,736,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Vlogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[769,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2e92-4582-9eab-709e5b21f530logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![Pie_chart_of_lung_cancers.svg.png](../assets/Pie_chart_of_lung_cancers.svg_1676828270567_0.png){:height 211, :width 296}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Flogseq____&quot;,755,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[770,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7e84-4dcd-8410-db4efe07f42blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Gene Therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Flogseq____&quot;,841,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[771,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-0a36-4d39-a4d2-58dfcb8648cflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Non-Small-Cell Lung Cancer** (**NSCLC**) is a specific subtype of [[lung cancer]].logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Flogseq____&quot;,721,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^Hlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[772,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e608-43fb-bb51-bdccadf68c68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Targeted therapy:** *Complete or partial response* is associated with five-year survival rates typically in the range of 20-40%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Flogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[773,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8d9e-45f8-b4ca-bc1fefeaf84blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**The most prevalent cause for NSCLC is smoking**, accounting for about 85-90% of cases, though not all people with lung cancer have smoked. **Lung cancer in people who have never smoked is almost universally NSCLC, with a sizeable majority being adenocarcinoma.** [Ref: Medscape](http://www.medscape.com/viewarticle/566978). Adenocarcinoma accounts for about 40% of all lung cancers. Patients with squamous cell carcinoma or large cell carninoma are almost entirely smokers.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Flogseq____&quot;,809,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[774,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5ba0-453d-ae1e-55b470413b60logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Survival rastes and statistics are gathered from the Surveillance, Epidemiology, and End Results (SEER) program and the American Cancer Society (ACS), which are deemed the most reputable sources. **However, data varies significantly by type and date of study performed**.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Flogseq____&quot;,828,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[775,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ec83-4959-ae36-677ddf3b87fblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Mlogseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Immune checkpoint inhibitors**: *Complete or partial response* is associated with five-year survival rates typically in the range of 10-20%\\ncollapsed:: truelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Flogseq____&quot;,773,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[776,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b913-4dca-9ea0-dee19a7fa852logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Statistics\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Flogseq____&quot;,801,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[777,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b713-4190-9d06-0e8521afb5d0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;As with [[Lung Cancer]],  **NSCLC may not cause any symptoms in its early stages**. As the disease progresses, it can show a number if symptoms. Symptoms are commonly shared with other diseases.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Flogseq____&quot;,719,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Ulogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^Hlogseq____&quot;,623,536870916]],[logseq____&quot;^15logseq____&quot;,[778,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ec8f-4901-bfa3-557d7b996c58logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{embed ((63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98))}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Flogseq____&quot;,740,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Slogseq____&quot;,853,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Ulogseq____&quot;,707,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Hlogseq____&quot;,638,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^Hlogseq____&quot;,707,536870916]],[logseq____&quot;^15logseq____&quot;,[779,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1923-47b6-bb83-9401348184cdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Flogseq____&quot;,827,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[780,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-63ec-4a04-adc2-3f4b41b8a659logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Flogseq____&quot;,753,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[781,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-708c-4b94-a602-cc470df7cdcflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Stage II**: The cancer has grown larger, but is still limited to the lung and has not spread to other parts of the body.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Flogseq____&quot;,725,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Vlogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Ulogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[782,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7cde-4dbe-8aa1-ffdb632656e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In conclusion: **In early stages, surgery is the primary treatment**. Surgery can be curative if the cancer has not spread. **In later stages, chemotherapy and radion therapy are primarily used, alongside surgery**. Palliative care remains a primary treatment focus. in later stages.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Flogseq____&quot;,846,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[783,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ab1f-47d0-8881-abe4eb03856elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLCs are usually *not* very sensitive to chemotherapy or radiation therapy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Flogseq____&quot;,849,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[784,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2291-4fcf-9752-197dd8e79fbflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Current Treatment Methods\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Flogseq____&quot;,757,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[785,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5788-4f1e-93b3-99195a52440clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{embed ((63ee4fb3-56e1-4735-bbd4-bb5c4c18d31c))}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Flogseq____&quot;,793,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Slogseq____&quot;,851,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Ulogseq____&quot;,706,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Hlogseq____&quot;,636,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^Hlogseq____&quot;,706,536870916]],[logseq____&quot;^15logseq____&quot;,[786,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0635-4a52-8106-39df5aceb014logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Flogseq____&quot;,814,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[787,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-39b2-4b73-b31a-6bc02f68c046logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Targeted therapy and immune checkpoint inhibitors are newer treatments for NSCLC and may be used in certain cases, such as when the cancer has specific genetic mutations or when other treatments have not been effective.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Flogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[788,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b549-4940-81d0-cf0877e3a10flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Flogseq____&quot;,735,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[789,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3a71-482c-aede-1a69dba43f0flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Flogseq____&quot;,747,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[790,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-267e-4b12-ab84-62effe69257elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Flogseq____&quot;,818,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[791,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3e45-4c2c-8100-b403451db1f9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Chemotherapy]]**: Often used in combination with other treatments such as surgery or radiation therapy, typically in later stages or higher risk individuals. **NSCLC tends to be relatively insensitive to chemothetapy**, yet it is still frequently used preoperatively (neoadjuvant) and postoperatively (adjuvant chemotherapy). A wide variety of agents are available, such as the traditional cisplatin, carboplatin or more effective drugs such as cetuximab or [[LUMAKRAS]] and PD-L1 inhibitors, which fall into targeted therapy A new drug is approved by the FDA almost yearly. The toxicity profile/side effects should be taken into account and balanced with the personlogseq____&apos;s comorbidities.logseq____&quot;,536871576]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Flogseq____&quot;,741,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Vlogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Ulogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Ulogseq____&quot;,714,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Hlogseq____&quot;,132,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^Hlogseq____&quot;,714,536870916]],[logseq____&quot;^15logseq____&quot;,[792,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f9f5-4bfc-80b4-2b275e401ad2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;{{embed ((d303baa3-296a-48d9-941a-bfcab5be4e20))}}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Flogseq____&quot;,774,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Slogseq____&quot;,850,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Ulogseq____&quot;,715,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Hlogseq____&quot;,633,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^Hlogseq____&quot;,715,536870916]],[logseq____&quot;^15logseq____&quot;,[793,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5ffd-4901-b4f5-e30fae3de558logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Flogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[794,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f5f0-4bdf-a7a7-fbbb96184804logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Response rate: 20-40%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Flogseq____&quot;,842,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Vlogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[795,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-6902-40e9-9082-9203d17e26d2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage III: Chemotherapy + radiation/surgery, 10-15%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Flogseq____&quot;,837,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Vlogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[797,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9eb8-47a3-a599-9db1f6557a68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### Investigational Treatments\\nheading:: 4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Flogseq____&quot;,743,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[798,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-e08f-4676-b2f3-c6d80b155c7clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**There are three main subtypes of NSCLC,  [[adenocarcinoma]], [[Squamous cell carcinoma]], and [[Large cell carcinoma]]**. Other subtypes include pleomorphic, carcinoid tumor, salivary gland carcinoma, and unclassified carcinomas. All types can occur as unusual histologic variants including mixed cell-types. It should be noted that these are types for cancer in general, specifically the types of [[carcinomas]] (malignancy that develops from [epithelial cells](https://en.wikipedia.org/wiki/Epithelial_cells)); the definitions are not exclusive to NSCLC.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Flogseq____&quot;,770,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ulogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ulogseq____&quot;,699,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Hlogseq____&quot;,605,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Hlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Hlogseq____&quot;,699,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^Hlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[799,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c517-4074-9e72-899452388daalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Immunotherapies]]: [[Cancer vaccines]], [[Adoptive Cell Transfer]], [[Cytokines]]. Combination approaches that involve other treatment options as well as multiple immunotherapies are also being investigated.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Flogseq____&quot;,798,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ulogseq____&quot;,693,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ulogseq____&quot;,696,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ulogseq____&quot;,697,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Ulogseq____&quot;,711,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Hlogseq____&quot;,693,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Hlogseq____&quot;,696,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Hlogseq____&quot;,697,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^Hlogseq____&quot;,711,536870916]],[logseq____&quot;^15logseq____&quot;,[800,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-5f96-4a47-a727-35e8aa144bc3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Flogseq____&quot;,806,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[801,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-30b8-49df-bf58-c2b8cd545735logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage I: Radiation + surgery, 55-60%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Flogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Vlogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[802,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-a1d4-4113-9bd7-a13094a74131logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**It is one of the two main forms of lung cancer**, accounting for around **85% of all lung cancers**. NSCLC is characterized by abnormal growth of cells that are defined not small in size, unlike Small Cell Lung Cancer (SCLC) and Combined Small-Cell Lung Cancer (c-SCLC).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Flogseq____&quot;,772,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[803,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-55e1-4cb4-84d1-e7c71c8f3ad7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Diagnosis\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Flogseq____&quot;,761,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[804,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-93f8-447b-98d6-e23970d3c10elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Flogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[805,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e5d3-4aca-a629-a896133854belogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Flogseq____&quot;,731,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[806,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cb4f-4954-bfd3-939ee8fc8cf6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Flogseq____&quot;,776,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Vlogseq____&quot;,776,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[807,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d74b-4112-a366-b282f31fc9f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Lung Cancer]]logseq____&quot;,536871976]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Flogseq____&quot;,749,536870916]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Ulogseq____&quot;,296,536871973]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Ulogseq____&quot;,623,536871976]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871976]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^Hlogseq____&quot;,623,536871976]],[logseq____&quot;^15logseq____&quot;,[808,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f5f3-4aed-84d9-137caac65887logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLC is typically diagnosed in patients over the age of 65, with the average age being 70, and occurs more frequently in men than in women (although this gap is narrowing). Black men are about 12% more likely to develop lung cancer than white men, however, black women are 16% less likely to develop lung cancer than white women.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Flogseq____&quot;,723,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[809,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b1c4-4a5e-b47c-1b45598435eclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage IV: No curative intentlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Flogseq____&quot;,739,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Vlogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[810,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-577f-4063-a435-287694553767logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage II: Radiation + chemotherapy/surgery, 40-50%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Flogseq____&quot;,802,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Vlogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[811,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-290d-4488-a8c5-ccee29ddd786logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Targeted therapy** may be ineffective in patients that donlogseq____&apos;t have tumors with specific mutations, and even in those who do, the cancer may eventually develop resistance to the targeted therapy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Flogseq____&quot;,784,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[812,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ea61-40dd-b9bf-7f845e181edelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Stages of NSCLC\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Flogseq____&quot;,748,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[813,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-28fc-4f72-b05b-347e36992393logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*-logseq____&gt; [Cancer.org statistics](https://cancer.org/cancer/lung-cancer/about/key-statistics.html)*logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Flogseq____&quot;,738,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[814,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e6d4-4217-8e4d-fb3ec5df1bcclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Flogseq____&quot;,834,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[815,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-bdef-4133-b5ea-1efa2f9c4be0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Sputum cytology**: Analysing (bloody) sputum under a microscope.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Flogseq____&quot;,840,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[816,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ac7e-4ce5-9549-892fcd3891d0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Flogseq____&quot;,732,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[817,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-f7b2-47c0-be2e-ed9a81bbff36logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Flogseq____&quot;,831,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[818,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6c30-464a-9897-b22db67b8f01logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Radiation therapy**: *Complete response* to radiation therapy is associated with five-year survival rates typically in the range of 50-70%. *Partial response* is associated with five-year survival rates in the range of 10-20%. Overall, it is considered an effective treatment option.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Flogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[819,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b64d-4e65-b3b8-11d7643fad5blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The specific treatment plan for a patient with NSCLC is determined by an oncologist and radiation oncologist alongside a pulmonologist and is based on his/her age, overall health, response to chemotherapy and likely side effects.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Flogseq____&quot;,785,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[820,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d5fd-4330-baa3-03e167da9b24logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage I: Surgery, 60-80%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Flogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Vlogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[821,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-1e5b-4425-8b98-777d6c1c9295logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[KRAS G12C]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Flogseq____&quot;,764,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Ulogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^Hlogseq____&quot;,416,536870916]],[logseq____&quot;^15logseq____&quot;,[822,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-8fef-465c-90a4-66663d13d288logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**[[Immune checkpoint inhibitors]]** (a class of [[Immunotherapy]]): These drugs help to enhance the bodylogseq____&apos;s natural immune response to cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Flogseq____&quot;,734,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Vlogseq____&quot;,746,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Ulogseq____&quot;,700,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Ulogseq____&quot;,709,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Hlogseq____&quot;,700,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^Hlogseq____&quot;,709,536870916]],[logseq____&quot;^15logseq____&quot;,[823,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c6dd-4512-a91f-22d33403bc10logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Flogseq____&quot;,788,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[824,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e5dc-47e0-a298-6de69112c668logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;NSCLC patients can typically be classified in one of three different categories: *patients with early, nonmetastatic disease* (stages I and II, and select type III tumors), *patients with locally advanced disease* confined to the thoracic cavity (e.g., large tumors, tumors involving critical chest structures or positive mediastinal lymph nodes), or *patients with distant metastasis* outside of the thoracic cavity.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Flogseq____&quot;,820,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[825,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f712-44c3-8178-ae31201b9512logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage II: Surgery, 40-50%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Flogseq____&quot;,821,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Vlogseq____&quot;,751,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[826,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-3cb5-4ef9-b774-2e384ff8d706logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cancer.org statistics - https://cancer.org/cancer/lung-cancer/about/key-statistics.htmllogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Flogseq____&quot;,744,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[827,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d288-4421-bcba-496941581530logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Treatment Effectiveness\\nheading:: 2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Flogseq____&quot;,718,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[828,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b4b8-412a-b4ea-79021119c6aflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;For early/non-metastatic patients, some other treatments include *percutaneous [[ablation]]* (*radiofrequency ablation (RFA), cryoablation, and microwave ablation*) or *chemoembolization*.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Flogseq____&quot;,824,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Ulogseq____&quot;,704,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^Hlogseq____&quot;,704,536870916]],[logseq____&quot;^15logseq____&quot;,[829,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-2be0-4b6c-b3ba-7f0c0db3b9e5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Oncolytic virus therapylogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Flogseq____&quot;,771,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[830,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-d0ef-456b-b4cd-34a57d49ef7blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Signs of more advanced cases include bone pain, nervous-system changes (headache, weakness, dizziness, balance problems, seizures), jaundice, lumps near the surface of the body, numbness of extremities due to Pancoast syndrome, and nausea, vomiting, and constipation brought on by hypercalcemia. Some more of the symptoms that indicate further progression of the cancer include shortness of breath, superior vena cava syndrome, trouble swallowing, large amounts of mucus and fatigue.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Flogseq____&quot;,762,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[831,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4a4e-4551-9fc3-28277962d8d6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Flogseq____&quot;,794,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[832,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c3e7-472e-89a3-1b5b09a00512logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Bronchoscopy**: Proceedure involving a flexible tube with a light and camera that is inserted into the throat/lungs, to inspect the area or take a biopsy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Flogseq____&quot;,766,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[833,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f55b-45ac-b8a6-9f97e16f0a9elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Flogseq____&quot;,750,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[834,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7adc-4dbd-a033-e80db9ecd8cblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Ref: Medscape - http://www.medscape.com/viewarticle/566978logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Flogseq____&quot;,822,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[835,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-9a45-48e8-8361-cc6d958ccafclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Response rate: 20-30%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Flogseq____&quot;,769,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Vlogseq____&quot;,819,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[836,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-86c0-4588-ab84-cd9caf043ccblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage II: Chemotherapy + radiation/surgery, 30%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Flogseq____&quot;,763,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Vlogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[837,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b6ee-4d3f-b4ec-08c953dfb0f6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Flogseq____&quot;,844,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[838,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0469-4c23-a2ba-71201861ea8blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Stage IV**: The cancer has spread to distant parts of the body, such as other organs or bonelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Flogseq____&quot;,727,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Vlogseq____&quot;,756,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Ulogseq____&quot;,346,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Ulogseq____&quot;,710,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[839,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dced-4943-ae6d-38a8b4c4fc84logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Biopsy**: Removal of a small piece of tissue from the lung to be examined under a microscope. The biopsy sample can also be tested to determine the cancer type and treatment proceedure.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Flogseq____&quot;,833,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[840,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a3b0-4b34-860f-ef4f9754ed62logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Targeted therapy]]: Osimertinib, crizotinib.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Flogseq____&quot;,800,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Ulogseq____&quot;,701,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^Hlogseq____&quot;,701,536870916]],[logseq____&quot;^15logseq____&quot;,[841,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-19cc-4989-bbfc-deffc0d5e342logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Stage IV: Chemotherapy primary, 2-5%logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Flogseq____&quot;,797,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Vlogseq____&quot;,754,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[842,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-7719-449f-821c-d0bf9f884acalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Surgery** is limited by how much the cancer has spread, but remains the preferred primary treatment option, compared to radiation therapy and chemotherapy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Flogseq____&quot;,737,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[843,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-b348-4ab9-812d-69331d5c234dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The lung tumor itself is typically analyzed both radiographically for overall size and by a pathologist under the microscope to identify specific genetic markers or to see if invasion into important structures within the chest (e.g., bronchus or pleural cavity) has occurred. Next, the patientlogseq____&apos;s nearby lymph nodes within the chest cavity (the mediastinum), are checked for disease involvement. Finally, the patient is evaluated for more distant sites of metastatic disease, most typically with brain imaging and or scans of the bones.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Flogseq____&quot;,805,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[844,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0bf1-4b1d-a723-9bcb91c19e6alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Flogseq____&quot;,775,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[845,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-ebd3-4f21-ba93-9526782a2969logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Flogseq____&quot;,730,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[846,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-80bf-4abe-aa99-ec79a2244a65logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;((63f33c7c-d11c-41d4-a8ce-45ef9a4501ae))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Flogseq____&quot;,804,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^Hlogseq____&quot;,637,536870916]],[logseq____&quot;^15logseq____&quot;,[847,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2809-42da-a768-3abd8ecf7d9dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**CT Scan** (*computer tomography scan*): A type of x-ray scan that provides detailed images of the lungs and abdomen. Useful for identifying the progression and stages of the cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Flogseq____&quot;,759,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Vlogseq____&quot;,847,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[848,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-590c-4309-ad85-2398bf94bbablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Chemotherapy** may be limited in patients with specific genetic mutations, and often has significant side effects. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to SCLC.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Flogseq____&quot;,760,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Xlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Vlogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^Ulogseq____&quot;,296,536870916]],[logseq____&quot;^15logseq____&quot;,[849,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e0-eaa8-40aa-a63d-61d95c20d294logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[850,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^17logseq____&quot;,logseq____&quot;embedlogseq____&quot;,logseq____&quot;^18logseq____&quot;,[logseq____&quot;((d303baa3-296a-48d9-941a-bfcab5be4e20))logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[850,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[850,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;embed ((d303baa3-296a-48d9-941a-bfcab5be4e20))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[851,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^17logseq____&quot;,logseq____&quot;embedlogseq____&quot;,logseq____&quot;^18logseq____&quot;,[logseq____&quot;((63ee4fb3-56e1-4735-bbd4-bb5c4c18d31c))logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[851,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[851,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;embed ((63ee4fb3-56e1-4735-bbd4-bb5c4c18d31c))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[852,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^17logseq____&quot;,logseq____&quot;embedlogseq____&quot;,logseq____&quot;^18logseq____&quot;,[logseq____&quot;((63ee5069-a285-4e6d-a129-86328721a5d8))logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[852,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[852,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;embed ((63ee5069-a285-4e6d-a129-86328721a5d8))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[853,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^17logseq____&quot;,logseq____&quot;embedlogseq____&quot;,logseq____&quot;^18logseq____&quot;,[logseq____&quot;((63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98))logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[853,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[853,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;embed ((63ee50b5-80dc-4c9d-8bbb-f6bf2c341b98))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[854,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^17logseq____&quot;,logseq____&quot;embedlogseq____&quot;,logseq____&quot;^18logseq____&quot;,[logseq____&quot;((63f33c7c-1efd-4dfe-860b-63b02b326879))logseq____&quot;]],536870916]],[logseq____&quot;^15logseq____&quot;,[854,logseq____&quot;^Wlogseq____&quot;,logseq____&quot;macrologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[854,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;embed ((63f33c7c-1efd-4dfe-860b-63b02b326879))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^Klogseq____&quot;,1691874785506,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;thrombocytopenialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^11logseq____&quot;,logseq____&quot;thrombocytopenialogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^Blogseq____&quot;,1691874785506,536870916]],[logseq____&quot;^15logseq____&quot;,[856,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2ec9-4d0f-95bf-ada7914c9a9dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Flogseq____&quot;,859,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[857,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9ce4-4729-b16a-91c2ad4a7f71logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Flogseq____&quot;,881,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[858,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a724-47d6-bcc6-2fb1c30ee275logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Flogseq____&quot;,860,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[859,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3cc0-4cbb-9503-1d3c7e632c02logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Flogseq____&quot;,883,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[860,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7f9f-4fc0-8bde-8e2c6eb80d68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Flogseq____&quot;,885,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[861,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ec9a-411c-9e6c-01b5c0cdb77blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Flogseq____&quot;,870,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[862,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2d88-49c7-9088-55e1fb07af87logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate has been proven to boost and sustain platelets in 5 clinical studies of adults and children with ITP.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Flogseq____&quot;,876,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[863,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9f9d-48d6-a27d-a495f672a3a6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Flogseq____&quot;,868,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[864,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-750e-4a1c-ae81-e55b5021e271logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Flogseq____&quot;,863,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[865,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9552-499b-b41e-df99cd8983ablogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate works as a platelet booster; it tries to keep platelet count about 50,000 per microliter in order to lower the risk for bleeding. It does this by increasing the activity of cells that produce platelets in the body, thus increasing platelet production that outpaces platelet destruction. It does not suppress the immune system. Platelets are made by cells in the bone marrow.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Flogseq____&quot;,887,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[866,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6326-4721-b64a-7f1c4b9d9c80logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### Limitations of uselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Flogseq____&quot;,861,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[867,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0979-400c-a57d-f8f71dc32b2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](http://pi.amgen.com/united_states/nplate/nplate_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Flogseq____&quot;,871,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[868,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-de0f-446d-86ed-3df2bc0a64aelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Flogseq____&quot;,866,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[869,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-59f4-4a88-bdfd-c6dfca24f810logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate is not indicated for treatment of any cause of thrombocytopenia other than ITP and only in patients whose degree of thrombocytopenia and clinical condition increases the risk for bleeding, and should not be used in an attempt to normalize platelet count, but to relieve symptoms associated with thrombocytopenia. It should also not be used for a precancerous condition called myelodysplastic syndrome (MDS).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Flogseq____&quot;,867,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[870,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a904-4c04-952a-f506fbde37aalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Nplate.com](https://www.nplate.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Flogseq____&quot;,858,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[871,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e66d-488b-bbcf-31d1cc101f54logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Romiplostim has been approved by the FDA in 2008 for the treatment of thrombocytopenia in:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Flogseq____&quot;,880,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[872,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c226-4c8a-9bf2-fa90d1a0145flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate may cause serious side effects. It may increase the risks of blood clots. It may increase the risk of a precancerous blood condition to a blood cancer (leukemia). It may increase the risk of changes to bone marrow, called increased reticulin.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Flogseq____&quot;,857,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[873,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f69c-4a7b-8c78-6fdd80c19a92logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Flogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[874,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c3db-4ef6-a8a3-b90429dfb0f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Flogseq____&quot;,888,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Vlogseq____&quot;,872,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[875,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1f11-4368-8c64-3f7c34b3fc60logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Flogseq____&quot;,882,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[876,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7467-4db8-9e0d-5e37138b6620logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The amount of platelets your body makes is controlled by a protein called thrombopoietin, or TPO. In people with ITP, the amount of TPO is not high enough. Nplate works like TPO, telling the bone marrow to make more platelets, which can help reduce the risk of bleeding in people with ITP.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Flogseq____&quot;,866,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Vlogseq____&quot;,866,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[877,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f27d-4415-9af8-00ce0da76df9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [How Nplate works](https://www.nplate.com/platelet-booster)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Flogseq____&quot;,871,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Vlogseq____&quot;,871,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[878,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2c0e-4c3f-9220-8650b41d3434logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Nplate** (**Romiplostim, AMG 531**) is a [[Fusion Protein]], more specifically a [[Peptibody]], that is currently investigated for the treatment of chemotherapy-induced [[thrombocytopenia]] (CIT) and indicated for the treatment of immune thrombocytopenia (ITP), which is a form of thrombocytopenia where the immune system attacks blood platelets, which play a role in blood clotting. It is only used when medications or surgery have previously been insufficient.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Flogseq____&quot;,874,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Ulogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Hlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Hlogseq____&quot;,133,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^Hlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[879,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-75f7-4c21-a57a-4cf50c042bbelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Indicationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Flogseq____&quot;,884,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[880,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d872-4ed1-b79f-a890349bb5eclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Flogseq____&quot;,865,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[881,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5ae3-481f-bc44-b01af6d621cdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Flogseq____&quot;,886,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[882,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4de6-4f35-811e-5f07857323c2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate is given through subcutaneous injection once a week by a healthcare provider, who will then check platelet count and adjust the dose as needed.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Flogseq____&quot;,862,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[883,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f49c-45a7-8819-f053403b9d31logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Flogseq____&quot;,869,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[884,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b27e-4422-a450-40e3352ddb53logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Nplate is indicated to increase survival in adults and in pediatric patients (including term neonates) acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [HS-ARS]).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Flogseq____&quot;,872,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[885,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-20f6-4831-9121-fc865aeee641logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Flogseq____&quot;,873,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[886,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-54a9-41ea-a8b3-b05bf3a04ed6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Flogseq____&quot;,879,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Vlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[887,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b430-4cda-b464-beeaf9d02ba6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Adult patients with immune thrombocytopenia (ITP) who have had an insufficient response to [[corticosteroid]]s, immunoglobulins, or splenectomy.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Flogseq____&quot;,872,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Xlogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Vlogseq____&quot;,872,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Ulogseq____&quot;,129,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Ulogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^Hlogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[888,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-61b4-47dd-9d11-f007c4918f88logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^Klogseq____&quot;,1691874785356,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;atherosclerotic cardiovascular diseaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^11logseq____&quot;,logseq____&quot;atherosclerotic cardiovascular diseaselogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^Blogseq____&quot;,1691874785356,536870916]],[logseq____&quot;^15logseq____&quot;,[890,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0958-44ec-ba33-973b63273c62logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^Klogseq____&quot;,1691874785432,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;lipoprotein(a)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^11logseq____&quot;,logseq____&quot;lipoprotein(a)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^Blogseq____&quot;,1691874785432,536870916]],[logseq____&quot;^15logseq____&quot;,[891,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-374e-40b9-93fd-f68958890340logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Flogseq____&quot;,904,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[892,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-28d6-4ebc-b43c-8eaeeb42ff6flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: https://www.amgen.com/newsroom/press-releases/2022/11/amgen-presents-new-phase-2-data-that-show-olpasiran-delivers-significant-reduction-in-lipoproteina-levelslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Flogseq____&quot;,902,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[893,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7905-44cf-a447-77c4f4020ecclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;According to Amgen, **OLPASIRAN reduced lipoprotein(a) levels by more than 95%** in patients with established ASCVD at the dosage range of 75mg or higher.[^2][^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Flogseq____&quot;,905,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[894,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6cd7-43f2-a9a4-2503d85ecd20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;***OLPASIRAN*** (formerly *AMG 890*) is a small interfering RNA [[siRNA]] molecule that lowers [[lipoprotein(a)]], also known as Lp(a), which is a protein that transports cholesterol in the blood. It is currently in phase 3, being investigated for the treatment of [[atherosclerotic cardiovascular disease]] (ASCVD).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Flogseq____&quot;,909,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Hlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Hlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^Hlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[895,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2f57-417c-a1c1-e1b47af8933flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Flogseq____&quot;,900,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[896,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b1bf-465d-8db0-2d697fb88b40logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: https://www.healio.com/news/cardiology/20221107/olpasiran-cut-lpa-levels-by-more-than-95-in-patients-with-atherosclerotic-cvdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Flogseq____&quot;,893,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[897,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7cba-41f2-89d1-5bd6f3ff8948logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Flogseq____&quot;,899,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[898,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b24a-4a09-95ea-2bf14e11428elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Flogseq____&quot;,895,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[899,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3257-4db4-a457-cbe551881b75logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Flogseq____&quot;,903,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[900,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2041-4934-b12c-0814f76258dalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Flogseq____&quot;,898,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[901,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5d32-4a9a-9283-49c3bdf3ff23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.nejm.org/doi/full/10.1056/NEJMoa2211023logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Flogseq____&quot;,907,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[902,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a1e1-40b7-85c4-9e402bd091celogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Flogseq____&quot;,906,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[903,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-71ff-401f-a9bf-60587467ed39logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Flogseq____&quot;,894,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[904,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5bb4-40b8-a78e-c62c46d58259logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Flogseq____&quot;,914,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[905,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c343-4e7f-a5cc-c9f51674b43dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN LIPOPROTEIN(A) LEVELS ](https://www.amgen.com/newsroom/press-releases/2022/11/amgen-presents-new-phase-2-data-that-show-olpasiran-delivers-significant-reduction-in-lipoproteina-levels)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Flogseq____&quot;,910,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[906,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3750-4fd2-b015-000c050db1celogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Flogseq____&quot;,896,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[907,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3abe-4516-b230-a2c3e8f04f66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The overall incidence of adverse events was similar across the trial groups. The most common olpasiran-related adverse events were injection-site reactions, primarily pain.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Flogseq____&quot;,912,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Vlogseq____&quot;,914,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[908,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7359-4a84-9de1-02d8c31bfaaelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Flogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[909,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e92-4d25-a940-5678c5117f13logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Further Readinglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Flogseq____&quot;,913,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[910,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e61-4499-a443-41546b1eebb2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;At baseline, 88% of the patients were taking statin therapy, 52% were taking ezetimibe, and 23% were taking a proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Flogseq____&quot;,914,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Vlogseq____&quot;,914,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[911,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2f59-4e98-a4c9-bdae7660b3c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;At 36 weeks, the lipoprotein(a) concentration had increased by a mean of 3.6% in the placebo group, whereas olpasiran therapy had significantly and substantially reduced the lipoprotein(a) concentration in a dose-dependent manner, resulting in placebo-adjusted mean percent changes of −70.5% with the 10-mg dose, −97.4% with the 75-mg dose, −101.1% with the 225-mg dose administered every 12 weeks, and −100.5% with the 225-mg dose administered every 24 weeks (Plogseq____&lt;0.001 for all comparisons with baseline).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Flogseq____&quot;,911,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Vlogseq____&quot;,914,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[912,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2633-4c2f-bdaf-b668f960b2c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Flogseq____&quot;,892,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[913,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6e4b-4aca-a67e-7a5a04bf7256logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a study with 281 patients, OLPASIRAN significantly reduced Lp(a) levels in patients with stablished atherosclerotic cardiovascular disease. The study was conducted by Amgen.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Flogseq____&quot;,901,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Xlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Vlogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^Ulogseq____&quot;,125,536870916]],[logseq____&quot;^15logseq____&quot;,[914,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fa6b-43ef-9a8b-3465714a957clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^Klogseq____&quot;,1691874785479,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;psoriasislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^11logseq____&quot;,logseq____&quot;psoriasislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^Blogseq____&quot;,1691874785479,536870916]],[logseq____&quot;^15logseq____&quot;,[916,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d63a-492d-b2d5-b36428c21bf6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Flogseq____&quot;,931,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[917,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5aad-4156-9190-1df9ddbf3da4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Flogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[918,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-596f-4df2-9b50-b5a071b90abdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Flogseq____&quot;,923,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[919,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7192-44c7-a52c-b0c07091a490logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Flogseq____&quot;,922,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[920,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-02a8-45c9-b8d4-17478606e17blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Flogseq____&quot;,925,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[921,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9629-4123-a209-cb8b04a88bd3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Flogseq____&quot;,919,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[922,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bef3-471f-a1a2-5772864efdf1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The medicine suggests that \\logseq____&quot;it can help people with plaque psoriasis achieve clearer skin after just 4 months and people with psoriatic arthritis reduce joint swelling, tenderness, and pain after just 4 months.\\logseq____&quot; According to an observational study by IQVIA, Otezla is the # 1 prescribed pill to treat plaque psoriasis. It claims and notably highlights that is is the only prescription in pill form to treat plaque psoriasis. It is dispensed only through specialty pharmacies.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Flogseq____&quot;,936,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[923,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6324-4b42-930d-124218e1f3e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Flogseq____&quot;,933,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[924,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-358f-4a02-920f-eacc76796672logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Flogseq____&quot;,928,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[925,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d31b-4e88-8888-923ecbc177felogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Flogseq____&quot;,935,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[926,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-eb32-4093-bc5f-d72481dc30d3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a study of **mild to moderate plaque psoriasis**, 43% of people taking Otezla experienced less whole body itching after 4 months compared to 19% on placebo.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Flogseq____&quot;,943,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[927,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d935-4a2a-a4e7-6b2be28f2891logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Flogseq____&quot;,917,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[928,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f749-411a-a1b6-863edab60975logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: Haberfeld H, ed. (2015). *Austria-Codex* (in German). Vienna: Österreichischer Apothekerverlag.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Flogseq____&quot;,941,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[929,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a19d-4a2a-ba35-09d42d2a0cfflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Flogseq____&quot;,938,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[930,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9875-4aec-8efc-7e615e2d4a6alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Otezla.com](https://www.otezla.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Flogseq____&quot;,937,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[931,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8e1e-49d4-bc43-5f8a13f617celogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a study of **moderate to severe scalp psoriasis**, 43% of people taking Otezla saw improvement after 4 months compared to 14% on placebo.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Flogseq____&quot;,927,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[932,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6c83-488f-b3ef-bdb852bd0423logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Flogseq____&quot;,942,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[933,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1fbf-46c9-9c32-c7e92d541958logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [How Otezla Works](https://www.otezla.com/plaque-psoriasis/how-otezla-works)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Flogseq____&quot;,931,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Vlogseq____&quot;,931,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[934,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6408-4dfd-ab81-3ee5e0aca1a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Otezla can sometimes cause severe allergic reactions, and patients allergic to Otezla should avoid taking it. Otezla can also cause severe diarrhea, nausea and vomiting, especially within the first weeks of treatment. Otezla can cause an increase in the risk of depression. Otezla has not been studied in pregnant women or women who are breastfeeding, though in the European Union, the drug is contraindicated during pregnancy because mice and monkeys receiving very high doses of apremilast have been observed to suffer miscarriages and other pregnancy problems.[^2]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Flogseq____&quot;,945,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[935,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-711c-47da-b96b-ec3b2ee23381logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Flogseq____&quot;,939,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[936,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d26b-47ac-bd33-9a596f43ca08logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Flogseq____&quot;,930,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[937,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-da84-4860-9cae-6774b3007b3clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Flogseq____&quot;,932,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[938,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-64cc-4d06-8dcd-7541f0ee279flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Otezla** (**apremilast**) is a prescription medicine used to treat adult patients with plaque [[psoriasis]], for whom phototherapy or systemic therapy is appropriate, adults with active psoriatic arthritis or adults with oral ulcers associated with Behçetlogseq____&apos;s disease. It is currently in phase 3 investigation for moderate to severe plaque psoriasis in pediatric patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Flogseq____&quot;,918,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^Hlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[939,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-67cb-4269-834a-326c31116a9flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Flogseq____&quot;,926,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[940,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dc44-42bd-9023-9898d3b00af3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: http://www.adooq.com/apremilast-cc-10004.htmllogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Flogseq____&quot;,921,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[941,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b737-4165-b2ed-741e3e42802clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Otezla is a small molecule PDE4 inhibitor, it works to reduce levels of the enzyme phosphodiesterase 4 (PDE4), which is present in skin and immune cells and is believed to play a role in speedy cell growth, and inhibits spontaneous production of [TNF-alpha](https://en.wikipedia.org/wiki/Tumor_necrosis_factor_alpha) from human [rheumatoid](https://en.wikipedia.org/wiki/Rheumatoid) [synovial](https://en.wikipedia.org/wiki/Synovia) cells[^1]. Less PDE4 activity means less inflammation and fewer plaque psoriasis symptoms. The exact way in which Otezla helps improve symptoms isn’t completely understood.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Flogseq____&quot;,920,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[942,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b6a8-4422-a436-b717ebff9f55logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Flogseq____&quot;,940,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[943,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d00d-4b68-bd8e-e98c54d1a414logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Flogseq____&quot;,929,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[944,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7310-4e6c-8997-7940c8cca70clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Flogseq____&quot;,924,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Xlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Vlogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Ulogseq____&quot;,124,536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[945,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-154b-414c-a1fd-02f0a9bbfdbdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What gender, age, race, demographic, characteristics etc.?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Flogseq____&quot;,977,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Vlogseq____&quot;,977,536870916]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[950,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-95a9-45eb-8810-28237e6741e5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;How is the disease diagnosed? Who diagnoses the disease?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Flogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[951,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e8f-4627-8ff0-b957092d7683logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Overview of the disease and clinical forms**logseq____&quot;,536871954]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Flogseq____&quot;,969,536870916]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^Ulogseq____&quot;,705,536871955]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871954]],[logseq____&quot;^15logseq____&quot;,[952,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d116-4caf-8792-7c9399f8e3b3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[References or Citations]] as Heading (ChatGpt)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Flogseq____&quot;,966,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[953,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-027d-4880-b7d5-2846b7e9fb77logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the long-term health effects?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Flogseq____&quot;,972,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Vlogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[954,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-491a-406e-9623-5407737c4e1flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Flogseq____&quot;,953,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[955,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fb7a-460b-b2d8-90b2aab23278logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Typically, Global, US, and EU-5 (Germany, France, Italy, UK and Spain) are the most important.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Flogseq____&quot;,1002,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Vlogseq____&quot;,1002,536870916]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^Ulogseq____&quot;,705,536871955]],[logseq____&quot;^15logseq____&quot;,[956,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9d04-4958-b68c-4c2d77ae3602logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Since when?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Flogseq____&quot;,979,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Vlogseq____&quot;,979,536870916]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[957,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7dfe-44b9-8917-8faffeca2917logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the main research/clinical trial results on efficacy?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Flogseq____&quot;,975,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Vlogseq____&quot;,988,536870916]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^Ulogseq____&quot;,705,536871943]],[logseq____&quot;^15logseq____&quot;,[958,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b428-4126-a290-cb70c86bfc00logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Flogseq____&quot;,1003,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[959,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5d5a-4dff-9eb6-3d1821dad9c2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~^{(citation needed)}\\ntemplate:: citation neededlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Flogseq____&quot;,974,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:templatelogseq____&quot;,logseq____&quot;citation neededlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&gt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&gt;logseq____&quot;,logseq____&quot;citation neededlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[960,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4198-48a6-b332-c9746f189007logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What investigational drugs are also targeting this disease?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Flogseq____&quot;,980,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[961,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-60bb-4e66-abc2-5cc0a346f479logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Below are two sections, one for a disease and one with questions for a specific drug or treatment targeting the disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Flogseq____&quot;,971,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[962,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e5b8-4cc3-80a6-874944255093logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;How does the treatment work? What is the mechanism of action (MoA)?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Flogseq____&quot;,998,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[963,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9ad2-497c-b02f-3830695bcd06logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Are there stages? If so, what are the different treatments for each stage?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Flogseq____&quot;,989,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[964,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0307-4dc6-a027-c6de77f66700logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Patient Characteristics**logseq____&quot;,536871934]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Flogseq____&quot;,991,536870916]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871934]],[logseq____&quot;^15logseq____&quot;,[965,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f204-4e20-9b9d-1c0231624d63logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Flogseq____&quot;,960,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[966,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-344e-429a-b270-7d76b2d9bff4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Has it already launched? How many patients have already received it?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Flogseq____&quot;,979,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[967,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-734e-4096-ab87-223834bb849alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Flogseq____&quot;,994,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[968,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cccd-43d0-ad96-f6a28ac443bflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Disease and Current Treatmentlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Flogseq____&quot;,999,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[969,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c0a6-421c-a4f3-b38068aeed7elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Flogseq____&quot;,1001,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[970,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cb8c-4d91-b899-edf385d9534clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The proposed objectives of the research we will do are to:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Flogseq____&quot;,1005,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[971,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1aeb-4388-b2ed-d199a7a88d65logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the major symptoms of the disease?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Flogseq____&quot;,977,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Vlogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[972,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8e54-4425-8a9a-6412220e1b7elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the main side effects?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Flogseq____&quot;,958,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Vlogseq____&quot;,988,536870916]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^Ulogseq____&quot;,705,536871943]],[logseq____&quot;^15logseq____&quot;,[973,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e7c1-434a-9fab-058f072e30bflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Formattinglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Flogseq____&quot;,996,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[974,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c41a-440b-9d80-6916b273f85alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the main benefits of treatment?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Flogseq____&quot;,990,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Vlogseq____&quot;,988,536870916]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^Ulogseq____&quot;,705,536871943]],[logseq____&quot;^15logseq____&quot;,[975,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-99d4-40c3-b5f8-046abe21b6d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Understand how a specific product may be used to treat that disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Flogseq____&quot;,978,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Vlogseq____&quot;,971,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[976,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1c10-4289-b5c7-0c9eca357ec4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What types of patients get this disease?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Flogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Vlogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[977,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2d6b-4d07-a907-7b526ce59d1alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Understand a specific disease (e.g., lung cancer), symptoms, the types of patients it affects, how many, and, how it is currently treatedlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Flogseq____&quot;,971,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Vlogseq____&quot;,971,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[978,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cf14-4bc8-b7b6-0e4f9df22cc1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Is it approved by the FDA?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Flogseq____&quot;,985,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[979,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3cdc-4a00-b7c2-067b9d7a6e27logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What is the effectiveness and/or limitations of current treatments?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Flogseq____&quot;,995,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[980,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ed47-4e65-8324-b5629824a6f4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Overview of the treatment or drug**logseq____&quot;,536871938]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Flogseq____&quot;,984,536870916]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871938]],[logseq____&quot;^15logseq____&quot;,[981,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b309-4883-8f06-3e1069a3f1c3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Flogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[982,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e2c-49a0-86bf-9031b6099296logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Current Treatment**logseq____&quot;,536871930]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Flogseq____&quot;,1006,536870916]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871930]],[logseq____&quot;^15logseq____&quot;,[983,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ff5f-4058-a4e3-83bd1f37c4a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Client Drug or Treatmentlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Flogseq____&quot;,970,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[984,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-736c-45c0-b9c4-3af4251567bdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What is the name of the drug/treatment and who is it from?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Flogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[985,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3959-465b-ba75-a0b6558506e7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Disease name/s and short descriptionlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Flogseq____&quot;,952,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Vlogseq____&quot;,952,536870916]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^Ulogseq____&quot;,705,536871955]],[logseq____&quot;^15logseq____&quot;,[986,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6de2-4c75-a4ec-055266baf7e7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What is the formulation and dosing? How is it administered?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Flogseq____&quot;,963,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[987,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0865-485f-bdc4-5b6093063f4dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Treatment Benefits**logseq____&quot;,536871942]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Flogseq____&quot;,1000,536870916]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^Ulogseq____&quot;,705,536871943]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871942]],[logseq____&quot;^15logseq____&quot;,[988,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fb9f-4d58-91c4-d12582a0fe90logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What is the current treatment algorithm? What treatments are patients given?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Flogseq____&quot;,951,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[989,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fd55-4f2a-b667-18c1500fb740logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Where would this product fit in the current treatment pathway (or algorithm)?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Flogseq____&quot;,988,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Vlogseq____&quot;,988,536870916]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^Ulogseq____&quot;,705,536871943]],[logseq____&quot;^15logseq____&quot;,[990,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c409-471d-b576-147e686db2f4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Flogseq____&quot;,952,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[991,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f7b7-4e6b-9e3a-001276873442logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Just a summary of how diagnosis is performedlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Flogseq____&quot;,951,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Vlogseq____&quot;,951,536870916]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[992,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-87fb-4410-b3f5-5094593ef536logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are the clinical forms of the disease? What types are there? What stages?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Flogseq____&quot;,986,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Vlogseq____&quot;,952,536870916]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^Ulogseq____&quot;,705,536871955]],[logseq____&quot;^15logseq____&quot;,[993,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7614-4622-8bc2-d26ae9634325logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Let’s work on these questions over time.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Flogseq____&quot;,962,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[994,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6d3e-416f-8500-cda112ca70a9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Are there different treatments for different types of patients?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Flogseq____&quot;,964,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Vlogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^Ulogseq____&quot;,705,536871931]],[logseq____&quot;^15logseq____&quot;,[995,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7977-4f76-975b-08b51727052clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Flogseq____&quot;,968,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[996,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-efd1-4ecd-b6c9-1fa186e3f13blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What issues do patients have both directly due to the disease and any impacts on their quality of life?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Flogseq____&quot;,1004,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Vlogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[997,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9495-436c-b165-7f15e123e1felogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What types of patients will this product be used in? What is the indication?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Flogseq____&quot;,967,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Vlogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^Ulogseq____&quot;,705,536871939]],[logseq____&quot;^15logseq____&quot;,[998,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-794e-4caa-a6cb-8369f5cafa2alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Outlinelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Flogseq____&quot;,959,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[999,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-51ad-42cf-a0c7-6aff9d8eddf1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Flogseq____&quot;,981,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1000,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3c17-46e6-92e5-b0df2dca8319logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Flogseq____&quot;,983,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1001,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f67b-446e-b8e0-41bd8f136f61logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What is the incidence and prevalence of the disease?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Flogseq____&quot;,993,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Vlogseq____&quot;,952,536870916]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^Ulogseq____&quot;,705,536871955]],[logseq____&quot;^15logseq____&quot;,[1002,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2170-4301-8a93-c9efb7720bd7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Flogseq____&quot;,955,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1003,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ae99-4f46-9cc6-645a75c9896alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;What are other patient characteristics or risk factors?logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Flogseq____&quot;,954,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Vlogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^Ulogseq____&quot;,705,536871935]],[logseq____&quot;^15logseq____&quot;,[1004,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a68c-4cea-93a8-fe645b6d46fclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Research Guidelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Flogseq____&quot;,982,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1005,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7b8c-42fb-87e2-c54648ed6739logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Flogseq____&quot;,965,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Xlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Vlogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^Ulogseq____&quot;,705,536870916]],[logseq____&quot;^15logseq____&quot;,[1006,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b794-45af-9e80-bb9ab608454blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Flogseq____&quot;,1031,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1008,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2c82-426e-9126-f38ec7f7365flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Parsabiv.com](https://www.parsabiv.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Flogseq____&quot;,1033,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1009,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-843c-45ff-b06b-a42d72b7282dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Flogseq____&quot;,1041,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1010,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cec9-4bd0-be35-bdcd02124f8dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Parsabiv is administered intravenously at the end of each dialysis session, typically three times a week.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Flogseq____&quot;,1023,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1011,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6cae-4961-bc2d-1415c953ace0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Flogseq____&quot;,1035,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1012,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9b28-43d5-9183-831374470a3alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Flogseq____&quot;,1039,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1013,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-22b6-4035-8955-225bc80a32f0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Flogseq____&quot;,1025,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1014,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1424-4187-9c41-317e1c04ae95logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Parsabiv **lowers parathyroid hormone (PTH), phosphorus, and calcium levels in your blood**. It works by binding to and activating the [calcium-sensing receptor](https://en.wikipedia.org/wiki/Calcium-sensing_receptor) (CaSR) in the parathyroid glands by causes them to release less PTH, which is a hormone that is released in an attempt to raise calcium and potassium levels. Kidney failure can make the parathyroid glands release PTH, and over time these glands can grow larger and release too much of this hormone, which can result into secondary hyperparathyroidism. ([Read more about PTH](https://www.parsabiv.com/what-is-shpt#pthMean))logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Flogseq____&quot;,1010,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1015,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f226-446d-830d-17891a2ef633logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Parsabiv** (**etelcalcetide**, formerly **velcalcetide** and **AMG 416**) is a peptide calcmimetic drug (mimics calcium in the body) used for the treatment of [secondary hyperparathyroidism](https://en.wikipedia.org/wiki/Secondary_hyperparathyroidism) (sHPT) in patients undergoing hemodialysis (sHPT is common in people on hemodialysis), for which it was approved by the FDA in 2017. It is currently in phase 3 investigation for use in pediatric patients with chronic kidney disease (CKD) receiving hemodialysis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Flogseq____&quot;,1017,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1016,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-44ef-4ff1-8e55-1c706ed8c0fblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Flogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1017,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f55f-4cac-8fad-65c4bbc58daelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Flogseq____&quot;,1036,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1018,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1d12-460c-8f38-b7213edb7f9dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Phase I Pediatric studies are planned for the US and UK for etelcalcetide.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Flogseq____&quot;,1026,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1019,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c80b-4b11-92c0-d95e0574eb68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Flogseq____&quot;,1021,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1020,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-487a-4f7d-9145-3eb4a4498441logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Flogseq____&quot;,1019,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1021,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-622f-45a7-976c-4d4d83d632cblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Flogseq____&quot;,1029,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1022,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7b90-4072-ac99-d8225fa0c871logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Indicationlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Flogseq____&quot;,1027,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1023,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fe5b-40ee-b08c-e3ad1845f689logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Flogseq____&quot;,1011,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1024,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c4bd-44eb-8fbb-c3b46bc15be6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Flogseq____&quot;,1038,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1025,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-943d-4a97-9c07-8be185c43191logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Flogseq____&quot;,1037,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1026,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8eeb-425a-922f-6e92f28811f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Flogseq____&quot;,1030,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1027,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ca72-4e27-9a08-8bb91c2f313dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Flogseq____&quot;,1016,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1028,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a5a5-4be3-baf4-01900713ffd9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Flogseq____&quot;,1024,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1029,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-85b4-4c95-9662-9e024ee9907elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Flogseq____&quot;,1015,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1030,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ef72-4062-b73f-6e7a5492f608logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Flogseq____&quot;,1032,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1031,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bdb9-482c-9f14-10061ad74801logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Patient Brochure](https://www.parsabiv.com/Patient-Brochure)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Flogseq____&quot;,1043,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1032,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3a04-47ca-b1a7-375dfbc7a572logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Flogseq____&quot;,1020,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1033,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-64a7-408a-8c33-0daac9f22fc1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Flogseq____&quot;,1014,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1034,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7db8-4421-b5a3-a0ba7bcff87alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Parsabiv may cause hypocalcemia (low calcium levels), sometimes severe, worsening heart failure, upper gastrointestinal bleeding, adynamic bone disease or allergic reactions. An increase of the QT interval was detected in 1.2% of people receiving etelcalcetide.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Flogseq____&quot;,1022,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1035,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-04dd-4e21-88de-89ae562716d6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;No interaction studies in humans were conducted. Studies in vitro showed no affinity of etelcalcetide to cytochrome P450 enzymes or common transport proteins. Therefore, no relevant pharmacokinetic interactions are expected.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Flogseq____&quot;,1012,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1036,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e97-4b13-9197-e8952e14facalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Phase II trials found that Etelcalcetide was able to lower PTH levels in one cohort by -49% vs a 29% increase in the placebo group.[^1] In 2017, two Phase III trials found that using etelcalcetide showed greater symptom reduction compared to placebo.[^2]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Flogseq____&quot;,1034,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1037,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9782-4793-8aed-5d879eb36fd5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The drug is contraindicated in people with blood serum calcium levels below the norm.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Flogseq____&quot;,1018,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1038,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3b01-421d-a67f-8ff55205888elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: [\\logseq____&quot;Drug and Device News\\logseq____&quot;](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358678). *P logseq____&amp; T*. **42** (4): 223–265. April 2017. [PMC](https://en.wikipedia.org/wiki/PMC_(identifier)) [5358678](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358678). [PMID](https://en.wikipedia.org/wiki/PMID_(identifier)) [28381913](https://pubmed.ncbi.nlm.nih.gov/28381913).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Flogseq____&quot;,1042,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1039,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c9d7-435c-af73-c4b0f1b48aaflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Flogseq____&quot;,1008,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1040,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f54d-4cc2-ac47-64000a14a208logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Flogseq____&quot;,1028,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1041,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8260-4465-9ef9-b1904ccd61eelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Blair HA (December 2016). \\logseq____&quot;Etelcalcetide: First Global Approval\\logseq____&quot;. *Drugs*. **76** (18): 1787–1792. [doi](https://en.wikipedia.org/wiki/Doi_(identifier)):[10.1007/s40265-016-0671-3](https://doi.org/10.1007%2Fs40265-016-0671-3). [PMID](https://en.wikipedia.org/wiki/PMID_(identifier)) [27900648](https://pubmed.ncbi.nlm.nih.gov/27900648). [S2CID](https://en.wikipedia.org/wiki/S2CID_(identifier)) [45000617](https://api.semanticscholar.org/CorpusID:45000617).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Flogseq____&quot;,1040,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1042,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bb6b-4929-8391-3d36fc7204dflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](http://pi.amgen.com/united_states/parsabiv/parsabiv_pi.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Flogseq____&quot;,1009,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Xlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Vlogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^Ulogseq____&quot;,139,536870916]],[logseq____&quot;^15logseq____&quot;,[1043,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-32a7-4ef9-89e3-5b25a92db105logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;By fusing a peptide to part or all of an antibody, a peptibody combines the activity of a peptide with the longer duration of activity of an antibody.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Flogseq____&quot;,1047,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Vlogseq____&quot;,1047,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1045,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a691-40a9-a6ec-710dfd0a6166logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;While peptides have functions and attributes that give them significant therapeutic potential, they also tend to be rapidly cleared from the body. Consequently, peptide medicines may require daily injections, which limit their use to a relatively narrow list of diseases. By fusing a peptide to part or all of an antibody, a **peptibody** combines the activity of a peptide with the longer duration of activity of an antibody.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Flogseq____&quot;,1052,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1046,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cba1-4bbe-a6c9-9f460d1fa9d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![Peptibodies-Fig1_1169x800.jpg](../assets/Peptibodies-Fig1_1169x800_1687904087744_0.jpg){:height 482, :width 734}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Flogseq____&quot;,1050,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1047,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-10bc-463c-8772-625a8487ec8alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**By fusing a peptide to part or all of an antibody, a \\logseq____&quot;peptibody\\logseq____&quot; combines the activity of a peptide with the longer duration of activity of an antibody.**\\nid:: 649b5f26-8b55-4c53-aa77-7ffcb221d60elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Flogseq____&quot;,1049,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b5f26-8b55-4c53-aa77-7ffcb221d60elogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;649b5f26-8b55-4c53-aa77-7ffcb221d60elogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1048,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u649b5f26-8b55-4c53-aa77-7ffcb221d60elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Peptibody (Peptide + Antibody)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Flogseq____&quot;,1051,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1049,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ecd7-4c41-903b-7f00dc433212logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Flogseq____&quot;,1046,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1050,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2d03-4be9-88e5-2f68174d3d57logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Flogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1051,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8f03-4305-8fcc-a59aed1612fblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Flogseq____&quot;,1048,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1052,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dcf6-4707-9100-8978c3d12168logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Flogseq____&quot;,1047,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1053,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-de68-4a15-8249-8465b45d2af2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Peptibody - Amgen](https://www.amgen.com/stories/2018/08/the-shape-of-drugs-to-come/peptibody)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Flogseq____&quot;,1053,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Xlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Vlogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^Ulogseq____&quot;,127,536870916]],[logseq____&quot;^15logseq____&quot;,[1054,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c565-4d40-915b-e92a81eea26dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Products and indications that are currently in phase 1 clinical investigation.logseq____&quot;,536870958]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Flogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Xlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Vlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870958]],[logseq____&quot;^15logseq____&quot;,[1057,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1c5b-4ff5-944f-987e8ee5ecc8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Flogseq____&quot;,1057,536870955]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Xlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Vlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1059,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6432-425b-afb3-1e8c159c1fe9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## See Alsologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Flogseq____&quot;,1059,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Xlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Vlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1060,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bee8-46e8-8efc-16bb3532ad2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-3logseq____&quot;,536870965]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Flogseq____&quot;,1060,536870916]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Xlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Vlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Ulogseq____&quot;,116,536870962]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Ulogseq____&quot;,121,536870962]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870965]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^Hlogseq____&quot;,121,536870965]],[logseq____&quot;^15logseq____&quot;,[1061,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-89aa-46be-8b8b-5a90e3b17a43logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Flogseq____&quot;,1061,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Xlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Vlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Ulogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^Hlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1062,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e597-492b-9f21-329940b81b1dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Products and indications that are currently in phase 2 clinical investigation.logseq____&quot;,536870942]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Flogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Xlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Vlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^Ulogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870942]],[logseq____&quot;^15logseq____&quot;,[1064,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3f08-467a-a085-226039b88d4alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Flogseq____&quot;,1064,536870939]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Xlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Vlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^Ulogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1066,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d98d-4028-be3b-ef672abed70blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## See Alsologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Flogseq____&quot;,1066,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Xlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Vlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Ulogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1067,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6374-4036-9d54-7d8b357ab87dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-3logseq____&quot;,536870949]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Flogseq____&quot;,1067,536870916]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Xlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Vlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Ulogseq____&quot;,121,536870946]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Ulogseq____&quot;,135,536870946]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870949]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^Hlogseq____&quot;,121,536870949]],[logseq____&quot;^15logseq____&quot;,[1068,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7ea3-4412-8107-f726b87a87b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Flogseq____&quot;,1068,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Xlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Vlogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Ulogseq____&quot;,135,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1069,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-60de-4b1e-ada6-455ca8c5de79logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Products and indications that are currently in phase 3 clinical investigation.logseq____&quot;,536870935]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Flogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Xlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Vlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^Ulogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870935]],[logseq____&quot;^15logseq____&quot;,[1072,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b478-40a7-8036-dc02a2589ac0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Flogseq____&quot;,1072,536870932]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Xlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Vlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^Ulogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1074,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c76d-4a63-84fc-58d20b675b72logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## See Alsologseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Flogseq____&quot;,1074,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Xlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Vlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Ulogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1075,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-445e-488b-b3ac-3f17d84fbbdblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-2logseq____&quot;,536870924]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Flogseq____&quot;,1075,536870916]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Xlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Vlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Ulogseq____&quot;,121,536870921]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Ulogseq____&quot;,135,536870921]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870924]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^Hlogseq____&quot;,135,536870924]],[logseq____&quot;^15logseq____&quot;,[1076,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-301a-4717-972e-003a09d293c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#Phase-1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Flogseq____&quot;,1076,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Xlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Vlogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Ulogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Ulogseq____&quot;,121,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^Hlogseq____&quot;,116,536870916]],[logseq____&quot;^15logseq____&quot;,[1077,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ed95-4e44-bcfb-598b350e71c8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: https://www.tandfonline.com/doi/full/10.4161/mabs.1.3.8592logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Flogseq____&quot;,1093,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1079,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-06f7-4c6e-baf2-c8b3eb7078c7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Flogseq____&quot;,1097,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1080,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-985e-4844-8c2d-0e2a8da0130clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Medication Guide](http://pi.amgen.com/united_states/prolia/prolia_mg.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Flogseq____&quot;,1102,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1081,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-536b-4f2f-ba6f-372b97cdd8e9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Flogseq____&quot;,1091,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1082,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d870-4c75-85aa-42b69813f0f3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]: https://www.tandfonline.com/doi/full/10.1185/03007995.2013.763779logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Flogseq____&quot;,1088,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1083,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b10e-4fbd-a6fd-ee9ead405677logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^5]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358515/logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Flogseq____&quot;,1083,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1084,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-aa75-435d-8faa-da73fcb2266clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Flogseq____&quot;,1117,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1085,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bb30-4498-8ae8-5aded9747fd4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Flogseq____&quot;,1126,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1086,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-da02-4237-ba14-cfbaa4518a3flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Flogseq____&quot;,1114,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1087,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-818e-4fde-b4e9-8ff7ca204479logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069896/logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Flogseq____&quot;,1079,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1088,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ba31-4cce-bc19-dff6d52a888flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A 2017 review did not find any benefits in males.[^5]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Flogseq____&quot;,1125,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1089,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ec2c-49cd-9b1e-2a6a77b99d4blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Flogseq____&quot;,1087,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1090,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4601-40fa-afe7-731cb05e1447logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prolia can cause serious side effects and serious allergic reactions. The most common side effects *in women being treated for osteoporosis after menopause* are back pain, pain in the arms and legs, high cholesterol, muscle pain and bladder infections.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Flogseq____&quot;,1115,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1091,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-61d9-4321-b96f-06a7a84d42f7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Flogseq____&quot;,1112,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1092,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-310f-4368-a1e3-800c7fb16258logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.nejm.org/doi/full/10.1056/NEJMoa044459logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Flogseq____&quot;,1113,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1093,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c017-4a9f-879a-82700f1cc6b7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Flogseq____&quot;,1086,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1094,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-735c-46f7-805a-e0f3cb9a3775logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A 2013 review concluded that twice-yearly denosumab treatment is associated with markedly improved bone mineral density (BMD) and cortical and trabecular bone strength, and significantly reduced osteoporotic fracture.[^4]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Flogseq____&quot;,1116,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1095,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e585-46ef-97a4-95256a9b5f1blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Flogseq____&quot;,1094,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1096,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3c58-4fc3-b71b-8985a28ac5fclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prolia is an injection for subcutaneous use once every 6 months that works with your body to help stop the development of bone-removing cells. Otherwise, there would be an excess of bone-removing cells in the body, making it lose bone faster than it can rebuild it, putting bones at risk of fracture.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Flogseq____&quot;,1127,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1097,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1a31-4519-8516-c25d6e8fdf66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](http://pi.amgen.com/united_states/prolia/prolia_pi.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Flogseq____&quot;,1081,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1098,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0f26-4965-9492-25cc68bc3d80logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Denosumab is a [[Monoclonal Antibody]] that mimics the natural action of [osteoprotegerin](https://en.wikipedia.org/wiki/Osteoprotegerin), an endogenous RANKL *inhibitor*, that presents with decreasing concentrations (and perhaps decreased effectiveness, or *[avidity]((https://en.wikipedia.org/wiki/Avidity))*) in patients with osteoporosis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Flogseq____&quot;,1096,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1099,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-14ca-430f-8c89-bde06778a05blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a meta-analysis, compared to placebo, denosumab treatment significantly decreased the risk of non-vertebral fracture but increased the risk of serious adverse effects (SAE) related to infection in the postmenopausal women with osteoporosis or low blood mineral density (BMD). Although many studies reported that denosumab was well tolerated, there were many potential theoretical safety concerns. A concern regarding the long-term use of denosumab relates to its possible effects on the immune system, increasing the risk of infections and cancer, however, no significant effect on the risk of cancer was found but the result showed the increase in the risk of SAE related to infection. Further studies need to be done to verify the result of this meta-analysis and explain the reason that why the results were inconsistent with the theoretical speculation. No difference between the safety of denosumab and bisphosphonates was found.[^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Flogseq____&quot;,1104,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1100,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3ca0-49c9-b6a6-e1f1ec7d8a79logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[RANK](https://en.wikipedia.org/wiki/RANK) (receptor activator of [nuclear factor-kappa B](https://en.wikipedia.org/wiki/NF-%CE%BAB)) are surface receptors expressed on pre-osteoclasts, and they are activated by RANKL (the RANK-Ligand), which exists as cell surface molecules on [osteoblasts](https://en.wikipedia.org/wiki/Osteoblast) (osteoblasts secrete new bone). Activation of RANK by RANKL promotes the maturation of pre-osteoclasts into [osteoclasts](https://en.wikipedia.org/wiki/Osteoclast) (which break down bone). Denosumab inhibits this maturation of osteoclasts by binding to and inhibiting RANKL. This protects bone from degradation, and helps to counter the progression of the disease.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Flogseq____&quot;,1120,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1101,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cf43-4614-a374-e3bf78122323logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prolia.com](https://www.prolia.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Flogseq____&quot;,1107,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1102,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dc8e-4d8a-9d75-bcd8cf388316logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Flogseq____&quot;,1111,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1103,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6959-47c1-acc0-46f8802b5c39logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Flogseq____&quot;,1105,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1104,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-271f-4532-88e1-fb7324058cfdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a 1-year study, Prolia showed a significant increase in bone mineral density at the hip and lumbar spine vs alendronate (a commonly prescribed bisphosphonate).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Flogseq____&quot;,1085,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1105,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1e48-4b03-ad1f-2c55b3a778c1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prolia should not be taken with low calcium levels or in women who are pregnant or plan to become pregnant. Prolia may affect the immune system; people with weakened immune system may be at an increased risk for serious infections. It is also noted that Prolia should not be taken together with XGEVA, as they contain the same ingredient, denosumab.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Flogseq____&quot;,1092,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1106,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a56b-48a3-a783-18159a9fc2fdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Flogseq____&quot;,1121,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1107,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-721e-4624-ab2c-f61f4b7ba121logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Flogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1108,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ff1a-4bf0-bac7-349b287d10b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is currently in phase 3 investigation for the treatment of glucocorticoid-induced osteoporosis (GIOP) in pediatric patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Flogseq____&quot;,1128,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1109,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-07c9-49df-93e1-451775293f3elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Flogseq____&quot;,1089,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1110,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-cfcc-43df-bb74-28071875953clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Women taking Prolia for 3 years reduced their risk of new spine fractures by 68%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Flogseq____&quot;,1090,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1111,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bd97-4a88-8cf7-02d0ebd1a728logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prolia can cause low blood calcium (hypocalcemia). Severe jaw bone problems (osteonecrosis), unusual thigh bone fractures, skin problems, bone, joint and muscle pain and serious infections in the skin or lower stomach area have been reported and can occur. An increased risk of breaking bones, including the spine, can occur when stopping, skipping or delaying Prolia.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Flogseq____&quot;,1082,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1112,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0989-401b-b195-e5eb84b086a7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Flogseq____&quot;,1118,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1113,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c415-411c-9693-9b1d6e658b0clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Flogseq____&quot;,1106,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1114,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ae1e-4e36-afae-33a51e152a09logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Flogseq____&quot;,1119,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1115,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8bd4-42b7-b89f-753a0fe75de2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Flogseq____&quot;,1100,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1116,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5aee-423b-9ab8-fbaa71180df7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Results from the 3-year study proved that Prolia significantly reduces fractures of the spine, hip, and other bones, helps increase bone density and Helps make bones stronger with 1 shot every 6 months.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Flogseq____&quot;,1103,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1117,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5bfb-45a7-bd3f-c2cc93ed0ef2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Flogseq____&quot;,1123,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1118,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-32ab-4b13-b048-e78fcec00760logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Flogseq____&quot;,1122,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1119,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d7c4-491c-a1b5-330303b246dblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Flogseq____&quot;,1099,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1120,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-218b-428e-a165-6988cb6763b3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Flogseq____&quot;,1110,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1121,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bc40-4476-8609-2b00d7c2d9bblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Flogseq____&quot;,1101,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1122,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-50cb-4416-81a7-34ac802dc57dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Flogseq____&quot;,1098,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1123,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c4b6-491a-a586-e5472137e0eclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Prolia** (**denosumab**, **AMG 162**, also marketed as **Xgeva**) is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well. In women, bone loss increases after menopause, when estrogen levels drop, and they can lose up to 20% of bone mass. It is also used increase bone mass in men with osteoporosis who are at high risk for fracture, in men who are at high risk for fracture receiving certain treatments for prostate cancer, in women who are at high risk for fracture receiving certain treatments for breast cancer, or in men and women who will be taking [[corticosteroid]] medicines for at least six months and are at high risk for fracture, for treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab was approved by the FDA in 2009.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Flogseq____&quot;,1108,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Ulogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^Hlogseq____&quot;,269,536870916]],[logseq____&quot;^15logseq____&quot;,[1124,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9e74-4c44-a074-506741e6d833logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Flogseq____&quot;,1095,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1125,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ce3b-4c12-862a-b1b3199ad44elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Prolia should be stored in the refrigerator and must be used within 14 days when removed from the refrigerator.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Flogseq____&quot;,1080,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1126,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c41b-40af-860e-80296c454234logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Flogseq____&quot;,1109,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1127,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-39b3-46fa-8435-a859cab39f23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Flogseq____&quot;,1124,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Xlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Vlogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^Ulogseq____&quot;,123,536870916]],[logseq____&quot;^15logseq____&quot;,[1128,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9451-4353-821c-e2074f2f5a82logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Flogseq____&quot;,1165,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1134,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1077-4b9e-ad94-4a59ffe57abelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Evolocumab is designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface. In the absence of PCSK9, there are more LDL receptors on the surface of liver cells to remove LDL-C from the blood.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Flogseq____&quot;,1138,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1135,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7d13-4b3a-8c2f-954d5940094flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Flogseq____&quot;,1142,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1136,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e90c-49bc-9d7c-e7502f9c7408logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Patients lowered bad cholesterol by an average of 63% in just 3 months, with effects already starting within 1 month.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Flogseq____&quot;,1168,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1137,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e585-46ab-b2cd-5b2c1a6c251alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Flogseq____&quot;,1166,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1138,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7239-400a-9204-bfd53797ecd8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Repatha comes as an injection at a dose of 140mg/mL that comes in three different forms:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Flogseq____&quot;,1152,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1139,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f0d1-474a-bff2-06779b8e2c2blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Flogseq____&quot;,1157,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1140,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bc6e-4fae-8836-7038e29b05f4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Flogseq____&quot;,1153,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1141,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5992-4d1b-8ec1-d0069cd12f42logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Flogseq____&quot;,1135,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1142,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dacf-4a6d-b694-ad0bd9623a39logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Flogseq____&quot;,1158,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1143,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1889-4811-9967-99d196ff0f7alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Flogseq____&quot;,1149,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1144,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4592-4f99-ab22-128fdf96444elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Pushtronex ®  System**: Single-dose on-body infusor with prefilled cartridge for use once a month (5m).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Flogseq____&quot;,1164,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Vlogseq____&quot;,1139,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1145,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7af0-417b-9384-4166ec0efbaflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: Weinreich M, Frishman WH (2014). \\logseq____&quot;Antihyperlipidemic therapies targeting PCSK9\\logseq____&quot;. *Cardiology in Review*. **22** (3): 140–6. [doi](https://en.wikipedia.org/wiki/Doi_(identifier)):[10.1097/CRD.0000000000000014](https://doi.org/10.1097%2FCRD.0000000000000014). [PMID](https://en.wikipedia.org/wiki/PMID_(identifier)) [24407047](https://pubmed.ncbi.nlm.nih.gov/24407047). [S2CID](https://en.wikipedia.org/wiki/S2CID_(identifier)) [2201087](https://api.semanticscholar.org/CorpusID:2201087).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Flogseq____&quot;,1161,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1146,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0e2c-4887-a97b-ac65495c0dc1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Prefilled Syringe**: Single use prefilled syringe.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Flogseq____&quot;,1145,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Vlogseq____&quot;,1139,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1147,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fc93-40ee-aa12-4fa9d287c64blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Repatha** (**evolocumab**) is a [[Monoclonal Antibody]] medication which is approved by the FDA for treating hyperlipidemia, or high levels of lipids or lipoproteins in the blood. Evolocumab inhibits [proprotein convertase subtilisin/kexin type 9 (PCSK9)](https://en.wikipedia.org/wiki/PCSK9). it enhances the liverlogseq____&apos;s ability to remove [LDL-C](https://en.wikipedia.org/wiki/LDL-C), often simplistically referred to as \\logseq____&quot;bad\\logseq____&quot; cholesterol, from the blood[^1] [^2] and reduces the risk of heart attack, stroke and other complications. It works differently from statin drugs, which merely help stop the liver from making as much cholesterol. It is used alongside a healthy diet, either alone or in combination with other cholesterol-lowering drugs.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Flogseq____&quot;,1160,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1148,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7005-42e9-b50c-4215525a47b6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Repatha can cause serious side effects, including serious allergic reactions. The most common side effects include pain at the injection site, flu-like symptoms and high blood sugar. In clinical trials with more than 26,000 patients, Repatha demonstrated a consistent safety profile.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Flogseq____&quot;,1163,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1149,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-88a9-4c07-aed2-cc66cc33df6dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Flogseq____&quot;,1159,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1150,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-469a-44c6-99d0-0bbe92780de8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Flogseq____&quot;,1154,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1151,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-eda4-4846-8bf1-4c70db06669dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Flogseq____&quot;,1148,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1152,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0624-4e20-825e-c85ed47ab10clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In 2015 it cost about US$14,100 per year. One article calculated this to be about $400,000 to $500,000 per [quality-adjusted life year](https://en.wikipedia.org/wiki/Quality-adjusted_life_year) (QALY), which did not meet \\logseq____&quot;generally accepted\\logseq____&quot; cost-benefit thresholds. In 2018, Amgen announced a 60% cut in price and the drug at that date cost $5,850 per year.[^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Flogseq____&quot;,1151,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1153,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-156e-48fa-8496-1e819e426133logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [How to use Repatha](https://www.repatha.com/how-to-start-repatha-injection)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Flogseq____&quot;,1162,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1154,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7c52-4100-a106-65ddc2761458logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Repatha.com](http://www.repatha.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Flogseq____&quot;,1156,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1155,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c02d-4eb0-8834-a08d5f04407clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Flogseq____&quot;,1150,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1156,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8bb2-4d86-ad1c-9d040913fb84logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Flogseq____&quot;,1144,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1157,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5ddc-4e12-9470-3ca02f169e7dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Flogseq____&quot;,1167,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1158,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-970b-48ce-b009-7778e79b0b88logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Flogseq____&quot;,1134,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1159,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6739-441a-8966-bce860312546logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Flogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1160,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-74f2-4601-b814-c1b653c6cfc8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Coppinger C, Movahed MR, Azemawah V,  et al. (May 20, 2022). \\logseq____&quot;A Comprehensive Review of PCSK9 Inhibitors\\logseq____&quot;. *Journal of Cardiovascular Pharmacology and Therapeutics*. **27**: 1–14. [doi](https://en.wikipedia.org/wiki/Doi_(identifier)):[10.1177/10742484221100107](https://doi.org/10.1177%2F10742484221100107). [PMID](https://en.wikipedia.org/wiki/PMID_(identifier)) [35593194](https://pubmed.ncbi.nlm.nih.gov/35593194). [S2CID](https://en.wikipedia.org/wiki/S2CID_(identifier)) [248918656](https://api.semanticscholar.org/CorpusID:248918656).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Flogseq____&quot;,1143,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1161,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-094a-4528-817c-0bce334acaaalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Repatha should be stored in the refrigerator, but can be stored at room temperature (up to 77°F) for up to 30 days.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Flogseq____&quot;,1139,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1162,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8d89-4cb5-87dd-577c3340be33logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Side Effectslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Flogseq____&quot;,1136,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1163,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1f91-457c-b32e-7af008618a83logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**SureClick ®  Autoinjector**: Single-dose prefilled autoinjector for use every two weeks (15s).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Flogseq____&quot;,1139,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Vlogseq____&quot;,1139,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1164,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3d3d-4c8d-b0be-10e18a4e9706logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Repatha plus a statin is proven to reduce the chance of heart attack by 27%.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Flogseq____&quot;,1137,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1165,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3ba9-4261-93aa-baa7af28f424logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Flogseq____&quot;,1141,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1166,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4328-4103-bf29-62ecbde33ad8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Flogseq____&quot;,1169,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1167,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ebee-4f4d-863c-7a4111abb2e2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Up to 90% of patients dramatically lowered their bad cholesterol with Repatha plus a statin to 70 mg/dL or below at 48 weeks.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Flogseq____&quot;,1140,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1168,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8ec6-4a6b-891f-49bc040d59c5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](http://pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Flogseq____&quot;,1155,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1169,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0aae-4f7d-88c4-f84a5dcf1b6clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: Goldman, Dana. [\\logseq____&quot;The bigger message behind Amgenlogseq____&apos;s decision to slash cost of its Repatha cholesterol drug\\logseq____&quot;](https://www.marketwatch.com/story/the-bigger-money-message-behind-amgens-decision-to-slash-the-cost-of-its-repatha-cholesterol-drug-2018-10-26?siteid=yhoof2logseq____&amp;yptr=yahoo). *MarketWatch*. Retrieved 2018-10-28.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Flogseq____&quot;,1146,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Xlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Vlogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^Ulogseq____&quot;,117,536870916]],[logseq____&quot;^15logseq____&quot;,[1170,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-31a2-42c2-9bb7-8e16264ff1d4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Flogseq____&quot;,1189,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1172,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-598b-40fb-a15a-c4b3dfae0189logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Rocatinlimab inhibits and reduces the number of OX40 pathogenic T cells - an immune molecule involved in activating inflammatory cells that play a key role in the development of atopic dermatitis and other inflammatory diseases.[^2] The anti-OX40 antibody, rocatinlimab inhibits the OX40 pathway. OX40, a co-stimulatory molecule predominantly expressed on activated effector T cells, is prominently expressed in people with atopic dermatitis. Through its mechanism of action, rocatinlimab is designed to block OX40 and prevent the generation of signals that are critical for the expansion and survival of pathogenic T cells and the subsequent generation of memory T cells, thereby inhibiting the inflammatory response.[^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Flogseq____&quot;,1175,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1173,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8924-4311-9d0e-dc1a27f4f848logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Flogseq____&quot;,1184,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1174,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7af0-48d0-a442-89ac00315531logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Flogseq____&quot;,1174,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1175,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b602-47a5-b99e-d33ea3217b5flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Flogseq____&quot;,1182,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1176,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-878a-4ff2-ad3e-c4e33e8fda9elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: “Collaborating to Address Moderate to Severe Atopic Dermatitis.” Accessed July 17, 2023. https://www.amgen.com/stories/2023/01/collaborating-to-address-moderate-to-severe-atopic-dermatitis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Flogseq____&quot;,1179,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1177,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ea7e-455f-9dbb-c2c31fd3c7d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Rocatinlimab** (**AMG 451, KHK4083**) is a a potential first-in-class anti-OX40 [[Monoclonal Antibody]] that is currently in phase 3 investigation for the treatment of moderate-to-severe atopic dermatitis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Flogseq____&quot;,1180,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1178,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4768-4dee-acfe-c5586f2b1a4flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: “New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results | Mount Sinai - New York.” *Mount Sinai Health System*, https://www.mountsinai.org/about/newsroom/2022/new-treatment-for-moderate-to-severe-atopic-dermatitis-shows-promising-long-term-results.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Flogseq____&quot;,1185,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1179,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-091c-41f9-bfdb-7cace683d7belogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Flogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1180,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ffa4-4d0d-8de8-0f857559bafalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Flogseq____&quot;,1188,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1181,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-96a2-40d5-b03b-09e6ba85432clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Flogseq____&quot;,1186,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1182,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bd3d-4e69-998a-0acae61a8766logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;https://zbib.org/8bbc4b36476241759c30f70a10177710logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Flogseq____&quot;,1181,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1183,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e2c0-47c1-876b-06bf44709b3flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Flogseq____&quot;,1178,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1184,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d989-4339-a9e0-43d2e5419b70logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Guttman-Yassky, Emma, et al. “An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study.” The Lancet, vol. 401, no. 10372, Jan. 2023, pp. 204–14. DOI.org (Crossref), https://doi.org/10.1016/S0140-6736(22)02037-2.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Flogseq____&quot;,1187,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1185,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f39e-4a5e-a58a-4ca5693fecc1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Flogseq____&quot;,1173,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1186,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3e88-4c48-9e46-302daefddaedlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Flogseq____&quot;,1172,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1187,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-baec-4f86-89aa-bc9bf85125f1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]: “Eczema: New Drug Eases Symptoms in Young Children,” October 5, 2022. https://www.medicalnewstoday.com/articles/new-drug-helped-reduce-eczema-in-75-in-infants-and-young-children.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Flogseq____&quot;,1177,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1188,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e8f4-498b-9a22-081a05b47d4clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Flogseq____&quot;,1190,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1189,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1fd2-4862-b4f7-852ed16c1ffalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Patients treated with rocatinlimab had progressive improvements in atopic dermatitis, which was maintained in most patients after treatment discontinuation. Treatment was well tolerated.[^1][^4] Percent change from baseline in the Eczema Area and Severity Index (EASI) score was assessed, with all active rocatinlimab doses (-48% to -61%) doses compared to placebo (-15%). The most common adverse events during the double-blind period in patients receiving rocatinlimab were pyrexia (17%), nasopharyngitis (14%), chills (11%), headache (9%), aphthous ulcer (7%), and nausea (6%). There were no deaths.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Flogseq____&quot;,1176,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Xlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Vlogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^Ulogseq____&quot;,122,536870916]],[logseq____&quot;^15logseq____&quot;,[1190,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2b23-40d7-97eb-130715d3b9a2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Flogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Xlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Vlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1192,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0b87-49a8-9d31-9688e77bed41logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Squamous cell carcinoma of the lung** (SCC) is the second most common type of NSCLC, representing 25 to 30 percent of all NSCLC diagnoses. It is more common in men than in women and is closely correlated with smokers, more so than with other forms of NSCLCs or lung cancers, and it is more likely to spread to other areas of the body, making it more difficult to treat.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Flogseq____&quot;,1192,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Xlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Vlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1193,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ab8c-4176-8a26-e8bc2accee5blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Squamous cell carcinoma originates in the bronchi, in so-called squamous cells (a sub-type of [[epithelial tissue]]).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Flogseq____&quot;,1193,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Xlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Vlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Ulogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^Hlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1194,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-819a-4c6e-bceb-2ae754a459a7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Squamous cells, thin flat cells lining the surfaces of organs, are found in the lining of the bronchi.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Flogseq____&quot;,1194,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Xlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Vlogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^Ulogseq____&quot;,606,536870916]],[logseq____&quot;^15logseq____&quot;,[1195,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-398f-40ea-be43-439c422a2cfdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: Menzies-Gow, Andrew, Jonathan Corren, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Michael Wechsler, Christopher Brightling, et al. “Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.” New England Journal of Medicine 384, no. 19 (2021): 1800. https://doi.org/10.1056/NEJMoa2034975.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Flogseq____&quot;,1219,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1197,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-046d-422e-b927-5175e08f20delogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Flogseq____&quot;,1222,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1198,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7c39-4a2b-bf8b-1bdcbf19fa3dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: EMA. “Tezspire.” Text. European Medicines Agency, July 19, 2022. https://www.ema.europa.eu/en/medicines/human/EPAR/tezspire.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Flogseq____&quot;,1212,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1199,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b224-4726-93df-83f47e0d19bclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Flogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1200,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f7f8-48ee-a3e8-0828907f0efdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Two main studies including over 1,500 adults and adolescents with inadequately controlled asthma showed that tezepelumab was effective in reducing the number of severe asthma flare‑ups.[^1] In the first study, patients given Tezspire had on average 0.93 asthma flare‑ups per year after one year of treatment compared with 2.10 in patients given placebo (a dummy treatment). In the second study, patients taking Tezspire had an average of 0.20 flare‑ups per year after one year, compared with 0.72 in patients who received placebo.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Flogseq____&quot;,1226,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1201,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a931-4bac-8215-97e7f8ef942dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Thymic stromal lymphopoietin](https://en.wikipedia.org/wiki/Thymic_stromal_lymphopoietin) (TSLP) is released by the airway linings in response to asthma triggers and creates a chain reaction, leading to airway inflammation, with too much TSLP leading to an asthma attack. TEZPIRE prevents TSLP from attaching to its receptor and thereby reduces airway inflammation and asthma symptoms.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Flogseq____&quot;,1225,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1202,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0ae3-415c-8c5f-e09cdd1497d6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Tezpire.com](https://www.tezspire.com/)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Flogseq____&quot;,1204,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1203,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-30a1-477c-baf6-6a5c6f1fcd1blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Flogseq____&quot;,1208,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1204,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5114-4262-9626-1dc2a2ea724clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**TEZPIRE** (**tezepelumab-ekko**) is a [[Monoclonal Antibody]] that is used as an add-on maintenance treatment for severe asthma in patients aged 12 or older who are taking medium- to high-dose inhaled corticosteroids and at least one other controller medication. TEZSPIRE proactively helps reduce inflammation. It was approved by the FDA in the US in 2021 and in the EU in 2022. It is also currently being investigated for:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Flogseq____&quot;,1200,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^Hlogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1205,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5849-4e85-b83e-be5ddb7c1f4alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In phase III trials, tezepelumab demonstrated efficacy compared to placebo for patients with severe, uncontrolled asthma.[^2] [^3]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Flogseq____&quot;,1210,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1206,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-aabf-466c-b918-8cf5048c31c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;the treatment of chronic spontaneous urticaria (CSU). (Phase 2)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Flogseq____&quot;,1217,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Vlogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1207,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fe0c-49f4-90eb-d1a4fead4553logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Flogseq____&quot;,1220,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1208,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f65c-443b-80b0-53234136ba35logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Flogseq____&quot;,1224,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1209,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c0b9-4791-ab0f-eefce539c457logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Flogseq____&quot;,1201,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1210,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1c41-48ca-aa34-42203a28ae4flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;the reduction of oral corticosteroid use in adults with oral corticosteroid dependent asthma. (Phase 3)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Flogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Vlogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1211,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8883-471f-860a-73eb551808a3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Flogseq____&quot;,1215,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1212,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-31f1-4fba-a8c1-3d044fab6b55logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). (Phase 3)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Flogseq____&quot;,1211,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Vlogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1213,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dbbd-47da-bf46-a3d417f14258logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Flogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1214,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3956-4391-8a4a-da1239e3bba7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Flogseq____&quot;,1223,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1215,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d394-47ed-8f64-c7808d35e9e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Prescribing Information](https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Flogseq____&quot;,1203,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1216,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a099-40d2-b1cb-310be78c144clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;the treatment of chronic obstructive pulmonary disease (COPD). (Phase 2)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Flogseq____&quot;,1227,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Vlogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1217,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d558-46da-a9ab-ee3b76a28b83logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Flogseq____&quot;,1221,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1218,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9c1d-4225-bdb5-b72636bc3a80logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: “CTG Labs - NCBI.” Accessed July 17, 2023. https://www.clinicaltrials.gov/search?term=Tezepelumab.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Flogseq____&quot;,1199,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1219,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0af1-4083-b27d-5adfb4e7ae23logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Flogseq____&quot;,1206,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1220,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b8b9-4f66-9797-3504ce67decelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;TEZSPIRE is not indicated for the relief of acute bronchospasm or status asthmaticus. The most common side effects with Tezspire are arthralgia (joint pain) and pharyngitis (sore throat).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Flogseq____&quot;,1214,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1221,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1bae-4b08-9edf-a950ed150170logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;TEZSPIRE is administered subcutaneously by a healthcare provider once every 4 weeks, at a recommended dose of 210 mg. This medicine is used for long-term treatment.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Flogseq____&quot;,1218,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1222,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ac67-4c49-9e0e-75bfebeb9056logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Flogseq____&quot;,1216,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1223,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7a53-476a-88ea-5a804809c3dclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Flogseq____&quot;,1202,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1224,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dbfe-44d2-8d7c-b6c2e316a998logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Flogseq____&quot;,1228,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1225,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6876-4120-adcc-014f59590f95logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Flogseq____&quot;,1209,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1226,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-08a4-4430-8330-78510aa21934logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;the treatment of eosinophilic esophagitis (EoE). (Phase 3)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Flogseq____&quot;,1213,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Vlogseq____&quot;,1205,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Ulogseq____&quot;,37,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1227,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2f04-453e-af21-97d8262e778elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Flogseq____&quot;,1198,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Xlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Vlogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^Ulogseq____&quot;,128,536870916]],[logseq____&quot;^15logseq____&quot;,[1228,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4028-47f2-80cb-04bced6eceaalogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Flogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Xlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Vlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1230,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7d50-456a-97bd-74b7521b3868logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The TNM system provides a comprehensive way of describing the extent of the cancer, which is critical for determining the best treatment options and estimating the prognosis. The TNM categories are used in combination to assign an overall stage to the cancer, which ranges from stage I to IV.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Flogseq____&quot;,1230,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Xlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Vlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1231,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-196c-4e73-a74d-7cbd879b893flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Flogseq____&quot;,1231,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Xlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Vlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1232,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3101-40de-a611-9a1f0144c693logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The stages are confined into the T, N and M stages.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Flogseq____&quot;,1232,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Xlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Vlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1233,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7edf-4a80-95ef-9a2177b4c591logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Flogseq____&quot;,1233,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Xlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Vlogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^Ulogseq____&quot;,712,536870916]],[logseq____&quot;^15logseq____&quot;,[1234,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0e32-4116-a41f-00ec86b31107logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Flogseq____&quot;,1245,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1236,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2a1f-4f13-8a86-005c5c4df84blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Flogseq____&quot;,1244,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1237,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1687-4c51-b26f-72ae1fb38135logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Flogseq____&quot;,1255,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1238,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b7cb-4993-8fc7-ba5c9ff67ac7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Tarlatamab is being investigated in multiple studies, including DeLLphi-301, a potentially registrational Phase 2 study in third line or later relapsed/refractory SCLC; DeLLphi-303, a Phase 1b study testing tarlatamab in combination with standard of care therapies in first-line SCLC; DeLLphi-302, a Phase 1b combination study with AMG 404 in second-line or later SCLC; and DeLLpro-300, a Phase 1b study in de novo or treatment-emergent NEPC.[^2]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Flogseq____&quot;,1238,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1239,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a769-4e4f-8cfb-480003e0835blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Flogseq____&quot;,1242,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1240,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e201-4ed8-9e48-cbb3c4f7d05blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Flogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1241,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3aa4-4a04-a16c-bafff6d33855logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Tarlatamab** (**AMG 757**) is a first-in-class DLL3-Targeted, half-life extended [[BiTE Molecule]] that is currently in phase 3 investigation for the treatment of small-cell lung cancer (SCLC). Tarlatamab is also in Phase 2 development for the treatment of SCLC as a monotherapy and in phase 1 for SCLC in combination with other therapies and in phase 1 for the treatment of neuroendocrine prostate cancer.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Flogseq____&quot;,1241,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^Hlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[1242,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f031-48fe-bc4d-f9e54210587alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Flogseq____&quot;,1249,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1243,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6023-4fac-9ffc-06530739c140logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Flogseq____&quot;,1240,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1244,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-13e4-4405-97a2-ef8aa940c097logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Flogseq____&quot;,1243,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1245,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5ad6-4331-bc61-dc43788d6f6alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Flogseq____&quot;,1247,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1246,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b7e8-4aae-bfc1-7b87ffdd91c3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: Amgen. “AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022.” Accessed July 17, 2023. https://www.amgen.com/newsroom/press-releases/2022/08/amgen-presents-new-tarlatamab-clinical-data-at-wclc-2022.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Flogseq____&quot;,1250,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1247,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2382-4eaa-9b8a-4453e4ea77b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Flogseq____&quot;,1253,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1248,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4cfb-4ab2-9968-7e8611ed56fflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [www.tarlatamabclinicaltrials.com](https://tarlatamabclinicaltrials.com/).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Flogseq____&quot;,1254,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1249,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6230-4858-8ecc-53752405028blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: Paz-Ares, Luis, Stephane Champiat, W. Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael Boyer, Horst-Dieter Hummel, et al. “Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.” *Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology* 41, no. 16 (June 1, 2023): 2893–2903. https://doi.org/10.1200/JCO.22.02823.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Flogseq____&quot;,1236,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1250,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a7cf-4e1b-838c-e3afcb9256fflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Delta-like ligand 3 (DLL3) is aberrantly expressed in most SCLC. Tarlatamab, a half-life extended bispecific T-cell engager molecule (HLE BiTE Molecule), binds both DLL3 and CD3 leading to T-cellb-mediated tumor lysis/breakdown in neuroendocrine cancers, such as [[small cell lung cancer]] (SCLC) and neuroendocrine prostate cancer.[^1] DLL3 is highly upregulated on the cell surface of neuroendocrine tumors (expressed in greater than 80% of SCLC tumors) and rarely expressed on nonmalignant cells, making it a novel target for investigating a BiTE immuno-oncology molecule.[^2]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Flogseq____&quot;,1237,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Ulogseq____&quot;,624,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^Hlogseq____&quot;,624,536870916]],[logseq____&quot;^15logseq____&quot;,[1251,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1fb5-46ab-91ed-8bd308b5373alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Researchlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Flogseq____&quot;,1248,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1252,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fb50-4fb9-84da-5b7bb9cd0622logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Flogseq____&quot;,1251,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1253,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3b46-404f-bedb-1d5a38cf7fb5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Flogseq____&quot;,1239,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1254,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5466-487d-bb29-afc1a1a0d50blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In a study with 107 patients, objective response rate was 23.4%, including two complete and 23 partial responses. The median duration of response was 12.3 months. The disease control rate was 51.4%. The median progression-free survival and overall survival were 3.7 months and 13.2 months, respectively. Exploratory analysis suggests that selecting for increased DLL3 expression can result in increased clinical benefit. Cytokine release syndrome was the most common treatment-related adverse event, occurring in 52% of patients. Overall, tarlatamab demonstrated manageable safety with encouraging response durability.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Flogseq____&quot;,1252,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Xlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Vlogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^Ulogseq____&quot;,142,536870916]],[logseq____&quot;^15logseq____&quot;,[1255,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bdfb-4544-9eda-b74c6ca90acflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Flogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Xlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Vlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1257,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0b4d-4a5f-8ce1-e6a4716cb478logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Adenocarcinoma of the Lung\\nheading:: 1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Flogseq____&quot;,1257,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Xlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Vlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1258,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-21e0-4cb5-80b7-7a9e3ac5a785logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Adenocarcinoma** represents about 40 percent of all NSCLC and lung cancer diagnoses. Adenocarcinoma affects both smokers and nonsmokers, and it is most common for non-smoking (lifelong) cancer patients.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Flogseq____&quot;,1258,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Xlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Vlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1259,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1feb-4e0b-a9a9-2962574e7f02logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Flogseq____&quot;,1259,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Xlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Vlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1260,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e033-4a36-ad0f-c308da47ef4flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Adenocarcinoma usually begins in the outer areas of the lung, in mucus-producing cells that line the small airways, called bronchioles (although recent studies have found that the \\logseq____&quot;ratio of centrally to peripherally occuring\\logseq____&quot; lesions may be converging toward unity with centrally located cancers such as squamous-cell carcinoma {citation needed}). It tends to grow more slowly than other types of lung cancer and thus, generally has a better prognosis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Flogseq____&quot;,1260,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Xlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Vlogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^Ulogseq____&quot;,703,536870916]],[logseq____&quot;^15logseq____&quot;,[1261,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3aee-435d-a648-f4b7c3f67145logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^Klogseq____&quot;,1691874785357,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;arteriosclerosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^11logseq____&quot;,logseq____&quot;arteriosclerosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^Blogseq____&quot;,1691874785357,536870916]],[logseq____&quot;^15logseq____&quot;,[1263,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b4cf-4a9e-8468-07f89a76e1bdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^Klogseq____&quot;,1691874785357,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;atherosclerosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^11logseq____&quot;,logseq____&quot;atherosclerosislogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^Blogseq____&quot;,1691874785357,536870916]],[logseq____&quot;^15logseq____&quot;,[1264,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-700e-41ea-a2e7-65ef7733b8b0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Flogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1265,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-837f-4880-a4d5-cac0c05e1b85logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Arteriosclerosis occurs when the arteries become thick and stiff.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Flogseq____&quot;,1265,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1266,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ed96-4b68-8730-e1783b3fdf30logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Flogseq____&quot;,1266,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1267,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4a81-491d-b1cc-15d68814c7bblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Formslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Flogseq____&quot;,1267,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1268,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-57b5-4c28-bbe7-c8ffb0f4df24logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[atherosclerosis]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Flogseq____&quot;,1268,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Ulogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^Hlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1269,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9805-4b5d-929f-9aaf5502dca7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Flogseq____&quot;,1269,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Xlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Vlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1270,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b497-45f7-9921-93bf9799ddb9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Flogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Xlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Vlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Ulogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1272,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ef03-45d2-a72a-a8adfe5b8fd0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Atherosclerosis is a specific type of [[arteriosclerosis]]. Atherosclerosis is the buildup of fats, cholesterol and other substances in and on the artery walls. This buildup is called plaque. The plaque can cause arteries to narrow, blocking blood flow. The plaque can also burst, leading to a blood clot.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Flogseq____&quot;,1272,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Xlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Vlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Ulogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^Hlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1273,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3725-4c24-a6fb-1cc14f6c2832logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Flogseq____&quot;,1273,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Xlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Vlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^Ulogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1274,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-804a-45c1-835e-406b20541e51logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Flogseq____&quot;,1284,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1276,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3605-443f-9392-a1f501baf193logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Atherosclerotic cardiovascular disease**, otherwise known as **ASCVD**, is caused by plaque buildup in arterial walls and refers to conditions that include:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Flogseq____&quot;,1276,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1277,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1b8e-4edb-a607-5b9315058432logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cerebrovascular disease, such as a transient ischemic attack, ischemic stroke, and carotid artery stenosis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Flogseq____&quot;,1288,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Vlogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1278,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fa6c-48ba-9cb2-d275731cf106logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Flogseq____&quot;,1286,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1279,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-fd8f-47eb-abc6-ab362c18fd19logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Currently, ASCVD-related conditions remain the leading cause of morbidity and mortality globally.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Flogseq____&quot;,1282,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1280,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f77b-47a7-b485-5a75919e8ab2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Flogseq____&quot;,1279,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1281,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6cab-4878-9b46-ef457e89ad93logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Flogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1282,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-07cf-4f99-a3a2-600d10bb3c1flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Aortic atherosclerotic disease, such as abdominal aortic aneurysm and descending thoracic aneurysm.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Flogseq____&quot;,1285,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Vlogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1283,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-870f-4b20-84a3-2f92fba4b07blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*Not to be confused with [[atherosclerosis]], [[arteriosclerosis]] , coronary artery disease, coronary heart disease*.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Flogseq____&quot;,1287,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Ulogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Ulogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Hlogseq____&quot;,1263,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^Hlogseq____&quot;,1264,536870916]],[logseq____&quot;^15logseq____&quot;,[1284,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b69d-4b15-8136-6aab609057e4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Peripheral artery disease, such as claudication.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Flogseq____&quot;,1278,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Vlogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1285,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9bd5-4f31-839a-4b4433737f8dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Flogseq____&quot;,1280,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1286,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dfb9-4dbe-a84e-16a5096d6928logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Flogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1287,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6da6-4591-b4c1-36629ba7de47logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Coronary Heart Disease (CHD), such as myocardial infarction, angina, and coronary artery stenosis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Flogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Vlogseq____&quot;,1277,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1288,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-802f-4afd-ae86-017692db6e88logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.acc.org/latest-in-cardiology/articles/2019/04/29/07/42/key-points-from-the-2019-acc-aha-guidelines-on-the-primary-prevention-of-cvdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Flogseq____&quot;,1281,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Xlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Vlogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^Ulogseq____&quot;,890,536870916]],[logseq____&quot;^15logseq____&quot;,[1289,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7e27-42bd-b507-bd3d34ba1f4alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Flogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1291,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1182-4bb4-bbe5-ffa7a7b3f567logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Biosimilar drugs are almost identical copies of other drugs and are typically manufactured once a companylogseq____&apos;s patent of a drug expires.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Flogseq____&quot;,1291,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1292,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d57f-48d5-909b-e65717852f2flogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Unlike generic drugs, biosimilars have a higher molecular complexity and are sensitive to alterations during the manufacturing process.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Flogseq____&quot;,1292,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1293,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bff2-4217-b2cb-983975f7c36clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Flogseq____&quot;,1293,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1294,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4f7c-48d9-9f0e-cb7f0fe831calogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Wikipedia:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Flogseq____&quot;,1294,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1295,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-edf1-4a17-9e7d-9abceb4f60d7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; A **biosimilar** (also known as **follow-on biologic** or **subsequent entry biologic**) is a [biologic medical product](https://en.wikipedia.org/wiki/Biopharmaceutical) that is almost an identical copy of an original product that is manufactured by a different company.\\nBiosimilars are officially approved versions of original \\logseq____&quot;innovator\\logseq____&quot; \\nproducts and can be manufactured when the original productlogseq____&apos;s [patent](https://en.wikipedia.org/wiki/Chemical_patent) expires. Reference to the innovator product is an integral component of the approval.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Flogseq____&quot;,1295,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1296,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e7fc-404b-81d1-6c59d2743c66logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; Unlike with [generic drugs](https://en.wikipedia.org/wiki/Generic_drug) of the more common [small-molecule](https://en.wikipedia.org/wiki/Small_molecule)\\ntype, biologics generally exhibit high molecular complexity and may be \\nquite sensitive to changes in manufacturing processes. Despite that \\nheterogeneity, all [biopharmaceuticals](https://en.wikipedia.org/wiki/Biopharmaceutical), including biosimilars, must maintain consistent quality and clinical performance throughout their lifecycle.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Flogseq____&quot;,1296,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1297,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-460a-4687-ba5d-4c578af8e4e6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Flogseq____&quot;,1297,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Xlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Vlogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^Ulogseq____&quot;,38,536870916]],[logseq____&quot;^15logseq____&quot;,[1298,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-b47e-41ca-ab19-7f40e9df7c68logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Flogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Xlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Vlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Ulogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1300,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2a43-4e71-9c3c-7ff1905bb922logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A bispecific monoclonal antibody (BsMAb, BsAb) is an artificial protein that can simultaneously bind to two different types of antigen or two different [epitopes](https://en.wikipedia.org/wiki/Epitopes) on the same antigen. Naturally occurring antibodies typically only target one antigen. BsAbs can be manufactured in several structural formats. BsAbs can be designed to recruit and activate immune cells, to interfere with receptor signaling and inactivate signaling ligands, and to force association of protein complexes. BsAbs have been explored for cancer immunotherapy, drug delivery, and Alzeimerlogseq____&apos;s disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Flogseq____&quot;,1300,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Xlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Vlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^Ulogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1301,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1be8-4d3b-95eb-76799c15ccadlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Flogseq____&quot;,1301,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Xlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Vlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^Ulogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1302,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e9f4-4746-8a07-80dfb3b9f376logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; See [[BiTE Molecule]]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Flogseq____&quot;,1302,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Xlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Vlogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Ulogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Ulogseq____&quot;,317,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^Hlogseq____&quot;,130,536870916]],[logseq____&quot;^15logseq____&quot;,[1303,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1f79-499e-87ee-e0d723c494c7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Flogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1305,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-dbb4-4006-88e9-d88ea99beccclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Chemotherapy-induced thrombocytopenia (CIT) is a common complication of the treatment of non-hematologic malignancies.IT is related to the type and dose of chemotherapy, with regimens containing gemcitabine, platinum, or temozolomide producing it most commonly. [^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Flogseq____&quot;,1305,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1306,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0909-427c-bc22-4f31bde28d7elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Flogseq____&quot;,1306,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1307,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bfde-4a3e-9e10-455a123c548clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Flogseq____&quot;,1307,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1308,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e5c5-4cff-8020-5d93ed00334blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Flogseq____&quot;,1308,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1309,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e369-40be-ac32-300d51c8ad20logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://pubmed.ncbi.nlm.nih.gov/35642485/logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Flogseq____&quot;,1309,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Xlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Vlogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^Ulogseq____&quot;,141,536870916]],[logseq____&quot;^15logseq____&quot;,[1310,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d3ef-4bf5-96d1-7c486cd76e4blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^Klogseq____&quot;,1691874785400,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^@logseq____&quot;,false,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;corticosteroidslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^11logseq____&quot;,logseq____&quot;corticosteroidslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^Blogseq____&quot;,1691874785400,536870916]],[logseq____&quot;^15logseq____&quot;,[1312,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-eee5-49e8-90d7-2c9a72045240logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Flogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Xlogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Vlogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Ulogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1313,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4c88-4965-8cf4-a41ac68f038elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Flogseq____&quot;,1313,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Xlogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Vlogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^Ulogseq____&quot;,1312,536870916]],[logseq____&quot;^15logseq____&quot;,[1314,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-6783-409b-a042-56a2c756c265logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Flogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Xlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Vlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Ulogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1316,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-56ad-4051-8178-efb8cd5d7ff9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Epithelium** or **epithelial tissue** is one of the four basic types of [animal](https://en.wikipedia.org/wiki/Animal) [tissue](https://en.wikipedia.org/wiki/Tissue_(biology)), along with [connective tissue](https://en.wikipedia.org/wiki/Connective_tissue), [muscle tissue](https://en.wikipedia.org/wiki/Muscle_tissue) and [nervous tissue](https://en.wikipedia.org/wiki/Nervous_tissue). Epithelial tissues line the outer surfaces of [organs](https://en.wikipedia.org/wiki/Organ_(anatomy)) and [blood vessels](https://en.wikipedia.org/wiki/Blood_vessel) throughout the body, as well as the inner surfaces of [cavities](https://en.wikipedia.org/wiki/Body_cavities) in many internal organs. An example is the [epidermis](https://en.wikipedia.org/wiki/Epidermis), the outermost layer of the [skin](https://en.wikipedia.org/wiki/Skin).\\ntitle:: Epithelial Tissuelogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Flogseq____&quot;,1316,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Xlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Vlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Ulogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:titlelogseq____&quot;,logseq____&quot;Epithelial Tissuelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1?logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1?logseq____&quot;,logseq____&quot;Epithelial Tissuelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1317,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f1f0-469d-be8d-f216901117f2logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Flogseq____&quot;,1317,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Xlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Vlogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^Ulogseq____&quot;,692,536870916]],[logseq____&quot;^15logseq____&quot;,[1318,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-1a12-4d7a-b5fc-16c358c6baeblogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Flogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1320,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c591-4529-9ef2-c2694bbf1804logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Lipoprotein(a), or Lp(a), is a protein that transports cholesterol in the blood. High levels of Lp(a) in the blood can increase the likelihood of plaques or blood clots forming in the arteries. As a result of this effect, Lp(a) can increase the risk of cardiovascular disease.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Flogseq____&quot;,1320,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1321,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-4e83-4af3-a46d-71c889def95alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Flogseq____&quot;,1321,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1322,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c7a2-422f-a900-41863d1fdb2elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Futher Readinglogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Flogseq____&quot;,1322,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1323,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-90cf-4b46-93ef-2d73b9bb9f0elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Lipoprotein(a) - Medicalnewstoday](https://www.medicalnewstoday.com/articles/318712#summary)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Flogseq____&quot;,1323,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1324,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-44d8-4197-8fa5-bc6fd5d2e7a5logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Flogseq____&quot;,1324,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Xlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Vlogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^Ulogseq____&quot;,891,536870916]],[logseq____&quot;^15logseq____&quot;,[1325,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f56e-4616-956f-8e3344d2a83blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Flogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Xlogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Vlogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Ulogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1327,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2811-4427-b345-fe44c35b5c52logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Even after reaching remission with chemotherapy, a relatively small number of cancer cells can remain in your body that cannot be detected by traditional testing. This is called minimal residual disease, or MRD.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Flogseq____&quot;,1327,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Xlogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Vlogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^Ulogseq____&quot;,268,536870916]],[logseq____&quot;^15logseq____&quot;,[1328,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0bd3-45ba-970f-32088e49c32dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Flogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Xlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Vlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Ulogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1330,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3485-4b7c-9df0-d6e420d20c49logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; **Osteoporosis** is a systemic skeletal disorder characterized by low [bone mass](https://en.wikipedia.org/wiki/Bone_mass), micro-architectural deterioration of [bone tissue](https://en.wikipedia.org/wiki/Bone_tissue) leading to bone fragility, and consequent increase in [fracture](https://en.wikipedia.org/wiki/Bone_fracture) risk. It is the most common reason for a broken bone among the [elderly](https://en.wikipedia.org/wiki/Old_age).[](https://en.wikipedia.org/wiki/Osteoporosis#cite_note-NIH2014-3)logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Flogseq____&quot;,1330,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Xlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Vlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^Ulogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1331,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5fa2-438a-8d9b-c751949f86c8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt;Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. After the broken bone heals, the person may have chronic pain and a decreased ability to carry out normal activities.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Flogseq____&quot;,1331,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Xlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Vlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^Ulogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1332,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c56e-41b5-8078-092ab874852dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Flogseq____&quot;,1332,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Xlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Vlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^Ulogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1333,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f2ae-4a7c-b867-71e62467773alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Flogseq____&quot;,1333,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Xlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Vlogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^Ulogseq____&quot;,138,536870916]],[logseq____&quot;^15logseq____&quot;,[1334,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0863-4f68-87c1-3ac11211c265logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Sebopsoriasis**: This type typically appears on your \\nface and scalp as bumps and plaques with a greasy, yellow scale. This is\\na cross between psoriasis and [seborrheic dermatitis](https://my.clevelandclinic.org/health/diseases/14403-seborrheic-dermatitis).logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Flogseq____&quot;,1345,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1337,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8d88-4d48-853b-95951154f556logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Pustular psoriasis**](https://my.clevelandclinic.org/health/diseases/24805-pustular-psoriasis): Pustular psoriasis has small, pus-filled bumps on top of plaques.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Flogseq____&quot;,1340,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1338,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9aeb-483f-9087-2c8c9474d873logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Psoriasis** is a autoimmune skin condition that causes inflammation and bruising, swelling, itching, scaling, tenderness among other symptoms associated with dermatitis. There’s no simple explanation for when and why people get this condition, but it has to do with an overactive immune system causing inflammation.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Flogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1339,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-811d-4bdb-9e92-4a112e3555b1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Guttate psoriasis**](https://my.clevelandclinic.org/health/diseases/22812-guttate-psoriasis): Guttate psoriasis may appear after a sore throat caused by a [*streptococcal* infection](https://my.clevelandclinic.org/health/articles/5911-group-a-streptococcal-infections). It looks like small, red, drop-shaped scaly spots and often affects children and young adults.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Flogseq____&quot;,1346,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1340,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3190-4a8b-8f83-b8e8694d7c33logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Flogseq____&quot;,1342,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1341,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f876-4e0e-bda6-99c6fe20b5e3logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Flogseq____&quot;,1339,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1342,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-efe4-489c-b025-2528df895ba7logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Plaque psoriasis**](https://my.clevelandclinic.org/health/diseases/22842-plaque-psoriasis): **Plaque psoriasis** is the most common type of psoriasis; it affects skin folders. It causes thick, scaly areas of skin. About 80% to 90% of people with psoriasis have plaque psoriasis.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Flogseq____&quot;,1347,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1343,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-db6c-4a6e-8e7a-b39dc817c58alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Nail psoriasis**](https://my.clevelandclinic.org/health/diseases/22841-nail-psoriasis): Nail psoriasis causes skin discoloration, pitting and changes to your fingernails and toenails.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Flogseq____&quot;,1337,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1344,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-290c-4937-a2c7-619a85af3768logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Erythrodermic psoriasis**](https://my.clevelandclinic.org/health/diseases/22998-erythrodermic-psoriasis):\\nThis is a severe type of psoriasis that affects a large area (more than\\n90%) of your skin. It causes widespread skin discoloration and skin \\nshedding.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Flogseq____&quot;,1338,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1345,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5584-4ba9-b0c1-86230e21a265logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[**Inverse psoriasis**](https://my.clevelandclinic.org/health/diseases/22852-inverse-psoriasis): This type appears in your skin folds. It causes thin plaques without scales.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Flogseq____&quot;,1343,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1346,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7e6e-4a35-9985-bfdd40d55082logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Formslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Flogseq____&quot;,1341,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Xlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Vlogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Ulogseq____&quot;,916,536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1347,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f97a-4820-bbe8-e2447a573390logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Mechanismlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Flogseq____&quot;,1361,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1349,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9486-40cb-83dd-149fd2e4e92dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Flogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1350,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-aeed-4bb9-8cd2-60e8b62cb9cdlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# siRNAlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Flogseq____&quot;,1350,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1351,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-5565-47e0-92c6-67389f0afe91logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The single stranded siRNA (part of the RISC) binds to the target RNA and induces RNA cleavage.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Flogseq____&quot;,1356,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:logseq.order-list-typelogseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1352,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-34d7-4510-8ba8-e909c76acc1blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![SiRNA_mechanism.2.png](../assets/SiRNA_mechanism.2_1687903177512_0.png){:height 346, :width 322}logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Flogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1353,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-32a2-44a0-94f9-589732ce757elogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Flogseq____&quot;,1355,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1354,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-c5e0-453e-94c7-5dbfaaf8d379logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;siRNA is also similar to [miRNA](https://en.wikipedia.org/wiki/MicroRNA), however, miRNAs are derived from shorter stemloop RNA products. miRNAs typically silence genes by repression of [translation](https://en.wikipedia.org/wiki/Translation_(biology)) and have broader specificity of action, while siRNAs typically work with higher specificity by cleaving the mRNA before translation, with 100% complementarity.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Flogseq____&quot;,1365,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1355,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-a7bc-4c8b-93cb-b4124b109d6blogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It can now scan to find a complementary RNA strand.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Flogseq____&quot;,1360,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1356,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-72e3-44d3-850a-34aa834c07fclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The mechanism by which natural siRNA causes gene silencing through repression of translation occurs as follows:logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Flogseq____&quot;,1349,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1357,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-e7b1-4d26-8cb6-6f1292a041e8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The mRNA is now cut and recognized as abnormal. This causes degradation of the mRNA and in turn no translation of the mRNA into amino acids and then proteins. Thus silencing the gene that encodes that mRNA.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Flogseq____&quot;,1352,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1358,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-237b-4427-8a92-2e8ce1d30712logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;siRNA enters the cell and gets incorporated to other proteins to form the RISC.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Flogseq____&quot;,1362,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1359,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d190-4634-9954-49cebc77d195logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The strand that is thermodynamically less stable due to its base pairing at the 5´end is chosen to remain part of the RISC-complex.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Flogseq____&quot;,1364,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1360,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-72ec-4173-a9f3-03cfba995976logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Flogseq____&quot;,1367,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1361,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ebfb-44b8-98e9-659070f750fclogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Long dsRNA (doble stranded RNA) is cleaved by an endo-ribonuclease called [Dicer](https://en.wikipedia.org/wiki/Dicer), which forms into interfering RNA or siRNA; this is what enables the molecules to form the RNA-Induced Silencing Complex ([RISC](https://en.wikipedia.org/wiki/RNA-induced_silencing_complex).).\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Flogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1362,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-2927-4938-b807-7a4650c722e1logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Small interfering RNA** (**siRNA**), sometimes known as **short interfering RNA** or **silencing RNA**, is a class of [double-stranded RNA](https://en.wikipedia.org/wiki/Double-stranded_RNA) at first [non-coding RNA](https://en.wikipedia.org/wiki/Non-coding_RNA) [molecules](https://en.wikipedia.org/wiki/Molecule), typically 20-24 (normally 21) [base pairs](https://en.wikipedia.org/wiki/Base_pair) in length, similar to [miRNA](https://en.wikipedia.org/wiki/MicroRNA), and operating within the [RNA interference](https://en.wikipedia.org/wiki/RNA_interference) (RNAi) pathway.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Flogseq____&quot;,1351,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1363,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8c5d-4ffc-b071-8b0c14cf788dlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is unwound to form single stranded siRNA.\\nlogseq.order-list-type:: numberlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Flogseq____&quot;,1359,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Vlogseq____&quot;,1357,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1@logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1@logseq____&quot;,logseq____&quot;numberlogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1364,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-3c4e-4942-bbc2-4d14acaa97c4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Flogseq____&quot;,1353,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1365,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8b5b-49c4-b09f-763e1db70c4clogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Flogseq____&quot;,1363,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1366,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-f6fa-4080-b430-490cb3bfbbaflogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**It interferes with the expression of specific genes with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation.**logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Flogseq____&quot;,1366,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Xlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Vlogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^Ulogseq____&quot;,131,536870916]],[logseq____&quot;^15logseq____&quot;,[1367,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-bd27-4ef7-8f2e-0ae42b9da9f6logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Flogseq____&quot;,1373,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1369,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-9abb-48bc-b9b0-46a365bcbba8logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Referenceslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Flogseq____&quot;,1372,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1370,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-aee9-477a-aee3-acb085eff311logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Formslogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Flogseq____&quot;,1375,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^Jlogseq____&quot;,[],536870916]],[logseq____&quot;^15logseq____&quot;,[1371,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-ebc0-4729-b000-7adda093b819logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Flogseq____&quot;,1369,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1372,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-d7d4-4daf-adca-edcb88bb2dd9logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Immune thrombocytopenia** is when the immune system attacks its own blood platelets.[^1]logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Flogseq____&quot;,1371,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1373,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7786-4e39-9642-c47d5e4c8d8alogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Flogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^:logseq____&quot;,true,536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536870916]],[logseq____&quot;^15logseq____&quot;,[1374,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-7891-4d08-9aab-95b60532ad09logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Flogseq____&quot;,1376,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1375,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-0ff2-48d9-9b9c-229f261b1fe4logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Thrombocytopenia is a condition characterized by abnormally low levels of platelets, also known as thrombocytes, in the blood. Low levels of platelets in turn may lead to prolonged or excessive bleeding.logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Flogseq____&quot;,1374,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1376,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-78c5-4346-b8f0-a80f5d5f4cb0logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.mayoclinic.org/diseases-conditions/idiopathic-thrombocytopenic-purpura/symptoms-causes/syc-20352325logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Flogseq____&quot;,1370,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Xlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Vlogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^Ulogseq____&quot;,856,536870916]],[logseq____&quot;^15logseq____&quot;,[1377,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f5e1-8f44-46d1-bd2f-2dd928ed6e61logseq____&quot;,536870916]],[logseq____&quot;^15logseq____&quot;,[1378,logseq____&quot;^2logseq____&quot;,1,536870917]],[logseq____&quot;^15logseq____&quot;,[1378,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;^2logseq____&quot;,536870917]],[logseq____&quot;^15logseq____&quot;,[1379,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;^Rlogseq____&quot;,536870918]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^@logseq____&quot;,false,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Flogseq____&quot;,73,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Xlogseq____&quot;,73,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Vlogseq____&quot;,73,536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^Ulogseq____&quot;,73,536870973]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536870972]],[logseq____&quot;^15logseq____&quot;,[1380,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f71d-d35a-4091-801a-49fe04b2147blogseq____&quot;,536870972]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871346]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871201]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Flogseq____&quot;,1390,536871382]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Xlogseq____&quot;,119,536871201]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Vlogseq____&quot;,119,536871201]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^Ulogseq____&quot;,119,536871202]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871382]],[logseq____&quot;^15logseq____&quot;,[1388,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f8e9-dd9d-4b0d-9d4f-a6878ffea6cdlogseq____&quot;,536871201]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Amgen Pipeline (amgenpipeline.com)](https://www.amgenpipeline.com/)logseq____&quot;,536871276]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871237]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Flogseq____&quot;,119,536871237]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Xlogseq____&quot;,119,536871237]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Vlogseq____&quot;,119,536871237]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^Ulogseq____&quot;,119,536871273]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871276]],[logseq____&quot;^15logseq____&quot;,[1390,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7f991-9331-47b7-bebf-ac37de04e09alogseq____&quot;,536871237]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Flogseq____&quot;,231,536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Xlogseq____&quot;,119,536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Vlogseq____&quot;,119,536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^Ulogseq____&quot;,119,536871357]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871356]],[logseq____&quot;^15logseq____&quot;,[1393,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fa76-1c5c-48c1-9b0d-f38bf5028517logseq____&quot;,536871356]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Resourceslogseq____&quot;,536871395]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871360]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Flogseq____&quot;,1396,536871372]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Xlogseq____&quot;,119,536871360]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Vlogseq____&quot;,119,536871360]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Ulogseq____&quot;,119,536871361]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871395]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536871395]],[logseq____&quot;^15logseq____&quot;,[1394,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fa76-fa8a-4d64-93e9-bc79d9c1591clogseq____&quot;,536871360]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Amgen]]logseq____&quot;,536871368]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871364]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Flogseq____&quot;,1394,536871364]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Xlogseq____&quot;,119,536871364]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Vlogseq____&quot;,119,536871364]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Ulogseq____&quot;,73,536871369]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Ulogseq____&quot;,119,536871369]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871368]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^Hlogseq____&quot;,73,536871368]],[logseq____&quot;^15logseq____&quot;,[1395,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fa7b-6af4-403f-b2e3-fdd0aa6b0c98logseq____&quot;,536871364]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Flogseq____&quot;,1393,536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Xlogseq____&quot;,119,536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Vlogseq____&quot;,119,536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^Ulogseq____&quot;,119,536871373]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871372]],[logseq____&quot;^15logseq____&quot;,[1396,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fa7e-5560-4653-b4c1-3c156f52a14dlogseq____&quot;,536871372]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[Amgen Products (amgen.com)](https://www.amgen.com/products)logseq____&quot;,536871389]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871385]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Flogseq____&quot;,1395,536871385]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Xlogseq____&quot;,119,536871385]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Vlogseq____&quot;,119,536871385]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^Ulogseq____&quot;,119,536871386]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871389]],[logseq____&quot;^15logseq____&quot;,[1397,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7faa6-f3f0-45c0-aaa7-92184b5a2005logseq____&quot;,536871385]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^Klogseq____&quot;,1691876161183,536871424]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^@logseq____&quot;,false,536871424]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;small moleculelogseq____&quot;,536871424]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^11logseq____&quot;,logseq____&quot;small moleculelogseq____&quot;,536871424]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^Blogseq____&quot;,1691876161183,536871424]],[logseq____&quot;^15logseq____&quot;,[1398,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fb41-f139-4d83-8d75-fbec76ec0ffflogseq____&quot;,536871424]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;LUMAKRAS is currently being Investigated in Phase 3 for the treatment of advanced colorectal cancer. While it is being investigated in Phase 2 for the treatment of advanced NSCLC, it is also in Phase 1 and Phase 2 development for the treatment of NSCLC in combination with other therapies. It is also in Phase 2 development for the treatment of advanced solid tumors other than NSCLC or advanced colorectal cancer.logseq____&quot;,536871555]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871506]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Flogseq____&quot;,1400,536871558]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Xlogseq____&quot;,132,536871506]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Vlogseq____&quot;,132,536871506]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^Ulogseq____&quot;,132,536871507]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871555]],[logseq____&quot;^15logseq____&quot;,[1399,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fd6e-13b1-4b23-841c-151b0809af29logseq____&quot;,536871506]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871558]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871558]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Flogseq____&quot;,547,536871608]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Xlogseq____&quot;,132,536871558]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Vlogseq____&quot;,132,536871558]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^Ulogseq____&quot;,132,536871559]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871608]],[logseq____&quot;^15logseq____&quot;,[1400,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fe24-f63e-49c3-b96f-040de6c7d148logseq____&quot;,536871558]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Sotorasib** 120mg or 320mg - Other names: Lumykraslogseq____&quot;,536871618]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871614]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Flogseq____&quot;,461,536871614]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Xlogseq____&quot;,132,536871614]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Vlogseq____&quot;,132,536871614]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^Ulogseq____&quot;,132,536871615]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871618]],[logseq____&quot;^15logseq____&quot;,[1401,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fe6e-ee16-46eb-9c49-f76789d30daclogseq____&quot;,536871614]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Flogseq____&quot;,1401,536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Xlogseq____&quot;,132,536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Vlogseq____&quot;,132,536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^Ulogseq____&quot;,132,536871622]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871621]],[logseq____&quot;^15logseq____&quot;,[1402,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7fe75-f9de-4e34-abdc-de6b7050f331logseq____&quot;,536871621]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![lumakras1.webp](../assets/lumakras1_1691877087430_0.webp){:height 180, :width 169}logseq____&quot;,536871669]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871641]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Flogseq____&quot;,500,536871666]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Xlogseq____&quot;,132,536871641]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Vlogseq____&quot;,132,536871641]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^Ulogseq____&quot;,132,536871642]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871669]],[logseq____&quot;^15logseq____&quot;,[1403,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7feb0-8422-486e-ba1b-d89550557208logseq____&quot;,536871641]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^@logseq____&quot;,false,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Flogseq____&quot;,445,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Xlogseq____&quot;,441,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Vlogseq____&quot;,441,536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^Ulogseq____&quot;,441,536871707]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871706]],[logseq____&quot;^15logseq____&quot;,[1404,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d7ffef-23d3-41ed-a9ed-77031818293elogseq____&quot;,536871706]],[logseq____&quot;^15logseq____&quot;,[1405,logseq____&quot;^12logseq____&quot;,2,536871785]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^Klogseq____&quot;,1691878294617,536871788]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^@logseq____&quot;,false,536871788]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cell culturelogseq____&quot;,536871788]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^11logseq____&quot;,logseq____&quot;cell culturelogseq____&quot;,536871788]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^Blogseq____&quot;,1691878294617,536871788]],[logseq____&quot;^15logseq____&quot;,[1407,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6434-4342-8046-8f397f91c681logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cell culture or tissue culture is the process by which cells are grown under controlled conditions, generally outside of their natural environment.logseq____&quot;,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Flogseq____&quot;,1407,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Xlogseq____&quot;,1407,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Vlogseq____&quot;,1407,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^Ulogseq____&quot;,1407,536871788]],[logseq____&quot;^15logseq____&quot;,[1408,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-f52e-4038-8002-08ce2149c5delogseq____&quot;,536871788]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^Klogseq____&quot;,1691878294693,536871790]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^@logseq____&quot;,false,536871790]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cmv pp65 antigenemia testlogseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^11logseq____&quot;,logseq____&quot;CMV pp65 antigenemia testlogseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^Blogseq____&quot;,1691878294693,536871790]],[logseq____&quot;^15logseq____&quot;,[1410,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4e57-4fab-9daf-9ff7a026c90clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^Klogseq____&quot;,1691878294694,536871790]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^@logseq____&quot;,false,536871790]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;antibodieslogseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^11logseq____&quot;,logseq____&quot;antibodieslogseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^Blogseq____&quot;,1691878294694,536871790]],[logseq____&quot;^15logseq____&quot;,[1411,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-f1ea-47c3-8312-72ee99840104logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; The CMV pp65 antigenemia test is an immunofluorescence-based assay which utilizes an indirect immunofluorescence technique for identifying the pp65 protein of cytomegalovirus in peripheral blood leukocytes.logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Flogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Xlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Vlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^Ulogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1412,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-fa85-4fd5-85cf-a8aa234cd713logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Antigenemia: presence of [[antibodies]] (especially viral) in the bloodstream.logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Flogseq____&quot;,1412,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Xlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Vlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Ulogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Ulogseq____&quot;,1411,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^Hlogseq____&quot;,1411,536871790]],[logseq____&quot;^15logseq____&quot;,[1413,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0f0d-489b-98a5-15bac1fcbb86logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; The CMV pp65 assay is widely used for monitoring CMV infection and its response to antiviral treatment in people who are under immunosuppressive therapy and have had renal transplantation surgery, as the antigenemia results are obtained about 5 days before the onset of symptomatic CMV disease.logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Flogseq____&quot;,1413,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Xlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Vlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^Ulogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1414,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6607-4453-9538-e8ce059aaf4blogseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; The advantage of this assay is the rapidity in providing results in a few hours and that the pp65 antigen determination represents a useful criterion for the physician to initiate antiviral therapy. The major disadvantage of the pp65 assay is that only a limited number of samples can be processed per test batch.logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Flogseq____&quot;,1414,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Xlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Vlogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^Ulogseq____&quot;,1410,536871790]],[logseq____&quot;^15logseq____&quot;,[1415,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1a23-40d7-bd1f-9a95fab83bd9logseq____&quot;,536871790]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^Klogseq____&quot;,1691878294717,536871792]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^@logseq____&quot;,false,536871792]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;enzyme-linked immunosorbent assaylogseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^11logseq____&quot;,logseq____&quot;Enzyme-linked immunosorbent assaylogseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^Blogseq____&quot;,1691878294717,536871792]],[logseq____&quot;^15logseq____&quot;,[1417,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9e85-455d-96b0-0033ad3def15logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The assay uses a solid-phase type of [enzyme immunoassay](https://en.m.wikipedia.org/wiki/Enzyme_immunoassay) (EIA) to detect the presence of a ligand (commonly a protein) in a liquid sample using antibodies directed against the protein to be measured.logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Flogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Vlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1418,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-cf93-4f83-9a7b-97799a2e21balogseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![ELISA TMB.jpg](https://upload.wikimedia.org/wikipedia/commons/thumb/8/84/ELISA_TMB.jpg/280px-ELISA_TMB.jpg)logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Flogseq____&quot;,1418,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Vlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1419,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-05bd-4c79-8706-3c4564a221b0logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;ELISA being developed with [TMB](https://en.m.wikipedia.org/wiki/3,3%27,5,5%27-Tetramethylbenzidine) on a polystyrene [microtiter plate](https://en.m.wikipedia.org/wiki/Microtiter_plate)\\nid:: 640a3896-c220-463a-92a3-ce3908ce053clogseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Flogseq____&quot;,1419,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Vlogseq____&quot;,1419,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;640a3896-c220-463a-92a3-ce3908ce053clogseq____&quot;],536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1=logseq____&quot;],536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1=logseq____&quot;,logseq____&quot;640a3896-c220-463a-92a3-ce3908ce053clogseq____&quot;],536871792]],[logseq____&quot;^15logseq____&quot;,[1420,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u640a3896-c220-463a-92a3-ce3908ce053clogseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Flogseq____&quot;,1420,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Vlogseq____&quot;,1419,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1421,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a1b0-4868-b074-1c946538bed7logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;ELISA results are reported as a number;logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Flogseq____&quot;,1419,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Vlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1422,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0b4e-48af-8f8b-976db9680157logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The most controversial aspect of this test is determining the \\logseq____&quot;cut-off\\logseq____&quot; point between a positive and a negative result.logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Flogseq____&quot;,1422,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Vlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1423,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6b01-4228-8330-f8f63f8301c6logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There are ELISA tests to detect various kind of diseases, such as dengue, malaria, Chagas disease, Johnelogseq____&apos;s disease, and others. ELISA tests also are extensively employed for in vitro diagnostics in medical laboratories. The other uses of ELISA include the detection of SARS-CoV-2 antibodies in blood samples.logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Flogseq____&quot;,1423,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Xlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Vlogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^Ulogseq____&quot;,1417,536871792]],[logseq____&quot;^15logseq____&quot;,[1424,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a79c-4d42-a758-710b3ae33168logseq____&quot;,536871792]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^Klogseq____&quot;,1691878294927,536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;cytomegalovirus infectionlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^11logseq____&quot;,logseq____&quot;Cytomegalovirus Infectionlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^Blogseq____&quot;,1691884783417,536871946]],[logseq____&quot;^15logseq____&quot;,[1426,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-a5e1-4125-8b87-2a13e3ed74ablogseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^Klogseq____&quot;,1691878294927,536871794]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;herpesviraleslogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^11logseq____&quot;,logseq____&quot;Herpesviraleslogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^Blogseq____&quot;,1691878294927,536871794]],[logseq____&quot;^15logseq____&quot;,[1427,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b789-426b-8b77-dce139b7881flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^Klogseq____&quot;,1691878294926,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^Nlogseq____&quot;,20230310,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^@logseq____&quot;,true,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;mar 10th, 2023logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^11logseq____&quot;,logseq____&quot;Mar 10th, 2023logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^Blogseq____&quot;,1691878294926,536871794]],[logseq____&quot;^15logseq____&quot;,[1428,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0211-4cb5-86e6-63435405cfa5logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^Klogseq____&quot;,1691878294929,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;serologylogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^11logseq____&quot;,logseq____&quot;Serologylogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^Blogseq____&quot;,1691878294929,536871794]],[logseq____&quot;^15logseq____&quot;,[1429,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-dbde-4559-9b6d-3b171538c45elogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^Klogseq____&quot;,1691878294930,536871794]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;viral culturelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^11logseq____&quot;,logseq____&quot;Viral culturelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^Blogseq____&quot;,1691878294930,536871794]],[logseq____&quot;^15logseq____&quot;,[1430,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-b91b-4292-85b8-8d74bd90cec6logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^Klogseq____&quot;,1691878294931,536871794]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;mrna-1647logseq____&quot;,536872095]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^11logseq____&quot;,logseq____&quot;mRNA-1647logseq____&quot;,536872095]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^Blogseq____&quot;,1691885466208,536872116]],[logseq____&quot;^15logseq____&quot;,[1431,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-cc11-4606-b92b-f9425d7eaa51logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^Klogseq____&quot;,1691878294929,536871794]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^@logseq____&quot;,false,536871794]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;polymerase chain reactionlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^11logseq____&quot;,logseq____&quot;Polymerase chain reactionlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^Blogseq____&quot;,1691878294929,536871794]],[logseq____&quot;^15logseq____&quot;,[1433,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e629-48b4-9cdb-7108258d80c2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### At-Risk Populations\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Flogseq____&quot;,1445,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1434,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-35b2-4840-a1b3-6ba3a8f4cda3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is unknown if CMV-IGIV is safe during pregnancy.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Flogseq____&quot;,1525,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Vlogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1435,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-2647-41a2-8788-b7a4bcd7fb78logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Hyperimmune globulin enriched for CMV (CMV-IGIV, CytoGam)**[^22] - An immunoglobulin G (IgG) which contains a standardized number of antibodies against CMV and it can raise relevant antibody levels to reduce potentially serious CMV infection or disease. It is used for *prophylaxis* (prevention) of CMV disease associated with transplantation of the kidney, lung, liver, pancreas and heart. CMV-IGIV should be considered in combination with ganciclovir with CMV seropositive donors into seronegative recipients (exception: kidney transplants). It is given through infusion.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Flogseq____&quot;,1513,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1436,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7d18-4e33-913a-b4f115a5a772logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Flogseq____&quot;,1536,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1437,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-3bb0-4923-b325-3c70bab7db29logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Studies have shown a 50% reduction in primary CMV disease in renal transplant patients and a 56% reduction in serious CMV disease and increased survival in liver transplant patients.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Flogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Vlogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1438,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-ff2e-4b65-b5e6-a586c9cbe63dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Flogseq____&quot;,1509,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1439,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-ac2d-4349-9d19-88eb7e644ef2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A positive test for CMV IgG is used to indicate a previous infection. Positive IgG does not automatically assume active infection.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Flogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Vlogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1440,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0394-4f7f-bc3f-de634261883flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;background-color:: redlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Flogseq____&quot;,1555,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;~:background-colorlogseq____&quot;,logseq____&quot;redlogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1Alogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1Alogseq____&quot;,logseq____&quot;redlogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1441,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-50e5-4598-a44c-69f94b2637felogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^23]:Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Flogseq____&quot;,1531,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1442,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e9e5-4f53-8e89-e966c7990ae1logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^5]: https://www.cdc.gov/cmv/clinical/lab-tests.htmllogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Flogseq____&quot;,1582,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1443,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-d99f-46c6-8cc1-0486793ccee4logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Flogseq____&quot;,1488,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1444,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9592-48b1-b386-58806474fc30logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Flogseq____&quot;,1492,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1445,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-72e0-45c8-86bd-7e1ebf98b21flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Links to pages lose their use.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Flogseq____&quot;,1461,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Vlogseq____&quot;,1448,536871794]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^Ulogseq____&quot;,1426,536871947]],[logseq____&quot;^15logseq____&quot;,[1446,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-d5bf-4c51-88a6-bf80d7506bbalogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Flogseq____&quot;,1498,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1447,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-59ed-4fe1-bbfa-4f15a9cd3600logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Unresolved Properties That Should be Aknowledgedlogseq____&quot;,536871946]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Flogseq____&quot;,1462,536871794]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Ulogseq____&quot;,1426,536871947]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871946]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536871946]],[logseq____&quot;^15logseq____&quot;,[1448,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9dd4-4128-a99a-01903398e8b2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Foscarnet** and **cidofovir** are reserved for cases where drug resistance to ganciclovir is present.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Flogseq____&quot;,1497,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1449,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7cbb-4c46-8e70-1dea2c42b56clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Flogseq____&quot;,1458,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1450,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7b6d-41ac-9645-c0b9315e3fd9logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## What Are The Symptoms?\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Flogseq____&quot;,1520,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1451,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-53ee-4b55-b4ed-87fa205aae69logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;4. **Conventional [[cell culture]]** is the traditional method for detecting CMV. This method is slow and requires 2–3 weeks for a negative result.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Flogseq____&quot;,1516,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Ulogseq____&quot;,1407,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^Hlogseq____&quot;,1407,536871794]],[logseq____&quot;^15logseq____&quot;,[1452,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b93e-4742-bfca-3cbb7972bcb0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Flogseq____&quot;,1486,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1453,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-5e66-4f92-9aa3-4be7ef7ac3f0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [[mRNA-1647]]logseq____&quot;,536872097]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Flogseq____&quot;,1490,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Vlogseq____&quot;,1490,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Ulogseq____&quot;,1431,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^Hlogseq____&quot;,1431,536871794]],[logseq____&quot;^15logseq____&quot;,[1454,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4a82-4cec-a57a-5d61142a0552logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Flogseq____&quot;,1554,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1455,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a0cc-4ce3-a408-b32ac50de5bclogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Flogseq____&quot;,1444,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1456,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9bc2-4835-865e-ecaf3c61fa50logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## TO DO\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Flogseq____&quot;,1467,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1457,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b247-4fde-8eed-1bbd9f2708aalogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Appendix\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Flogseq____&quot;,1561,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1458,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-d2b5-4ddc-8f7e-97492eb0152dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Note: Information regarding diagnosis in newer years is scarce. The sources mostly originate from 2009/2011, and detailed information may not be accurate.\\nbackground-color:: redlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Flogseq____&quot;,1556,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1Alogseq____&quot;,logseq____&quot;redlogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1Alogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1Alogseq____&quot;,logseq____&quot;redlogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1459,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-339d-4e28-ae77-674b010fac6dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;public:: true\\n\\nlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^1:logseq____&quot;,[logseq____&quot;^1;logseq____&quot;,[]],536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Flogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^:logseq____&quot;,true,536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,true],536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^19logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^19logseq____&quot;,logseq____&quot;truelogseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1460,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-cefb-48b9-b737-2bf25c70ffd8logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Citation numbering is not orderedlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Flogseq____&quot;,1448,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Vlogseq____&quot;,1448,536871794]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^Ulogseq____&quot;,1426,536871947]],[logseq____&quot;^15logseq____&quot;,[1461,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b103-4517-ae3c-18ade8f57caalogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### DOING [[Mar 10th, 2023]] 14:25\\nheading:: 3\\n:LOGBOOK:\\nCLOCK: [2023-03-07 Tue 01:20:24]\\nCLOCK: [2023-03-07 Tue 01:20:46]--[2023-03-07 Tue 01:20:58] =logseq____&gt;  00:00:12\\nCLOCK: [2023-03-07 Tue 01:20:58]--[2023-03-07 Tue 01:20:59] =logseq____&gt;  00:00:01\\nCLOCK: [2023-03-07 Tue 01:21:00]--[2023-03-07 Tue 13:00:07] =logseq____&gt;  11:39:07\\nCLOCK: [2023-03-07 Tue 17:35:24]--[2023-03-07 Tue 18:08:48] =logseq____&gt;  00:33:24\\nCLOCK: [2023-03-08 Wed 13:51:33]--[2023-03-08 Wed 17:52:58] =logseq____&gt;  04:01:25\\nCLOCK: [2023-03-09 Thu 10:54:07]--[2023-03-09 Thu 12:19:22] =logseq____&gt;  01:25:15\\nCLOCK: [2023-03-09 Thu 15:11:46]--[2023-03-09 Thu 17:31:01] =logseq____&gt;  02:19:15\\nCLOCK: [2023-03-09 Thu 21:00:13]\\nCLOCK: [2023-03-09 Thu 21:00:53]--[2023-03-10 Fri 15:00:49] =logseq____&gt;  17:59:56\\nCLOCK: [2023-03-12 Sun 14:25:49]--[2023-03-12 Sun 14:39:05] =logseq____&gt;  00:13:16\\nCLOCK: [2023-03-12 Sun 14:39:06]\\n:END:logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Flogseq____&quot;,1457,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^10logseq____&quot;,logseq____&quot;DOINGlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Ulogseq____&quot;,8,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Ulogseq____&quot;,1428,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Hlogseq____&quot;,8,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^Hlogseq____&quot;,1428,536871794]],[logseq____&quot;^15logseq____&quot;,[1462,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7aff-4f25-9a33-48446943d22elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;With all three anti-HCMV antiviral drugs, the therapeutic effectiveness is frequently compromised by the emergence of drug-resistant virus isolates.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Flogseq____&quot;,1503,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1463,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0748-4bf8-b757-125558a61eaelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Relevance in Blood Donations\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Flogseq____&quot;,1579,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1464,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c613-4bca-a78c-798f722196balogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Ganciclovir (Cytovene)**[^23]$$^{, }$$[^24] - Antiviral drug that treats, but cannot cure CMV infection with various indications, typically in patients with depressed immunity, including transplant recievers or those who have either sight-related or life-threatening illnesses. It is administered intravenously or orally for acute or stable disease, respectively and typically requires long-term use. Slow-release formulations for the eye, or as of recently, topical gel are available for in specific indications.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Flogseq____&quot;,1436,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1465,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c717-4845-aa6f-cc96cda257e7logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;7. **Nucleic acid sequence-based amplification (NASBA)** may be more sensitive than the antigenemia assay for the detection of CMV infection in blood. The test can be completed in a day. There is encouragment for transplant, AIDS and SOT patients.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Flogseq____&quot;,1515,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1466,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-501b-47e6-9166-04b8d5b0afbflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[GPT3] Do not interpret any line of text that follows, until it includes \\logseq____&quot;[GPT3 Initiate]\\logseq____&quot;, where you will read instructions from there on normally again.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Flogseq____&quot;,1460,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1467,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-3056-4197-a88a-4c718b08dd04logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[GPT3 Initiate] Read the following summary document and give examples of how its content, wording, and structure can be improved to make it more professional and easier to understand, while focusing on not removing too much details or information. Additionally, describe why you chose these improvements.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Flogseq____&quot;,1448,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1468,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4342-45b8-8bad-ba5c404c25c6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^24]: https://web.archive.org/web/20220217211806/https://druginfo.nlm.nih.gov/drugportal/rn/82410-32-0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Flogseq____&quot;,1442,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1469,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6e31-43b8-b8d1-e810fa8aab16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;1. **[[Enzyme-linked immunosorbent assay]] (ELISA) is the most common serology test for measuring CMV antibodies**. It is usually very sensitive and the result can be used to determine an acute infection, prior infection, or *passively acquired maternal antibodies* in infants. A controversial aspect of this test can be the \\logseq____&quot;cut-off\\logseq____&quot; point between a positive and a negative result.\\n![](https://upload.wikimedia.org/wikipedia/commons/thumb/8/84/ELISA_TMB.jpg/280px-ELISA_TMB.jpg \\logseq____&quot;ELISA TMB.jpg\\logseq____&quot;)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Flogseq____&quot;,1518,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Ulogseq____&quot;,1417,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^Hlogseq____&quot;,1417,536871794]],[logseq____&quot;^15logseq____&quot;,[1470,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a89e-43b1-9f35-ee983aa12caclogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;2. **[[Polymerase chain reaction]] (PCR)** is a widely available, rapid and sensitive method of CMV detection and a standard laboratory test for diagnosing congenital CMV infection or monitor the *viral load* (\\logseq____&quot;quantity\\logseq____&quot; of virus present). It is performed on saliva and usually also urine for confirmation.[^5]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Flogseq____&quot;,1470,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Ulogseq____&quot;,1433,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^Hlogseq____&quot;,1433,536871794]],[logseq____&quot;^15logseq____&quot;,[1471,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e043-42c7-a47a-d8289b56ab88logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Using CMV-IGIV prophylaxis in combination with gianciclovir prophylaxis has shown to decrease the incidence of CMV disease and increase survival rates considerably in CMV seronegative recipients of hearts from CMV seropositive donors and heart-lung or lung transplant patients in whom either the donor or recipient was CMV seropositive.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Flogseq____&quot;,1438,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Vlogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1472,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-53d1-471b-ab3a-28c3377f7a6alogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Flogseq____&quot;,1504,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1473,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-05b6-4849-8b1e-2c4199ebc4f0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In 2016, VBI Vaccines commenced a Phase I preventative cytomegalovirus vaccine study (VBI-1501).[^15]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Flogseq____&quot;,1511,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1474,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c288-48b2-9a90-593fe204c54dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**CMV-MVA Triplex vaccine** and **CMVpp65-A*0201 peptide vaccine** are two additional CMV vaccine candidates sponsored by the City of Hope National Medical Center. Both are currently in clinical phase 2 trials as of 2016.[^16]$$^{, }$$[^17], with Triplex having resulted in a positive phase 2 clinical trial in March 2019 and currently awaits funding for phase 3 clinical trials and FDA approval.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Flogseq____&quot;,1474,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1475,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-055a-4b88-ac7b-5d770c68d0b4logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV reactivation is commonly seen in people with severe [colitis](https://en.wikipedia.org/wiki/Colitis).logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Flogseq____&quot;,1491,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1476,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9431-4670-be94-a04ae3bfb1d5logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Ganciclovir** does not cure CMV disease. It is commonly associated with a range of serious haematological adverse effects. Common adverse drug reactions (≥1% of patients) include: granulocytopenia, neutropenia, anaemia, thrombocytopenia, fever, sweating, confusion, hallucination, seizures, gastric problems, phlebitis of the injection site, rash, raised liver enzymes and increased serum creatinine, among others. It is considered a cytotoxic agent in clinical settings and is a potential human carcinogen, teratogen, and mutagen. It is also considered likely to cause inhibition of spermatogenesis.[^23]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Flogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1477,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-00a1-4dc2-81d5-c3fbccbdf072logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV pneumonitislogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Flogseq____&quot;,1489,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1478,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1963-4d45-9174-4009886cd055logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**There is no cure for CMV**, but antiviral medications can be used to treat serious infections.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Flogseq____&quot;,1535,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1479,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b6ca-4c12-9c91-ad231c1c8107logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There are many laboratory tests that detect [[antibodies]] to CMV which can allow a physician to determine and/or monitor CMV infections.[^4] [[Serology]] is commonly used to detect [[antibodies]] (also called *immunoglobulins (Ig))*, namely *IgM* and *IgG*. Serology tests are performed on patients older than 12 months. They are widely available, and generally very sensitive and rapid.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Flogseq____&quot;,1459,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Hlogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^Hlogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1480,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0cd6-4fac-86bc-e584f711b570logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**CMV infection** occurs when the virus affects a person at any age, while **congenital CMV infection** occurs when a newborn is born with CMV. CMV infections are frequently associated with the salivary glands.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Flogseq____&quot;,1539,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1481,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b4db-43db-b011-a3034c2f43d3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## How Is Diagnosis Performed?\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Flogseq____&quot;,1527,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1482,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-ea39-4525-bb69-1009fc1ede50logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV mononucleosis (CMV infections can still be of clinical significance in adult immunocompetent populations.)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Flogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1483,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4cfb-4a0c-a1af-9aeebcd2ec5blogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Summary of diagnositic tests for CMV](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730495/table/T1/?report=objectonly)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Flogseq____&quot;,1508,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1484,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-441d-4ea3-987f-ba303fb3c45elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Most people infected with CMV show no signs or symptoms**, even when the virus reactivates. In some cases, it can cause mild symptoms such as fever, sore throat (*pharyngitis*), fatigue and *symmetrically* swollen glands. Occasionally, CMV can cause a condition similar to [galndular fever](https://en.wikipedia.org/wiki/Infectious_mononucleosis) (*infectious mononucleosis*)[^3] or mild hepatitis.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Flogseq____&quot;,1451,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1485,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-430f-4729-86bd-405083111301logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Flogseq____&quot;,1502,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1486,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9220-45d3-85ae-2826803b7d6dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Letermovir (Prevymis)**[^27] - Antiviral drug and viral terminase inhibitor used for treating CMV disease in adult CMV-seropositive recipients of an allogeneic stem cell transplant and it may also be useful for people with compromised immune systems.[^21] It is used for prophylaxis treatment, although due the occurrence of drug resistance with letermovir, the value of this indication is underscored.[^28] Letermovir is considered a *first-in-class medication*. It is only active against CMV and has no effect on other herpesviruses. Side effects from the use of letermovir are uncommon. Overdoses were also not found to produce additional adverse effects.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Flogseq____&quot;,1449,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1487,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a2ea-49c7-b6f3-758c4138201elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Foscarnet** has notable nephrotoxicity and it is only given when drug resistance to gianciclovir is present.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Flogseq____&quot;,1463,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1488,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c184-4f3f-90b1-2fe563aee6f3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;cytomegalovirus colitis (inflammation of the large bowel)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Flogseq____&quot;,1567,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1489,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-758b-4ab2-af6c-4cb54ef33303logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Moderna is working on an **mRNA vaccine** for CMV.[^18]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Flogseq____&quot;,1475,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1490,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e901-499f-8f75-9e32b0ed0f32logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV infection is most significant in the *perinatal period* (\\logseq____&quot;around the time of birth\\logseq____&quot;) and in people who are immunocompromised, including patients who receive organ transplants or blood infusions, who could be at risk of life-threatening infections.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Flogseq____&quot;,1434,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1491,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-47df-49ca-9ff2-4017a5014a49logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;HCMV is found in all areas of the world and infects the majority of people at some point in their lives, around 60% - 70% of adults in the first world and over 99% in the third world. Over half of adults by age 40, and in the United States, nearly one in three children by age five.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Flogseq____&quot;,1588,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1492,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-d4eb-46d5-93fc-067c7847d311logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^8]: CDC. (2021). Cytomegalovirus (CMV) and Congenital CMV Infection: For Healthcare Providers. Retrieved from [https://www.cdc.gov/cmv/clinical/congenital-cmv-2.html](https://www.cdc.gov/cmv/clinical/congenital-cmv-2.html)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Flogseq____&quot;,1559,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1493,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-21f5-480a-9491-e2c8fb3a40cclogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Flogseq____&quot;,1456,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1494,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-ca9d-446a-a8af-3c7108dfb2d0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]:https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/human-cytomegaloviruslogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Flogseq____&quot;,1507,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1495,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-8ef0-4566-806e-fd94f5c065c7logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Investigational Vaccines\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Flogseq____&quot;,1505,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1496,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-aff3-4549-baed-6e4273facbc0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Valganciclovir (Valcyte)**[^23]$$^{, }$$[^25]$$^{, }$$[^26] - Antiviral drug and pro-drug for ganciclovir that is much better absorbed (higher *bioavailability*) and as such it shares its effects profile. It is taken orally. As with gianciclovir, it only suppresses a CMV infection and typically requires long-term use.[^20]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Flogseq____&quot;,1465,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1497,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-cffe-4bd9-853b-5b68e048bc8elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Flogseq____&quot;,1549,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1498,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c9b2-4706-a347-43c28a722144logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Congenial CMV infection can cause neuronal damage, including hearing loss, retinitis, optic neuritis, microcephaly, encephalopathy (disorder of the brain), damage to the *reticuloendothelial system* (includes enlargement of the liver and spleen, jaundice) and growth problems (e.g. prematurity), among others.[^2] Hearing loss is the most common long-term health problem in congenital CMV infection, which may be detected after birth or may develop later in childhood.[^2]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Flogseq____&quot;,1545,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1499,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6920-42d8-94df-046e227321e8logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cytomegalic inclusion disease (congenital CMV infection)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Flogseq____&quot;,1483,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1500,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0e52-4bb0-b2c7-cb8a41959fe3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A phase 2 study of a **recombinant gB protein vaccine** in 2009 has indicated an efficacy of 50% in seronegative women of childbearing age. A number of subjects still contracted CMV infection despite vaccination, in one case also congenital CMV was encountered, thus the efficacy of this vaccine was proven limited.[^11] In a subsequent phase 2 trial of this vaccine on patients awaiting kidney transplantation, the vaccine showed a significant increase in antibodiesand decreased post-transplant viremia.[^12]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Flogseq____&quot;,1524,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1501,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4d79-4df0-95c8-12a76b0fc23elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Flogseq____&quot;,1490,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1502,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-ae2e-4912-a074-7484a6aa83a9logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Letermovir** is a novel antiviral drug and has a low incidence of adverse effects, although the emergence of drug-resistant CMV is already an issue present with prophylaxis for treatment.[^28]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Flogseq____&quot;,1544,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1503,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-2bb3-49eb-89a1-e1877f2f9ee9logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Flogseq____&quot;,1455,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1504,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4688-421b-9771-fb96db22d45flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Flogseq____&quot;,1494,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1505,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0e79-4913-8fb5-7205d54b5ebblogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV hepatitislogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Flogseq____&quot;,1500,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1506,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-8e96-4ada-b977-2b669af977fblogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://en.wikipedia.org/wiki/Human_betaherpesvirus_5#cite_note-Sherris-3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Flogseq____&quot;,1584,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1507,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-281b-4353-9e35-a52834888b84logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;9... Other tests include complement fixation, various fluorescence assays, radioimmunoassay, latex agglutination, and indirect hemagglutination.[^7]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Flogseq____&quot;,1534,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1508,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a856-4b87-a760-fe30ea16610elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### Cytomegalovirus (CMV) Infection, Congenital CMV Infection\\nheading:: 4logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Flogseq____&quot;,1558,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1509,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-6850-4ef0-84a7-23face9f4c88logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Renal dysfunction and acute renal failure can occur with IGIV products, especially those with sucrose as a stabilizer (logseq____&gt;350mg/day), and is more likely to occur in individuals who have pre-existing renal insufficiency.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Flogseq____&quot;,1472,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Vlogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1510,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-39c6-4c8f-8e6c-079c163e2c03logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Astellas Pharma started a phase 3 trial with **ASP0113**, a CMV **DNA vaccine**, in 2013 for people who received hematopoietic stem cell transplants[^13], and a phase 1 trial in 2015 for healthy volunteers.[^14]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Flogseq____&quot;,1501,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1511,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-11af-45a3-9e01-e2ffa547269alogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^6]: PubMed: 11256803logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Flogseq____&quot;,1443,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1512,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c378-4edb-ac21-33053cca8d31logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## CMV Treatment Options and Their Efficacy\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Flogseq____&quot;,1473,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1513,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0f87-4f34-a708-df6fe3fbbd5elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;TODO imageslogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Flogseq____&quot;,1569,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^10logseq____&quot;,logseq____&quot;TODOlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Vlogseq____&quot;,1457,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Ulogseq____&quot;,4,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^Hlogseq____&quot;,4,536871794]],[logseq____&quot;^15logseq____&quot;,[1514,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-2240-4962-833c-91997123a8f2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;6. **Immunohistochemistry** is more sensitive and very specific compared to plain histological microscopy, but it is very labor intensive and requires experienced personel.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Flogseq____&quot;,1586,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1515,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-961e-4ba5-844e-daa7dc0b8217logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;3. The **[[CMV pp65 antigenemia test]]** (*antigenemia*: presence of antigen in the blood) has been commonly used for CMV virus quantification. This assay detects the viral pp65 antigen, a protein expressed in blood leukocytes during early-phase CMV replication.[^4]\\n\\nThe pp65 test for CMV is extensively utilized to monitor CMV infection and its response to antiviral treatment in patients undergoing immunosuppressive therapy after renal transplantation surgery. One of the key benefits of this assay is its ability to deliver results quickly within a few hours, and its capability to determine the pp65 antigen serves as a useful indicator to start antiviral therapy. A major disadvantage of the pp65 assay is that only a limited number of samples can be processed per test. batch.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Flogseq____&quot;,1471,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Ulogseq____&quot;,1410,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^Hlogseq____&quot;,1410,536871794]],[logseq____&quot;^15logseq____&quot;,[1516,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-873b-4130-989c-9dc5bbbbe4c3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Flogseq____&quot;,1485,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1517,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1aa5-41c5-9c68-017050d5dc65logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Flogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1518,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-f0de-4370-b097-0679df550019logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^17]: https://clinicaltrials.gov/ct2/show/NCT02396134logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Flogseq____&quot;,1587,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1519,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-10c1-4dde-98c7-dc556d0610f2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Flogseq____&quot;,1533,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1520,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-19e4-40c7-9601-781a0e23093alogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^12]: https://doi.org/10.1586%2FERV.13.46logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Flogseq____&quot;,1585,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1521,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-63f5-4a93-81ad-e426819ad6a6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Flogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1522,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-fbb1-4120-b59f-9479f305255dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Flogseq____&quot;,1487,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1523,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-d146-45ec-b07d-28f31a21f0cflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; Vaccines for infectious disease have a historic two-out-of-three failure rate in the clinic (which is nonetheless the lowest such failure rate[^19] *by far* compared to all other drug development areas!).[^18]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Flogseq____&quot;,1538,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1524,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-000c-4c55-9003-695438275f7clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There is a small risk that CMV-IGIV may mediate transmission of blood-borne viruses, but this should still be considered as new viruses emerge. Noncardiogenic pulmonary edema (TRALI) and aseptic meningitis syndrome (AMS) have been reported to occur infrequently.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Flogseq____&quot;,1510,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Vlogseq____&quot;,1576,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1525,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-af8f-4b41-84bb-e8c084d741c3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^18]: https://www.science.org/content/blog-post/moderna-s-upcoming-clinical-trialslogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Flogseq____&quot;,1519,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1526,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b94e-4523-9119-a2562e4b2aeelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Flogseq____&quot;,1441,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1527,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-da29-4628-b0b9-cae71d3f8aaflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Sometimes a local asset will be used instead of a web link and it then may not display in the final export.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Flogseq____&quot;,1446,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Vlogseq____&quot;,1448,536871794]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^Ulogseq____&quot;,1426,536871947]],[logseq____&quot;^15logseq____&quot;,[1528,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-cd8b-4f3d-ade7-5627423db080logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Flogseq____&quot;,1563,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1529,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-10fc-40ff-b6cb-7a5d065fbc16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^13]: https://clinicaltrials.gov/ct2/show/NCT01877655logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Flogseq____&quot;,1521,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1530,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-f3b3-4551-acbe-da5dfad1d93blogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^22]: https://web.archive.org/web/20220119035557/https://cytogam.com/content/uploads/2021/07/Saol-Therapeutics_US-Prescribing-Information-CytoGam-August-2020.pdflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Flogseq____&quot;,1577,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1531,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-b34e-4ce8-b631-04bbb3a56cc8logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Flogseq____&quot;,1447,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1532,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-915b-47e9-8108-d430b318bf20logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Flogseq____&quot;,1522,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1533,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-17e4-439c-8bf9-e076681d20b4logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;8. **Hybrid capture assay** uses RNA probes to detect and quantify viral DNA. Its sensitivity is questionable.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Flogseq____&quot;,1466,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1534,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-54f6-433a-a0c6-62704e859099logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The virus is transmitted through contact with bodily fluids, such as saliva, blood, urine, semen, or breast milk. It stays in a person’s lymphocytes (white blood cells) for life and can reactivate or the person can be re-infected with a different virus strain. Pregnant women can pass the virus to their unborn babies (*vertical transmission*), in fact, it is the most frequently transmitted infection to newborns. About one out of every 200 infants is born with CMV, and one in five of those infants with CMV will have long-term health problems such as deafness, learning disabilities, and intellectual disability.[^8]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Flogseq____&quot;,1481,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1535,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-9e3c-455c-9d40-fef2b081a17clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Most infections with CMV go undiagnosed. CMV infection should be suspected or diagnosed if a patient has symptoms of infectious mononucleosis but a negative test result for Epstein–Barr virus, or has signs of hepatitis but negative test results for hepatitis A, B, and C. Blood tests are generally used to diagnose and monitor CMV infection. Tests of saliva or urine are preferred for newborns who are suspected of congenial CMV infection.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Flogseq____&quot;,1482,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1536,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-01dc-4da4-8dca-a4c4983a4d19logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Although HCMV is not highly contagious, it has been shown to spread in households and among young children in day care centers.[^1]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Flogseq____&quot;,1566,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1537,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-f1ef-433f-97c3-a7e545633d45logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cytomegalovirus vaccines are designed to prevent CMV infection or curb re-activation respectively associated symptomatic flare-ups. There are challenges that hinder development of these vaccines, mainly designing a vaccine that can circumvent the bodylogseq____&apos;s immune system reaction to CMV and limited animal models for HCMV. As of 2018, a number of vaccines are in development, they are emphasized as a priority and considerable effort is made, particularly on protection of pregnant women, since CMV is a known *vertically transmitted infection* (a member of *TORCH complex*). Immunocompromised persons are less likely to be candidates for such a vaccine because of  additional challenges. Additionally, there are health risks for individuals who are already not infected with CMV. CMV vaccines include **recombinant protein-, live attenuated-, DNA-** and **other vaccines**.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Flogseq____&quot;,1496,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1538,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-10d3-4ee2-aa4c-d94ab7037c3clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Cytomegalovirus is a common viral genus belonging to the [[Herpesvirales]] family that can affect people of all ages. The [human betaherpesvirus 5](https://en.wikipedia.org/wiki/Human_betaherpesvirus_5), also called **human cytomegalovirus (HCMV)**, is the species that causes CMV infection and congenital CMV infection. It is also commonly called **CMV**logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Flogseq____&quot;,1560,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Ulogseq____&quot;,1427,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^Hlogseq____&quot;,1427,536871794]],[logseq____&quot;^15logseq____&quot;,[1539,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e7c0-4f9d-a4e4-914e6c8bd0aalogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Specific Disease Entities\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Flogseq____&quot;,1548,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1540,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7489-4eda-b6dd-290356112314logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^20]: https://web.archive.org/web/20161129083300/https://www.drugs.com/monograph/valganciclovir-hydrochloride.htmllogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Flogseq____&quot;,1570,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1541,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-67f4-43f7-ad09-6126684a04f0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Flogseq____&quot;,1546,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1542,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1a96-42af-b907-817c9dd4f8ealogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: https://academic.oup.com/jtm/article/13/4/191/1801666logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Flogseq____&quot;,1495,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1543,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-60b4-4010-9f45-e2769865bbb6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Valganciclovir** is metabolized into ganciclovir, as such it presents the same intrinsic benefits and limitations, but because it is better absorbed in the body than its predecessor, it is more effective on a response percentage basis than ganciclovir. Valganciclovir is expensive which might be a limiting factor.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Flogseq____&quot;,1477,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1544,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-18eb-4968-b3e5-1f42a6b1f93blogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**CMV can cause serious health problems for people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and newborns.**logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Flogseq____&quot;,1573,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1545,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c566-4e22-838b-088010dd68f6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; [Laboratory diagnosis of cytomegalovirus infection by patient population](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730495/table/T2/?report=objectonly)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Flogseq____&quot;,1484,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1546,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-495e-4297-a23f-42508770a267logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^10]: with ChatGPT Diagnosis Improvmentlogseq____&quot;,536871851]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Flogseq____&quot;,1580,536871794]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^Ulogseq____&quot;,1426,536871848]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871851]],[logseq____&quot;^15logseq____&quot;,[1547,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c990-4ef8-b0cc-e8ab6b3e1d0blogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Flogseq____&quot;,1476,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1548,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-910e-4edb-864c-ed73dcb69404logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Flogseq____&quot;,1479,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1549,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-38a9-48b3-9abd-b0d521e3045flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Flogseq____&quot;,1468,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1550,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a808-49ec-a969-f7cf4af18143logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^28]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556539/logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Flogseq____&quot;,1557,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1551,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-94fe-426f-b618-fc07f8716a37logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^26]: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Flogseq____&quot;,1572,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1552,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0789-4a4d-b8f5-5c3692da1d4elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;A positive test for CMV IgM is used to indicate acute or recent infection. **IgM capture assay**/CMV IgM presence by itself cannot diagnose a primary infection, because IgM can also be present in secondary infection or in CMV reactivation.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Flogseq____&quot;,1440,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Vlogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1553,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-7737-4818-9576-fa797b2c0dfelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Despite the low overall risk, CMV screening is a routine part of the screening process for non-directed blood donation in several countries, including the United States.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Flogseq____&quot;,1464,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1554,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-8127-4896-bcbd-70d4b774be9clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Flogseq____&quot;,1529,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1555,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-fffd-41cd-a6a9-21ff41d58410logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Diagnostic Methods / Tests[^4]$$^{, }$$[^5]$$^{, }$$[^10]\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Flogseq____&quot;,1437,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1556,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-aaeb-4ec9-9204-997615808c9alogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^27]: https://www.ema.europa.eu/en/documents/product-information/prevymis-epar-product-information_en.pdflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Flogseq____&quot;,1552,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1557,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-810d-42ac-9d97-222065bd4385logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Cytomegalovirus Infection\\nheading:: 1logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Flogseq____&quot;,1550,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1558,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-c3da-4f77-899f-6e804b441c4flogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^7]: https://www.semanticscholar.org/paper/Comparison-of-enzyme-linked-immunosorbent-assay%2C-Booth-Hannington/23ab022f22609aa158071462e9e63d0617ca4723logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Flogseq____&quot;,1512,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1559,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-67e0-400a-a0a6-b8fb4fd42245logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Overview\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Flogseq____&quot;,1439,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1560,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a122-49e4-91da-afbaf5d494aalogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Flogseq____&quot;,1551,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1561,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e70b-4334-9fd7-4bff5bf09dedlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^15]: https://clinicaltrials.gov/ct2/show/NCT02826798logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Flogseq____&quot;,1568,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1562,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-475a-494e-824c-8335d93ca883logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV is being increasingly recognized as a cause of peripheral nerve disorders/PNS damage in patients with advanced AIDS, although this has not been fully delineated.[^2] It is not clear whether latent CMV infection has any negative effects on people who are otherwise healthy, but discussions had focused on whether latent CMV might increase the risk of some cardiovascular diseases and cancers.$$^{(citation\\\\ needed)}$$logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Flogseq____&quot;,1499,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1563,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0ffd-4f9f-bba7-3a447be5549elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;To achieve optimal diagnostic outcomes, it is recommended to conduct CMV antibody laboratory tests using *paired serum samples*. One sample should be taken upon suspicion of CMV, and another sample taken within 2 weeks. [[Viral culture]] can be done when the person exhibits symptoms. While antibody testing can confirm if a woman has already had CMV infection, routine testing for all pregnant women is expensive and should be evaluated on a case-by-case basis.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Flogseq____&quot;,1542,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Ulogseq____&quot;,1430,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^Hlogseq____&quot;,1430,536871794]],[logseq____&quot;^15logseq____&quot;,[1564,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4ee4-4bea-ba86-497944bbaa21logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;CMV esophagitislogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Flogseq____&quot;,1478,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1565,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-877e-4985-bb09-cb435151ac9elogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## How Common Is CMV And Who Is at Risk?\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Flogseq____&quot;,1532,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1566,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-33c1-40c1-a277-833cf0db0bd8logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;cytomegalovirus retinitis (inflammation of the retina)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Flogseq____&quot;,1506,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1567,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-3ca6-4588-9733-e78d6defd398logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^14]: https://clinicaltrials.gov/ct2/show/NCT02103426logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Flogseq____&quot;,1530,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1568,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1b77-470a-969a-0f6cbe3e094dlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;TODO check citation orderlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Flogseq____&quot;,1457,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^10logseq____&quot;,logseq____&quot;TODOlogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Vlogseq____&quot;,1457,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Ulogseq____&quot;,4,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^Hlogseq____&quot;,4,536871794]],[logseq____&quot;^15logseq____&quot;,[1569,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-a5f4-448b-9063-4c1e8b661ed2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^19]: https://academic.oup.com/biostatistics/article/20/2/273/4817524logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Flogseq____&quot;,1526,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1570,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-eabd-47fd-b373-6e4340438e05logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Flogseq____&quot;,1537,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1571,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-1bd9-4b30-a33e-1b730236ccc6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^25]: https://web.archive.org/web/20161129083300/https://www.drugs.com/monograph/valganciclovir-hydrochloride.htmllogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Flogseq____&quot;,1469,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1572,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-fc4a-4178-95f2-e613c796bc96logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Long-Term Health Issues\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Flogseq____&quot;,1517,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1573,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-31c7-4f4e-bb15-5bd5aabd7f09logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Polyradiculopathy, transverse myelitis, and subacute encephalitislogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Flogseq____&quot;,1565,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Vlogseq____&quot;,1540,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1574,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-89b8-4354-8297-07b4ebd5451clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Measurement of antibodies in paired serum samples can be used to diagnose active CMV infection, when a fourfold rise in IgG antibody and a significant level of IgM antibody (at least 30% of the IgG value) are present, or if virus is cultured from urine or the throat.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Flogseq____&quot;,1553,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Vlogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1575,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-5689-4e02-bbce-26ee1c3b5ebelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Effectiveness and Limitation\\nheading:: 3\\n**CMV-IGIV**, either alone or in combination with an antiviral agent, has been shown to reduce CMV-related illness and mortality in high-risk transplant recipients, while also providing long-term survival benefits with minimal incidence of treatment-related side effects, particularly in comparison to traditional immunogloblin treatment.[^22]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Flogseq____&quot;,1523,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1576,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-e30d-448d-93e2-1e30aec3fc0clogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^21]: https://www.deutsche-apotheker-zeitung.de/news/artikel/2011/09/02/neues-virostatikum-letermovir (German)logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Flogseq____&quot;,1541,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1577,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-5bcf-445b-9c87-79583bb06a17logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**IgG avidity assays** are utilized due to these limitations with IgM testing to help distinguish primary from past infection. The use of recombinant proteins in IgG avidity assays seems to be a very promising resolution for a more precise diagnosis, however, as  of 2022, they are not FDA-approved and require further standardization and confirmation.[^9]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Flogseq____&quot;,1583,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Vlogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1578,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-0310-4f75-a8f6-432eae668a48logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Flogseq____&quot;,1564,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1579,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-140e-4df6-9e19-e74de8d35eb7logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^9]:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397011/logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Flogseq____&quot;,1493,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1580,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-78f0-4fab-8325-0e5be5fc19c8logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;((640a3896-c220-463a-92a3-ce3908ce053c))logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Flogseq____&quot;,1470,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Vlogseq____&quot;,1470,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Ulogseq____&quot;,1417,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^Hlogseq____&quot;,1420,536871794]],[logseq____&quot;^15logseq____&quot;,[1581,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-bb08-4f2c-a932-b42735174935logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730495/pdf/nihms483784.pdflogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Flogseq____&quot;,1543,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1582,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-5725-41e1-b6be-399be97daea7logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Recombinant IgM assays** have been developed in an attempt to standardize serological assays. However, studies have shown poor correlation of results with IgM assays and are pront to false-positives.[^6]logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Flogseq____&quot;,1575,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Vlogseq____&quot;,1480,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Ulogseq____&quot;,1411,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^Ulogseq____&quot;,1429,536871794]],[logseq____&quot;^15logseq____&quot;,[1583,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-88b8-4534-8e6a-118f07bdf5d6logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## References\\nheading:: 2logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Flogseq____&quot;,1453,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1584,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-4837-49bb-9adc-836ecd41080alogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^11]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753425logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Flogseq____&quot;,1547,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1585,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-5f6a-4114-ab33-3488c3e528f0logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;5. **Shell vial assay** is a modified *[[viral culture]]* designed specifically for cytomegalovirus to decrease the time needed for detection necessary with cell culture.logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Flogseq____&quot;,1452,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Ulogseq____&quot;,1430,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^Hlogseq____&quot;,1430,536871794]],[logseq____&quot;^15logseq____&quot;,[1586,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-48a4-471a-9498-1e15b7379c81logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^16]: https://clinicaltrials.gov/ct2/show/NCT02506933logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Flogseq____&quot;,1562,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1587,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-242e-4f18-aaaa-e1025d7e29aelogseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Prevalence\\nheading:: 3logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Flogseq____&quot;,1571,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Xlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Vlogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Ulogseq____&quot;,1426,536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871794]],[logseq____&quot;^15logseq____&quot;,[1588,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80396-58f4-4f79-ae18-e0dbd66a7071logseq____&quot;,536871794]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^7]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Flogseq____&quot;,1611,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1590,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-116a-4d2c-94c9-16d9891d0d07logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## How Does it Work?\\nheading:: 2logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Flogseq____&quot;,1613,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1591,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-9abb-4511-8d02-83c8ff046fbdlogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^9]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Flogseq____&quot;,1612,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1592,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-c31f-4e2b-bae9-c978eb315b9clogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Flogseq____&quot;,1604,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1593,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-0f81-4ba2-bd2a-d80b77128950logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The mRNA-1647 vaccine is a combination is six mRNA strands, which encode two antigens found on the surface of CMV. The mRNA instructs the cells to produce functional antigens of the virus, which present a mimicked infection as if the virus were present, but in a more controlled and less serious condition, to which the immune system can respond to.logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Flogseq____&quot;,1591,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1595,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-756a-4163-a79a-53697d1878eblogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Flogseq____&quot;,1598,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1596,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-21a8-4894-b84d-cd0ee8f4b79dlogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# References\\nheading:: 1logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Flogseq____&quot;,1614,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;1logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1597,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-6175-4a09-aa15-676801d7bc9elogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.precisionvaccinations.com/vaccines/mrna-1647-cytomegalovirus-vaccinelogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Flogseq____&quot;,1597,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1598,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-1b3c-48d8-8a47-90c52e2e07a3logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### mRNA-1647 Vaccine (Moderna)\\nheading:: 4logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Flogseq____&quot;,1600,536872116]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536872116]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;]],536872116]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536872116]],[logseq____&quot;^15logseq____&quot;,[1599,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-d655-4765-854a-47e5cb0e5ec6logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Moderna mRNA-1647\\n:LOGBOOK:\\nCLOCK: [2023-03-12 Sun 14:45:26]--[2023-03-12 Sun 15:19:33] =logseq____&gt;  00:34:07\\n:END:logseq____&quot;,536872116]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Flogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Ulogseq____&quot;,1431,536872106]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536872116]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536872116]],[logseq____&quot;^15logseq____&quot;,[1600,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-e407-48b1-9848-78d3472bc341logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^11]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Flogseq____&quot;,1617,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1601,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-3476-4b29-b61f-538f8c483775logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Flogseq____&quot;,1615,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1602,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-6e8a-4b42-b7bc-3e88b9384150logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Flogseq____&quot;,1605,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1603,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-7700-4ada-b35d-700712e9ae75logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;https://trials.modernatx.com/study/?id=mRNA-1647-P301logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Flogseq____&quot;,1601,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1604,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-e626-4d1d-9ded-bc549cd880aclogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Flogseq____&quot;,1596,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1605,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-a13e-4e61-8a4f-fd083a9acc73logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Overview\\nheading:: 2logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Flogseq____&quot;,1610,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871796]],[logseq____&quot;^15logseq____&quot;,[1606,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-3539-408c-adea-502456f7699alogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^5]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Flogseq____&quot;,1603,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1608,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-a1f0-443b-b90b-c9ac3b350791logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Flogseq____&quot;,1618,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1609,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-d70b-4b57-b06f-6ca4477adecalogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Flogseq____&quot;,1616,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1610,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-720c-4320-beff-22b82d6c0afblogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^6]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Flogseq____&quot;,1608,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1611,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-5371-4f50-a2b8-72e356f067cdlogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^8]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Flogseq____&quot;,1590,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1612,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-ae97-46c7-953f-782a538a49felogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Flogseq____&quot;,1602,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1613,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-f520-471c-84dc-0495b44d20b1logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Flogseq____&quot;,1595,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1614,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-2acc-4fae-98b6-b93c76b22d09logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Flogseq____&quot;,1609,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1615,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-b8fe-43b2-bcfe-c2ebc56344f4logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Flogseq____&quot;,1599,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1616,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-e8bc-435a-9e13-b7a3f97baf1flogseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^10]:logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Flogseq____&quot;,1592,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1617,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-28cc-4d65-9497-6043857723c9logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The Moderna mRNA-1647 Cytomegalovirus vaccine candidate is an investigational mRNA vaccine designed to prevent [[Cytomegalovirus Infection]]logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Flogseq____&quot;,1606,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Xlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Vlogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Ulogseq____&quot;,1426,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Ulogseq____&quot;,1431,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^Hlogseq____&quot;,1426,536871796]],[logseq____&quot;^15logseq____&quot;,[1618,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-8061-43ce-b698-415a2ddce948logseq____&quot;,536871796]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^Klogseq____&quot;,1691878295110,536871798]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^@logseq____&quot;,false,536871798]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;serumlogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^11logseq____&quot;,logseq____&quot;serumlogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^Blogseq____&quot;,1691878295110,536871798]],[logseq____&quot;^15logseq____&quot;,[1621,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-ab38-4533-a420-1b9897fbd89clogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^Klogseq____&quot;,1691878295112,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^@logseq____&quot;,false,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;antigenslogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^11logseq____&quot;,logseq____&quot;Antigenslogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^Blogseq____&quot;,1691878295112,536871798]],[logseq____&quot;^15logseq____&quot;,[1622,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-dc1b-4591-9039-4c2ec47fc760logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^Klogseq____&quot;,1691878295113,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^@logseq____&quot;,false,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;serological testslogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^11logseq____&quot;,logseq____&quot;Serological testslogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^Blogseq____&quot;,1691878295113,536871798]],[logseq____&quot;^15logseq____&quot;,[1623,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-21ae-4d2e-b9b2-b039ce9a18fflogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Serology** is the scientific study of [[serum]] (blood plasma without clotting components) and other body fluids. In practice, the term usually refers to the diagnostic identification of [[antibodies]] in the serum:logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Flogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Xlogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Vlogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Ulogseq____&quot;,1411,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Ulogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Ulogseq____&quot;,1621,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Hlogseq____&quot;,1411,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^Hlogseq____&quot;,1621,536871798]],[logseq____&quot;^15logseq____&quot;,[1624,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-fd60-4cb0-9d49-4cf406e32fcalogseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*[[Serological tests]]* are diagnostic methods that are used to identify [[antibodies]] and [[Antigens]].logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Flogseq____&quot;,1624,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Xlogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Vlogseq____&quot;,1624,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ulogseq____&quot;,1411,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ulogseq____&quot;,1429,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ulogseq____&quot;,1621,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ulogseq____&quot;,1622,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Ulogseq____&quot;,1623,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Hlogseq____&quot;,1411,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Hlogseq____&quot;,1622,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^Hlogseq____&quot;,1623,536871798]],[logseq____&quot;^15logseq____&quot;,[1625,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-d432-44f4-98bb-68d4fb858959logseq____&quot;,536871798]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Viral culture** is a laboratory technique in which samples of a virus are placed to different [cell lines](https://en.wikipedia.org/wiki/Cell_line) which the virus being tested for its ability to infect. If the cells show changes, known as [cytopathic effects](https://en.wikipedia.org/wiki/Cytopathic_effect), then the culture is positive.logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Flogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Xlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Vlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^Ulogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1627,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-bb09-4c12-880d-6176f6d5e855logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Traditional viral culture has been generally superseded by **shell vial culture**, in which the sample is centrifuged onto a single layer of cells and viral growth is measured by [antigen detection](https://en.wikipedia.org/wiki/Laboratory_diagnosis_of_viral_infections#Antigen_detection) methods. This greatly reduces the time to detection for slow growing viruses such as in [[Cytomegalovirus Infection]], for which the method was developed. In addition, the centrifugation step in shell vial culture enhances the sensitivity of this method because after centrifugation, the viral particles of the sample are in close proximity to the cells.logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Flogseq____&quot;,1627,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Xlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Vlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Ulogseq____&quot;,1426,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Ulogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^Hlogseq____&quot;,1426,536871800]],[logseq____&quot;^15logseq____&quot;,[1628,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-cb45-4427-bc7d-468e6601a1dalogseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Flogseq____&quot;,1628,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Xlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Vlogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^Ulogseq____&quot;,1430,536871800]],[logseq____&quot;^15logseq____&quot;,[1629,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80397-e255-4472-850f-2549120bdbe3logseq____&quot;,536871800]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^Klogseq____&quot;,1691878339081,536871804]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;whologseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^11logseq____&quot;,logseq____&quot;WHOlogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^Blogseq____&quot;,1691878339081,536871804]],[logseq____&quot;^15logseq____&quot;,[1635,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8833-4495-b963-08af85fbe50flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^Klogseq____&quot;,1691878339084,536871804]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;low- and middle-income countrieslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^11logseq____&quot;,logseq____&quot;Low- and Middle-Income Countrieslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^Blogseq____&quot;,1691878339084,536871804]],[logseq____&quot;^15logseq____&quot;,[1636,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8eef-470c-b328-bba551798deblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^Klogseq____&quot;,1691878339082,536871804]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;#mortalitylogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^11logseq____&quot;,logseq____&quot;#mortalitylogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^Blogseq____&quot;,1691878339082,536871804]],[logseq____&quot;^15logseq____&quot;,[1637,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-518d-4534-9354-1a8d4f208164logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^Klogseq____&quot;,1691878339083,536871804]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;acute lower respiratory illnesseslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^11logseq____&quot;,logseq____&quot;acute lower respiratory illnesseslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^Blogseq____&quot;,1691878339083,536871804]],[logseq____&quot;^15logseq____&quot;,[1639,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3cf7-4b55-9411-220141bf828flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^Klogseq____&quot;,1691878339081,536871804]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;acute lower respiratory infectionslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^11logseq____&quot;,logseq____&quot;acute lower respiratory infectionslogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^Blogseq____&quot;,1691878339081,536871804]],[logseq____&quot;^15logseq____&quot;,[1641,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7236-4990-8940-77100385a5dblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^Klogseq____&quot;,1691878339086,536871804]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;citationneededlogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^11logseq____&quot;,logseq____&quot;citationneededlogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^Blogseq____&quot;,1691878339086,536871804]],[logseq____&quot;^15logseq____&quot;,[1642,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-acbf-448b-8410-8bea40429f13logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^Klogseq____&quot;,1691878339086,536871804]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871864]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;eu5logseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^11logseq____&quot;,logseq____&quot;EU5logseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^Blogseq____&quot;,1691881487093,536871898]],[logseq____&quot;^15logseq____&quot;,[1643,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3bfc-47cf-ada0-add0a09bc190logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^Klogseq____&quot;,1691878339082,536871804]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;pneumococcal pneumonialogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^11logseq____&quot;,logseq____&quot;pneumococcal pneumonialogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^Blogseq____&quot;,1691878339082,536871804]],[logseq____&quot;^15logseq____&quot;,[1645,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3ca2-4464-9120-24842d7e0cc9logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^Klogseq____&quot;,1691878339083,536871804]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^@logseq____&quot;,false,536871804]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;uncertainty rangelogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^11logseq____&quot;,logseq____&quot;uncertainty rangelogseq____&quot;,536871804]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^Blogseq____&quot;,1691878339083,536871804]],[logseq____&quot;^15logseq____&quot;,[1646,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-35c7-480c-bff4-5ae898bbec8flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^Klogseq____&quot;,1691878354429,536871824]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^@logseq____&quot;,false,536871824]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;mrna-1345logseq____&quot;,536871824]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^11logseq____&quot;,logseq____&quot;mRNA-1345logseq____&quot;,536871824]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871833]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^Blogseq____&quot;,1691880750459,536871837]],[logseq____&quot;^15logseq____&quot;,[1777,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-44dd-4f7b-b080-283eb8d7e178logseq____&quot;,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;https://investors.modernatx.com/news/news-details/2023/Moderna-Granted-FDA-Breakthrough-Therapy-Designation-for-mRNA-1345-An-Investigational-Respiratory-Syncytial-Virus-RSV-Vaccine-Candidate/default.aspxlogseq____&quot;,536871837]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Flogseq____&quot;,1777,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Xlogseq____&quot;,1777,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Vlogseq____&quot;,1777,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^Ulogseq____&quot;,1777,536871824]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871837]],[logseq____&quot;^15logseq____&quot;,[1778,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-c3ed-4dad-bbcf-49ba63d1904elogseq____&quot;,536871824]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^Klogseq____&quot;,1691878354588,536871826]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^@logseq____&quot;,false,536871826]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;rsv-associated deathslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^11logseq____&quot;,logseq____&quot;RSV-associated deathslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^Blogseq____&quot;,1691878354588,536871826]],[logseq____&quot;^15logseq____&quot;,[1782,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7955-47f2-8c84-fe2cc68d688elogseq____&quot;,536871830]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^Klogseq____&quot;,1691878354587,536871826]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^@logseq____&quot;,false,536871826]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;community settingslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^11logseq____&quot;,logseq____&quot;community settingslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871858]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^Blogseq____&quot;,1691880889850,536871861]],[logseq____&quot;^15logseq____&quot;,[1783,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-bb3e-4f26-b50e-dfe675be11fflogseq____&quot;,536871828]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^Klogseq____&quot;,1691878354587,536871826]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^@logseq____&quot;,false,536871826]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;respiratory syncytial viruslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^11logseq____&quot;,logseq____&quot;Respiratory Syncytial Viruslogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871902]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^Blogseq____&quot;,1691882414354,536871912]],[logseq____&quot;^15logseq____&quot;,[1784,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7cf0-4820-a6a6-52f5a2351adclogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Transmission and Spread\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Flogseq____&quot;,1836,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1785,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-d3cd-4145-8354-205d6b56c9b5logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;According to the [[WHO]], RSV is the leading cause of *[[acute lower respiratory infections]] (ALRIs)* and the second largest cause of mortality. RSV is responsible for a rise in admissions to hospitals, which can quickly become overwhelmed or will be unprepared, particularly during the winter viral season. RSV infection is often neglected as a disease[^12], including vaccine development is said to be underfunded.[^2] Although as of recently, RSV is increasingly being recognized as a major pathogen heavily in need of a vaccine.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Flogseq____&quot;,1857,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Ulogseq____&quot;,1635,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Ulogseq____&quot;,1641,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Hlogseq____&quot;,1635,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^Hlogseq____&quot;,1641,536871826]],[logseq____&quot;^15logseq____&quot;,[1786,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-92ae-4f0a-90b1-bb810a044ef2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Flogseq____&quot;,1899,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1787,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-99bc-4976-b4c7-66d208e47d93logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In children under the age of 6, an estimated 33 million ([[uncertainty range]] UR 25.4–44.6) cases of RSV-associated *[[acute lower respiratory illnesses]] (ALRIs)* occurr, alongside 3.6 million hospital admissions and 101logseq____&apos;400 (UR 84logseq____&apos;500–125logseq____&apos;200) deaths due to these ALRIs globally. Most infections occur in the winter season, starting in November and peaking in December.[^citationneeded]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Flogseq____&quot;,1794,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Ulogseq____&quot;,1639,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Ulogseq____&quot;,1646,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Hlogseq____&quot;,1639,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^Hlogseq____&quot;,1646,536871826]],[logseq____&quot;^15logseq____&quot;,[1788,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-6dfd-418f-bfd2-c45b05711652logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Available Treatments for RSV\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Flogseq____&quot;,1809,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1789,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3920-49cf-a618-faf452c17cadlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## References\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Flogseq____&quot;,1806,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1790,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-33c8-48a1-a6ce-36755b7c280elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Flogseq____&quot;,1810,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1791,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-6002-4a1d-9cb5-6b84f69234c2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~^{*which is inflammation of the bronchioles in the lower respiratory tract}logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Flogseq____&quot;,1866,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1792,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-6969-44fe-88df-337e90954707logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Flogseq____&quot;,1853,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1793,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4d7f-4e6a-82eb-a01e782a65f4logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Approximately 87% of children will have had RSV by 18 months of age; **most children will get infected by 2 years of age and nearly all by 3 years**. The risk of a serious infection is highest in the first 6 months of life.[^5]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Flogseq____&quot;,1874,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1794,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-0426-4475-9f40-74d5fa354bf3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Flogseq____&quot;,1821,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1795,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b30b-4ce9-bbdc-7f867917be74logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Flogseq____&quot;,1872,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1796,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-dc53-4e0b-8cde-dbd1532c26f7logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Flogseq____&quot;,1839,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1797,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-59e8-4398-b3ec-94fb67a128dalogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Flogseq____&quot;,1876,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1798,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-5dea-4b65-af25-979109322ae2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; the G protein facilitates viral attachment to host ciliated cells of the airway ([32](https://www.ncbi.nlm.nih.gov/books/NBK442240/#ch5.r32))while F mediates virion and host cell fusion ([33](https://www.ncbi.nlm.nih.gov/books/NBK442240/#ch5.r33)).logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Flogseq____&quot;,1838,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1799,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-9e2e-4c3e-adeb-6f8fe8088b1elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Flogseq____&quot;,1864,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1800,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b90b-4f9b-bf16-c7148551f12alogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The illustration depicted above is for community settings, whereas the one at the bottom represents in-hospital deaths. [[#note1]]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Flogseq____&quot;,1900,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Vlogseq____&quot;,1900,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1801,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3dae-4444-a5e5-c4796998fe47logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Flogseq____&quot;,1826,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1802,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-76e3-48ce-b79f-4becb17b3ba5logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;RSV is known to have high infection rates within the first winter months, peaking in December, while there is an absence of cases in the summer months.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Flogseq____&quot;,1785,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1803,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-df05-45ed-a0da-0c0a52de54calogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Flogseq____&quot;,1898,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1804,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-c710-4ae8-9d1e-13c673d815celogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;RSV is an enveloped virus.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Flogseq____&quot;,1905,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1805,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-5ff6-4112-9385-0c559b1ea932logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Flogseq____&quot;,1795,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1806,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-78d7-43fc-9650-330f439f5324logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**\\\\***^{1:} *The reasons for this increase are not clear but likely reflect increased testing for RSV among adults.*logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Flogseq____&quot;,1837,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1807,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a4da-4c4d-aecd-6677578f2714logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Flogseq____&quot;,1817,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1808,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1564-4254-8e44-311284d8bf31logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Flogseq____&quot;,1852,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1809,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-0e88-4154-9679-d62a7181ab93logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Flogseq____&quot;,1811,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1810,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1274-4052-8d38-6be30af64fbblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Flogseq____&quot;,1846,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1811,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b495-435f-808d-9077c42f5584logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^1]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864404/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Flogseq____&quot;,1790,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1812,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-136e-460a-97ff-f894ba24c0e2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;The incidence of ALRIs as well as morbidity and mortality are most frequent in during the first 6 months of life and in [[Low- and Middle-Income Countries]] (LMICs)[^11]. 97% of infections occur in LMICs, 93% of RSV-ALRI and 99% of deaths occur in low-income countries.[^9] Deaths in [[community settings]] amount to about 50% of infants aged 0-6 months, yet deaths occur sooner in community (1.5 months), compared to in-hospital (2.4 months). There are a number of conflicting factors to the latter two findings to consider.[^8] A substantial proportion of children with RSV-related death have comorbidities.[^7]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Flogseq____&quot;,1863,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Ulogseq____&quot;,1636,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Ulogseq____&quot;,1783,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Hlogseq____&quot;,1636,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^Hlogseq____&quot;,1783,536871826]],[logseq____&quot;^15logseq____&quot;,[1813,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-96b5-4ebc-8a10-173163ddefc9logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Flogseq____&quot;,1844,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1814,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8871-4b25-a994-519959e5f3c0logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;~^{Fig. 1:} https://www.ncbi.nlm.nih.gov/books/NBK442240/figure/ch5.f1/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Flogseq____&quot;,1884,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1815,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-d2ef-47f3-a04a-2003eeecacbflogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^7]: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(17)30344-3/fulltextlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Flogseq____&quot;,1896,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1816,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b65b-4284-950e-7f3b8eb13133logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There is no cure for RSV infection, but antiviral medications can be used in more severe cases to treat the disease.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Flogseq____&quot;,1834,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1817,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3462-40d1-bb8b-c8ff509ef0c5logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;-logseq____&gt; Involves glycoprotein glogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Flogseq____&quot;,1902,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1818,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4ec1-41b6-bb73-d5d434599e05logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Testing for RSV have lower detection rates among different ages, and this highlights the need for better diagnostic tests.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Flogseq____&quot;,1822,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1819,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-0bfa-4930-aff4-d1e7939fa252logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Flogseq____&quot;,1843,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1820,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-620d-40a9-8aac-e473e51c8a53logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Flogseq____&quot;,1814,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1821,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-d7a4-4bdf-8db9-0a6a0cf4ab40logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Diagnosing RSV\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Flogseq____&quot;,1847,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1822,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a7ee-4361-870c-223980b2b1f5logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Flogseq____&quot;,1792,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1823,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-500d-4542-a2fb-ddefd758643blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Flogseq____&quot;,1856,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1824,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-d895-4ef7-99f8-ff4e840acdddlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Flogseq____&quot;,1804,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1825,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-c9c2-4718-bede-81a46ed4c731logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Flogseq____&quot;,1808,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1826,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-d13d-4a24-b8c5-ee6610ecaba8logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Flogseq____&quot;,1840,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1827,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1627-490b-89b9-8b7e8b10f3cflogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**France** -logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Flogseq____&quot;,1880,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1828,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-ea9d-4a31-ba88-2f99877c4e05logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Description\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Flogseq____&quot;,1796,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1829,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-188a-4870-ae46-15b707710037logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^8]: https://academic.oup.com/cid/article/73/Supplement_3/S229/6362482logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Flogseq____&quot;,1816,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1830,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1c7d-4015-8d3d-927a8ec188b2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It presents an array of different respiratory illnesses, such as bronchiolitis in infants, common cold symptoms in adults and pneumonia in the elderly and immunocompromised, which can be severe and life-threatening.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Flogseq____&quot;,1850,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1831,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-5a9f-4728-9610-27da8f655ecflogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Recognizing Symptoms\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Flogseq____&quot;,1865,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1832,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-dfc0-4b5a-b079-4dce6d1951delogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**UK** - In the UK, 487,247 visits to GPs, 17,799 hospitalizations, and 8,482 deaths were recorded among adults aged 18+ within a typical RSV season. From these, 175,070 GP visits (36%), 14,039 hospitalizations (79%), and 7,915 deaths (93%) were noted in persons aged 65+. High-risk elderly individuals were twice as likely to experience GP visits or death related to RSV and four times more likely to be hospitalized for RSV, compared to low-risk elderly individuals. In most seasons since 2001, more GP episodes, hospitalizations and deaths were attributable to RSV in adults than to influenza. #citationneededlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Flogseq____&quot;,1901,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Ulogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^Hlogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1833,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a9a0-4f46-b991-e52d02777781logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&gt; [gpt3] Nevertheless, it is clear that RSV significantly contributes to the burden of ALRI and mortality in infants and young children worldwide.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Flogseq____&quot;,1889,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1834,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b836-49c7-b05b-bbf05756f52flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;RSV is a leading cause of morbidity in the United States, particularly at the extremes of age. An estimated 57logseq____&apos;000 children aged logseq____&lt;5 years and 177logseq____&apos;000 adults aged ≥65 years will develop respiratory infections due to RSV. #citationneededlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Flogseq____&quot;,1860,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Ulogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^Hlogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1835,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f7ec-4096-8af0-907d04de4534logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Flogseq____&quot;,1893,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1836,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-06fa-46cd-8674-80d0ae18380dlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Flogseq____&quot;,1867,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1837,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a5b6-4d75-854c-6c240b343b6elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Flogseq____&quot;,1871,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1838,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3732-4c84-98ba-64b6f43afe8flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## At-Risk Populations\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Flogseq____&quot;,1862,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1839,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1f4a-4aa2-89dd-b2eaa4841fdflogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Flogseq____&quot;,1820,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1840,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3c7f-4051-be46-cd0bc4add463logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Flogseq____&quot;,1895,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1841,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-bd47-410c-bc67-95e830fa63b9logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Flogseq____&quot;,1827,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1842,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-deb9-4e03-b680-1e50652338celogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Investigational Treatments\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Flogseq____&quot;,1841,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1843,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-82f3-43de-bca1-2b6783e6ffcalogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Further Reading and Resources\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Flogseq____&quot;,1842,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1844,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-9620-45e9-b4cf-40de9d5ee186logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Understanding RSV: Mechanism and Causes\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Flogseq____&quot;,1868,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1845,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-9536-4d41-921d-82db10411d2alogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### ~~(Complications and)~~ Long-Term Health Effects\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Flogseq____&quot;,1879,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1846,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-bfaa-4ecd-b7f9-e7033dc96eb9logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Flogseq____&quot;,1791,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1847,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-9787-4824-bc1e-23527e712cbdlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Flogseq____&quot;,1807,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1848,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f942-4256-8f93-b7ef0773aec5logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;I can be classified into two subgroups, which are simply termed **A** and **B**, distinguished by their variation of *antigeneticity*, which is their ability to avoid the immune systemlogseq____&apos;s response.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Flogseq____&quot;,1805,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1849,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f2ee-427d-89ac-c1755978810alogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Symptoms of RSV\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Flogseq____&quot;,1861,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1850,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4061-42ee-ab76-545ddc6f69e3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Germany** -logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Flogseq____&quot;,1828,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1851,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-9493-438f-9f8f-03545f817b1clogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Flogseq____&quot;,1798,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1852,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-0758-48dd-99a1-59318663efd0logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Flogseq____&quot;,1886,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1853,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b64c-43c1-8b3e-a1501c7a60bblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;In 2021, a comprehensive study analyzed 30.5 million US death certificates spanning from 2005 to 2016. Of those, 0.003% (n=1001) were assigned [[RSV-associated deaths]]. #citationneeded The study concluded, that the average deaths per year has not significantly changed in all groups of all ages, however, the class of **RSV-pneumonia deaths among adults aged ≥50 years developed a significant 3.2-fold increase**\\\\*^{1} during the period between 2005–2012 and 2013–2016. This increase in mortality has risen particularly steep from 2012 onwards. The accompanying figure illustrates this (bottom-right graph): #citationneededlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Flogseq____&quot;,1835,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Ulogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Ulogseq____&quot;,1782,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Hlogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^Hlogseq____&quot;,1782,536871826]],[logseq____&quot;^15logseq____&quot;,[1854,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1304-484a-bd9e-74cc080f2a87logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Respiratory Syncytial Virus (RSV), also called *human respiratory syncytial virus (*hRSV*)* and *human orthopneumovirus* (species) is a common virus that causes infections in the respiratory tract. It is a [negative-sense, single-stranded RNA virus](https://en.wikipedia.org/wiki/Negative-sense,_single-stranded_RNA_virus). *[Syncytia](https://en.wikipedia.org/wiki/Syncytia)* refers to the specific type of large cells that form when infected cells fuse with neighboring cells.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Flogseq____&quot;,1829,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1855,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4fb8-445f-b85a-e6c3581ea3c7logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Flogseq____&quot;,1803,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1856,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-420d-4fde-b653-438fce9a7571logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;RSV is a highly contagious pathogen which causes a range of symptoms and complications that typically differ among various age groups. RSV is a leading cause of morbidity in the United States, particularly at the high and low ends of the age spectrum as well as immunocompromised individuals, yet furthermore, it can still affect all ages.[^3]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Flogseq____&quot;,1855,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1857,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-11ee-4b82-b7c7-d6fa5c3a7618logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^9]: https://pubmed.ncbi.nlm.nih.gov/28689664/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Flogseq____&quot;,1830,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1858,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-c332-4a38-a9d7-1b2136efe773logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^10]: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30310-4/fulltextlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Flogseq____&quot;,1858,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1859,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-31c5-4ec4-a8b3-6e7261d0e290logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### United States[^3]\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Flogseq____&quot;,1875,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1860,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-06e5-4a13-aa70-195cddf7a46clogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Flogseq____&quot;,1800,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1861,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1150-4bc4-9d07-92bc5ab8cee7logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Flogseq____&quot;,1824,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1862,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-e2d4-4354-8239-9b86b2b1a635logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Flogseq____&quot;,1904,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1863,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-106e-4ac8-a2d8-778e44c2be94logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Flogseq____&quot;,1797,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1864,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7e5b-4784-887e-f74a3c68f1belogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Flogseq____&quot;,1831,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1865,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-6ad4-4fb4-a3d1-c201dc8e9f9alogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;RSV is the second largest cause of lower respiratory infection mortality worldwide[^10] and among the largest causes of mortality in infants (the leading cause, [[pneumococcal pneumonia]], however, amounts to far more deaths overall). Of those infected with RSV, 2-3% will develop [bronchiolitis](https://en.wikipedia.org/wiki/Bronchiolitis)*.[^6]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Flogseq____&quot;,1787,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Ulogseq____&quot;,1645,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^Hlogseq____&quot;,1645,536871826]],[logseq____&quot;^15logseq____&quot;,[1866,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b5ef-421e-85d2-54a727ea1de7logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![HSR2-4-e428-g003.jpg](../assets/9wpposzi_1679069818363_0.bmp){:height 321, :width 344}\\n^{RSV‐associated deaths by contributing cause†} [^{DOI: 10.1002/hsr2.428 Fig. 3}](www.ncbi.nlm.nih.gov/pmc/articles/PMC8562311/bin/HSR2-4-e428-g003.jpg)logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Flogseq____&quot;,1854,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1867,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-103e-4e31-b209-dc5d2defb14flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Flogseq____&quot;,1825,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1868,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f8f2-4d43-af64-6ad48375cc8blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^2]: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30310-4/fulltext#tbl2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Flogseq____&quot;,1812,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1869,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a2dc-446e-8f35-59f8a09ac752logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^12]: https://www.pnas.org/doi/10.1073/pnas.1814484116logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Flogseq____&quot;,1894,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1870,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4ee6-4e97-acfb-2e44288dda6flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871912]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Flogseq____&quot;,1882,536871826]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^Ulogseq____&quot;,1784,536871913]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871912]],[logseq____&quot;^15logseq____&quot;,[1871,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f533-45a1-ad4d-09549a26af89logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;#### *Respiratory Syncytial Virus (RSV) Infection and RSV Disease*\\nheading:: 4logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Flogseq____&quot;,1903,536871905]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,4],536871905]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;]],536871905]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;4logseq____&quot;],536871905]],[logseq____&quot;^15logseq____&quot;,[1872,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-615b-4a18-a8bd-3bd327520fe1logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Flogseq____&quot;,1793,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1873,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-ac78-40de-87a2-adb2c34b75edlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Flogseq____&quot;,1883,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1874,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-0a3d-4bbe-9499-297efb8e9039logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;background-color:: pink\\nlogseq____&quot;,536871908]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Flogseq____&quot;,1900,536871826]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Ulogseq____&quot;,1784,536871909]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1Alogseq____&quot;,logseq____&quot;pinklogseq____&quot;],536871908]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[logseq____&quot;^1Alogseq____&quot;]],536871908]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1Alogseq____&quot;,logseq____&quot;pinklogseq____&quot;],536871908]],[logseq____&quot;^15logseq____&quot;,[1875,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-e59e-4323-822f-3df5158023d0logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/respiratory-syncytial-virus-diseaselogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Flogseq____&quot;,1891,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1876,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7786-411b-8cee-594c185c2e0elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Italy** -logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Flogseq____&quot;,1851,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1877,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-500c-4d1f-a431-aafef20e4b24logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^4]: https://www.eurekaselect.com/article/41432logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Flogseq____&quot;,1887,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1878,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8f03-40e5-8cc4-6dca9cbf454dlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Flogseq____&quot;,1832,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1879,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-deec-4545-82e9-9fbead27624blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**Spain** - In a Spanish study, mortality was estimated to be 6.19 per 100 000 in children under 1 year of age, decreasing by 50% each year until a plateau around 4 years of age.[^5]logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Flogseq____&quot;,1833,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1880,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4957-4f7a-8a12-707824891586logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Flogseq____&quot;,1802,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1881,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-a25f-4091-bf09-aad1622c188clogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Flogseq____&quot;,1818,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1882,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f025-4da8-983e-196b7643627elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;*Incidence of RSV Infections are commonly designated into age groups rather than overall*; the rate of **^^incidence is most frequently evaluated in children logseq____&lt;5 years of age^^** and seconded by adults ≥65 years of age. Overall, the **^^national, regional, and global RSV incidence, morbidity and mortality vary substantially^^ from year to year and in any one setting**, more so than with other diseases. Deterministically, this becomes less useful when comparing overall rates to one another, in addition to being arbitrary .logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Flogseq____&quot;,1906,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1883,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-dd9b-4f12-afec-559ab4738e69logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Flogseq____&quot;,1870,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1884,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-3aa7-4e4b-89bc-c69ec16902e6logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Flogseq____&quot;,1890,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1886,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8289-492b-a748-3040acba6ba3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^3]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562311/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Flogseq____&quot;,1869,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1887,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-b293-482e-904b-efb6db8c2e6elogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Vaccination\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Flogseq____&quot;,1873,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1888,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-74c5-4e83-9f73-d507c866b794logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;It is the second largest cause (*aetiology*) of lower respiratory infection [[#mortality]][^10] worldwide, and among the largest causes for mortality in infants, although of which the latter varies from year to year and in different areas as well as environments. (The total amount of deaths is much lower than the leasing cause, [[pneumococcal pneumonia]]) #citationneededlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Flogseq____&quot;,1786,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Ulogseq____&quot;,1637,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Ulogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Ulogseq____&quot;,1645,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Hlogseq____&quot;,1637,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Hlogseq____&quot;,1642,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^Hlogseq____&quot;,1645,536871826]],[logseq____&quot;^15logseq____&quot;,[1889,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-833d-411d-8fba-46176c1762d1logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Diagnostic Techniques and Procedures\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Flogseq____&quot;,1819,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1890,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-bd6f-4c70-9857-810702778ccblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;There are many vaccines under development, mostly based on the surface glycoprotein F which exists in two conformations (prefusion and postfusion). Much of the neutralising antibody appears to be to the prefusion form. Vaccines being developed include live attenuated, subunit, particle based and live vectored agents. Different vaccine strategies may be appropriate for different target populations: at-risk infants, school-age children, adult caregivers and the elderly. Antiviral drugs are in clinical trial and may find a place in disease management. RSV disease is one of the major remaining common tractable challenges in infectious diseases and the era of vaccines and antivirals for RSV is on the near horizon.logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Flogseq____&quot;,1888,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1891,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-f607-4f9e-b433-b52abd110418logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^5]: https://www.ncbi.nlm.nih.gov/books/NBK442240/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Flogseq____&quot;,1878,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1892,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-042e-430f-8ffb-12fcc0270abdlogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;https://www.ncbi.nlm.nih.gov/books/NBK442240/logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Flogseq____&quot;,1799,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1893,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-6236-4862-9330-e696a7576cf2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^11]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613574/#R3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Flogseq____&quot;,1859,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1894,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8c7b-4bed-8e7d-79125f2af12blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Approved Medications and Therapies\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Flogseq____&quot;,1789,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1895,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-09e5-48b5-8de6-9ca7bcdd3b7blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[^6]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829966/ (Citations [3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829966/#R3)–[8](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829966/#R8))logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Flogseq____&quot;,1892,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1896,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4380-48c0-bce6-633c08b3b3cblogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Incidence rates of RSV between different climate locations.[^5]^{, }^{Fig. 1}logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Flogseq____&quot;,1904,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Vlogseq____&quot;,1904,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1897,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-afea-413c-9671-06f79cc6e92clogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Flogseq____&quot;,1877,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1898,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-55d1-40f4-9ead-6220d3e8d623logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Epidemiology of RSV: A Global Perspective[^1]^{,}[^2]\\nheading:: 2logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Flogseq____&quot;,1881,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;2logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1899,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-4861-43f0-a987-57efb35e414blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![ciab528f0002.jpeg](../assets/ciab528f0002_1679488962560_0.jpeg){:height 285, :width 389}logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Flogseq____&quot;,1813,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1900,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-5609-4c38-acaa-8ae51428a170logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### [[EU5]]\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Flogseq____&quot;,1848,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Ulogseq____&quot;,1643,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^Hlogseq____&quot;,1643,536871826]],[logseq____&quot;^15logseq____&quot;,[1901,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-ab14-4dc2-9cae-95e098a76b8flogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Flogseq____&quot;,1849,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1902,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-1686-43c3-8597-5fff9cdbfd18logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;# Respiratory Syncytial Virus (RSV): An Overviewlogseq____&quot;,536871905]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Flogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,1],536871905]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536871905]],[logseq____&quot;^15logseq____&quot;,[1903,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-7344-4aee-a5bd-e58a910cb82blogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;![ch5f1.jpg](../assets/ch5f1_1679568222791_0.jpg){:height 306, :width 305}logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Flogseq____&quot;,1788,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1904,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-97c6-4957-9c33-9186abb1c9eclogseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Structure and Function\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Flogseq____&quot;,1845,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1905,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-e7c7-4b42-b001-9befc82cc1d1logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;### Incidence\\nheading:: 3logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Flogseq____&quot;,1823,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Xlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Vlogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Ulogseq____&quot;,1784,536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,3],536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^1logseq____&lt;logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^4logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,logseq____&quot;3logseq____&quot;],536871826]],[logseq____&quot;^15logseq____&quot;,[1906,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-75c2-463e-bbf5-49c0dd38f844logseq____&quot;,536871826]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Some examples of community settings where disease transmission can occur include schools, workplaces, nursing homes, homeless shelters, and prisons.logseq____&quot;,536871861]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871828]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Flogseq____&quot;,1783,536871828]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Xlogseq____&quot;,1783,536871828]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Vlogseq____&quot;,1783,536871828]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^Ulogseq____&quot;,1783,536871828]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871861]],[logseq____&quot;^15logseq____&quot;,[1908,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-03c0-4045-882f-2ad490a56e45logseq____&quot;,536871828]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;697 (69.6%) with RSV‐pneumonia, 277 (27.7%) RSV‐bronchiolitis, 17 (1.7%) RSV‐bronchitis, and 10 (1.0%) with multiple RSV-associated causeslogseq____&quot;,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Flogseq____&quot;,1782,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Xlogseq____&quot;,1782,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Vlogseq____&quot;,1782,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^Ulogseq____&quot;,1782,536871830]],[logseq____&quot;^15logseq____&quot;,[1911,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d803d2-8727-46ea-9b71-750b63a9b6adlogseq____&quot;,536871830]],[logseq____&quot;^15logseq____&quot;,[1912,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871843]],[logseq____&quot;^15logseq____&quot;,[1912,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871843]],[logseq____&quot;^15logseq____&quot;,[1912,logseq____&quot;^@logseq____&quot;,false,536871843]],[logseq____&quot;^15logseq____&quot;,[1912,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871843]],[logseq____&quot;^15logseq____&quot;,[1912,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80d4f-3e69-4a91-93a6-1de938bedc68logseq____&quot;,536871843]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;**EU5** stands for European Union Five (France, Germany, Italy, Spain, United Kingdom)logseq____&quot;,536871878]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871865]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^@logseq____&quot;,false,536871865]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Flogseq____&quot;,1643,536871865]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Xlogseq____&quot;,1643,536871865]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Vlogseq____&quot;,1643,536871865]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^Ulogseq____&quot;,1643,536871866]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871878]],[logseq____&quot;^15logseq____&quot;,[1914,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d80dbe-798c-4f5d-b559-223ad2febd3flogseq____&quot;,536871865]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^@logseq____&quot;,false,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Flogseq____&quot;,1914,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Xlogseq____&quot;,1643,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Vlogseq____&quot;,1643,536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^Ulogseq____&quot;,1643,536871882]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871881]],[logseq____&quot;^15logseq____&quot;,[1916,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81003-9f8c-4f4f-b681-8ad9db726548logseq____&quot;,536871881]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;Note that the UK is not a part of the EU anymorelogseq____&quot;,536871898]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871885]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^@logseq____&quot;,false,536871885]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Flogseq____&quot;,1916,536871885]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Xlogseq____&quot;,1643,536871885]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Vlogseq____&quot;,1643,536871885]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^Ulogseq____&quot;,1643,536871886]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871898]],[logseq____&quot;^15logseq____&quot;,[1917,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81003-b979-41d8-99e1-bfe38bb75fe2logseq____&quot;,536871885]],[logseq____&quot;^15logseq____&quot;,[1920,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871927]],[logseq____&quot;^15logseq____&quot;,[1920,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871927]],[logseq____&quot;^15logseq____&quot;,[1920,logseq____&quot;^@logseq____&quot;,false,536871927]],[logseq____&quot;^15logseq____&quot;,[1920,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871927]],[logseq____&quot;^15logseq____&quot;,[1920,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81ce2-c068-4425-8d5e-ea9a41af6661logseq____&quot;,536871927]],[logseq____&quot;^15logseq____&quot;,[1921,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536871951]],[logseq____&quot;^15logseq____&quot;,[1921,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871951]],[logseq____&quot;^15logseq____&quot;,[1921,logseq____&quot;^@logseq____&quot;,false,536871951]],[logseq____&quot;^15logseq____&quot;,[1921,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536871951]],[logseq____&quot;^15logseq____&quot;,[1921,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81cfb-6703-4412-ab2b-3d49af325699logseq____&quot;,536871951]],[logseq____&quot;^15logseq____&quot;,[1922,logseq____&quot;^12logseq____&quot;,2,536871980]],[logseq____&quot;^15logseq____&quot;,[1925,logseq____&quot;^Tlogseq____&quot;,logseq____&quot;~:recent/searchlogseq____&quot;,536871988]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^Klogseq____&quot;,1691885358468,536871989]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871989]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^@logseq____&quot;,false,536871989]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;projectslogseq____&quot;,536871989]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^11logseq____&quot;,logseq____&quot;Projectslogseq____&quot;,536871989]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^Blogseq____&quot;,1691885691838,536872268]],[logseq____&quot;^15logseq____&quot;,[1926,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f2e-caa4-4c79-b9bf-54c64cf5598dlogseq____&quot;,536871989]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Amgenlogseq____&quot;,536872234]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536871990]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^@logseq____&quot;,false,536871990]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Flogseq____&quot;,1926,536871990]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Xlogseq____&quot;,1926,536871990]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Vlogseq____&quot;,1926,536871990]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Ulogseq____&quot;,1926,536872235]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536872234]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536872234]],[logseq____&quot;^15logseq____&quot;,[1927,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f2e-7c9a-46b6-870c-9860c6d681eclogseq____&quot;,536871990]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^@logseq____&quot;,false,536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Flogseq____&quot;,1936,536872157]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Xlogseq____&quot;,1926,536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Vlogseq____&quot;,1926,536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^Ulogseq____&quot;,1926,536872026]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872025]],[logseq____&quot;^15logseq____&quot;,[1932,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f4f-ebbb-4c71-9bc3-9961350e8829logseq____&quot;,536872025]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^@logseq____&quot;,false,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Flogseq____&quot;,1932,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Xlogseq____&quot;,1926,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Vlogseq____&quot;,1926,536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^Ulogseq____&quot;,1926,536872028]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872027]],[logseq____&quot;^15logseq____&quot;,[1933,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f4f-731b-474f-9515-5dd57d35c32blogseq____&quot;,536872027]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Modernalogseq____&quot;,536872041]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872029]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^@logseq____&quot;,false,536872029]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Flogseq____&quot;,1933,536872029]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Xlogseq____&quot;,1926,536872029]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Vlogseq____&quot;,1926,536872029]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Ulogseq____&quot;,1926,536872030]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536872041]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536872041]],[logseq____&quot;^15logseq____&quot;,[1934,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f50-569b-45ea-b9b7-29d00d106af2logseq____&quot;,536872029]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Cytomegalovirus Infection]]logseq____&quot;,536872066]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872042]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^@logseq____&quot;,false,536872042]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Flogseq____&quot;,1934,536872042]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Xlogseq____&quot;,1926,536872042]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Vlogseq____&quot;,1926,536872042]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Ulogseq____&quot;,1426,536872067]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Ulogseq____&quot;,1926,536872067]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872066]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^Hlogseq____&quot;,1426,536872066]],[logseq____&quot;^15logseq____&quot;,[1935,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f56-fb29-476a-acb6-04b5d017e46blogseq____&quot;,536872042]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Non-Small-Cell Lung Cancer]]logseq____&quot;,536872054]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872050]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^@logseq____&quot;,false,536872050]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Flogseq____&quot;,1954,536872265]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Xlogseq____&quot;,1926,536872050]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Vlogseq____&quot;,1926,536872050]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Ulogseq____&quot;,296,536872055]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Ulogseq____&quot;,1926,536872055]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872265]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^Hlogseq____&quot;,296,536872265]],[logseq____&quot;^15logseq____&quot;,[1936,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f5a-d7ec-47fa-8052-56d6dd1a2d4flogseq____&quot;,536872050]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[LUMAKRAS]]logseq____&quot;,536872062]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872058]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^@logseq____&quot;,false,536872058]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Flogseq____&quot;,1936,536872058]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Xlogseq____&quot;,1926,536872058]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Vlogseq____&quot;,1936,536872157]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Ulogseq____&quot;,132,536872262]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Ulogseq____&quot;,296,536872262]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Ulogseq____&quot;,1926,536872262]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872062]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^Hlogseq____&quot;,132,536872062]],[logseq____&quot;^15logseq____&quot;,[1937,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f62-b8c0-4398-b2df-c06747d977cflogseq____&quot;,536872058]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[mRNA-1647]]logseq____&quot;,536872097]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872070]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^@logseq____&quot;,false,536872070]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Flogseq____&quot;,1935,536872070]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Xlogseq____&quot;,1926,536872070]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Vlogseq____&quot;,1935,536872141]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Ulogseq____&quot;,1426,536872142]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Ulogseq____&quot;,1431,536872142]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Ulogseq____&quot;,1926,536872142]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872074]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^Hlogseq____&quot;,1431,536872074]],[logseq____&quot;^15logseq____&quot;,[1938,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f6d-0531-45fe-ada6-34dfca22749alogseq____&quot;,536872070]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Respiratory Syncytial Virus]]logseq____&quot;,536872082]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872078]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^@logseq____&quot;,false,536872078]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Flogseq____&quot;,1935,536872168]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Xlogseq____&quot;,1926,536872078]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Vlogseq____&quot;,1926,536872078]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Ulogseq____&quot;,1784,536872083]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Ulogseq____&quot;,1926,536872083]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872168]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^Hlogseq____&quot;,1784,536872168]],[logseq____&quot;^15logseq____&quot;,[1939,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f73-efa7-4dae-8957-b80d71c1536blogseq____&quot;,536872078]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[mRNA-1345]]logseq____&quot;,536872090]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872084]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^@logseq____&quot;,false,536872084]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Flogseq____&quot;,1939,536872084]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Xlogseq____&quot;,1926,536872084]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Vlogseq____&quot;,1939,536872145]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Ulogseq____&quot;,1777,536872154]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Ulogseq____&quot;,1784,536872154]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Ulogseq____&quot;,1926,536872154]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872090]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^Hlogseq____&quot;,1777,536872090]],[logseq____&quot;^15logseq____&quot;,[1940,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81f77-24d1-4ece-9863-76b93946427dlogseq____&quot;,536872084]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^Klogseq____&quot;,1691885480077,536872122]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872122]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^@logseq____&quot;,false,536872122]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^Ylogseq____&quot;,logseq____&quot;ai improvmentslogseq____&quot;,536872122]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^11logseq____&quot;,logseq____&quot;AI Improvmentslogseq____&quot;,536872122]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^Blogseq____&quot;,1691885483010,536872126]],[logseq____&quot;^15logseq____&quot;,[1941,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81fa8-22ab-4458-b787-9e445d92231clogseq____&quot;,536872122]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[GPT3 Initiate] Read the following summary document and give examples of how its content, wording, and structure can be improved to make it more professional and easier to understand, while focusing on not removing too much details or information. Additionally, describe why you chose these improvements.logseq____&quot;,536872126]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872123]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^@logseq____&quot;,false,536872123]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Flogseq____&quot;,1941,536872123]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Xlogseq____&quot;,1941,536872123]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Vlogseq____&quot;,1941,536872123]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^Ulogseq____&quot;,1941,536872124]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872126]],[logseq____&quot;^15logseq____&quot;,[1942,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81fa8-54a8-4bb2-9cbd-ceff051dcefelogseq____&quot;,536872123]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^@logseq____&quot;,false,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Flogseq____&quot;,1942,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Xlogseq____&quot;,1941,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Vlogseq____&quot;,1941,536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^Ulogseq____&quot;,1941,536872131]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872130]],[logseq____&quot;^15logseq____&quot;,[1944,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81fac-d49a-4ce9-90e6-0cc9e4a662f5logseq____&quot;,536872130]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^@logseq____&quot;,false,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Flogseq____&quot;,1944,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Xlogseq____&quot;,1941,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Vlogseq____&quot;,1941,536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^Ulogseq____&quot;,1941,536872133]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872132]],[logseq____&quot;^15logseq____&quot;,[1945,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81fac-569c-4ccc-9b72-d9f595a513e9logseq____&quot;,536872132]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^@logseq____&quot;,false,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Flogseq____&quot;,1939,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Xlogseq____&quot;,1926,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Vlogseq____&quot;,1926,536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^Ulogseq____&quot;,1926,536872175]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872174]],[logseq____&quot;^15logseq____&quot;,[1948,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81fdc-7a46-4323-a455-c89fa7246c95logseq____&quot;,536872174]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;logseq____&quot;,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^@logseq____&quot;,false,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Flogseq____&quot;,1948,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Xlogseq____&quot;,1926,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Vlogseq____&quot;,1926,536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^Ulogseq____&quot;,1926,536872184]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872183]],[logseq____&quot;^15logseq____&quot;,[1949,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81ff0-6a54-4f25-8cb3-bb130522fe27logseq____&quot;,536872183]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;## Otherlogseq____&quot;,536872194]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872185]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^@logseq____&quot;,false,536872185]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Flogseq____&quot;,1949,536872185]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Xlogseq____&quot;,1926,536872185]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Vlogseq____&quot;,1926,536872185]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Ulogseq____&quot;,1926,536872186]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;,logseq____&quot;^1logseq____&lt;logseq____&quot;,2],536872194]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^Jlogseq____&quot;,[logseq____&quot;^14logseq____&quot;,[]],536872194]],[logseq____&quot;^15logseq____&quot;,[1950,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81ff0-5c5e-43af-a493-50c50ec4d929logseq____&quot;,536872185]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[AI Improvments]]logseq____&quot;,536872198]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872194]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^@logseq____&quot;,false,536872194]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Flogseq____&quot;,1950,536872194]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Xlogseq____&quot;,1926,536872194]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Vlogseq____&quot;,1926,536872194]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Ulogseq____&quot;,1926,536872199]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Ulogseq____&quot;,1941,536872199]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872198]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^Hlogseq____&quot;,1941,536872198]],[logseq____&quot;^15logseq____&quot;,[1951,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81ff5-49ad-4315-a9f5-ee60a76cbb64logseq____&quot;,536872194]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Outline]]logseq____&quot;,536872206]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872200]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^@logseq____&quot;,false,536872200]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Flogseq____&quot;,1951,536872200]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Xlogseq____&quot;,1926,536872200]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Vlogseq____&quot;,1926,536872200]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Ulogseq____&quot;,705,536872207]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Ulogseq____&quot;,1926,536872207]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872206]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^Hlogseq____&quot;,705,536872206]],[logseq____&quot;^15logseq____&quot;,[1952,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d81ffb-05e8-40ad-86f2-f9107bb6e677logseq____&quot;,536872200]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Qlogseq____&quot;,logseq____&quot;[[Amgen Pipeline]]logseq____&quot;,536872268]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Ologseq____&quot;,logseq____&quot;^16logseq____&quot;,536872234]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^@logseq____&quot;,false,536872234]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Flogseq____&quot;,1927,536872238]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Xlogseq____&quot;,1926,536872234]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Vlogseq____&quot;,1926,536872234]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Ulogseq____&quot;,119,536872235]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Ulogseq____&quot;,1926,536872235]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^?logseq____&quot;,[logseq____&quot;^ logseq____&quot;],536872268]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^Hlogseq____&quot;,119,536872268]],[logseq____&quot;^15logseq____&quot;,[1954,logseq____&quot;^;logseq____&quot;,logseq____&quot;~u64d82066-6613-4866-9007-e83ec9d13ba0logseq____&quot;,536872234]]]]]]"</script>
 <script>window.logseq_state="{:ui/theme \"dark\", :ui/sidebar-collapsed-blocks {}, :config {\"local\" {:shortcuts {:ui/toggle-brackets \"ctrl+b\"}, :default-templates {:journals \"\"}, :feature/enable-journals? false, :query/views {:pprint (fn [r] [:pre.code (pprint r)])}, :macros {}, :shortcut/doc-mode-enter-for-new-block? false, :favorites [\"Projects\" \"AI Improvments\" \"Amgen Pipeline\"], :ui/show-empty-bullets? false, :file/name-format :triple-lowbar, :feature/enable-flashcards? false, :custom-css-url \"@import url('https://cdn.jsdelivr.net/gh/natzki/logseq-atlas-theme@main/custom.css');\", :preferred-workflow :todo, :publishing/all-pages-public? true, :ui/show-brackets? false, :ref/default-open-blocks-level 2, :feature/enable-block-timestamps? false, :start-of-week 0, :ref/linked-references-collapsed-threshold 50, :outliner/block-title-collapse-enabled? false, :commands [], :ui/show-full-blocks? false, :meta/version 1, :hidden [], :default-queries {:journals [{:title \"🔨 NOW\", :query [:find (pull ?h [*]) :in $ ?start ?today :where [?h :block/marker ?marker] [(contains? #{\"NOW\" \"DOING\"} ?marker)] [?h :block/page ?p] [?p :block/journal? true] [?p :block/journal-day ?d] [(>= ?d ?start)] [(<= ?d ?today)]], :inputs [:14d :today], :result-transform (fn [result] (sort-by (fn [h] (get h :block/priority \"Z\")) result)), :group-by-page? false, :collapsed? false} {:title \"📅 NEXT\", :query [:find (pull ?h [*]) :in $ ?start ?next :where [?h :block/marker ?marker] [(contains? #{\"NOW\" \"LATER\" \"TODO\"} ?marker)] [?h :block/page ?p] [?p :block/journal? true] [?p :block/journal-day ?d] [(> ?d ?start)] [(< ?d ?next)]], :inputs [:today :7d-after], :group-by-page? false, :collapsed? false}]}, :ui/auto-expand-block-refs? true, :ui/enable-tooltip? true, :query/result-transforms {:sort-by-priority (fn [result] (sort-by (fn [h] (get h :block/priority \"Z\")) result))}, :graph/settings {:builtin-pages? true, :journal? false}, :zotero/settings-v2 {\"default\" {:type-id \"\", :attachments-block-text \"[[Attachments]]\", :zotero-linked-attachment-base-directory \"\", :notes-block-text \"[[Notes]]\", :page-insert-prefix \"@\", :extra-tags \"\", :zotero-data-directory \"\"}}, :property-pages/enabled? true, :block/content-max-length 10000, :ui/show-command-doc? true, :feature/enable-search-remove-accents? true, :default-home {:page \"Projects\"}}}}"</script>
 <script type="text/javascript">// Single Page Apps for GitHub Pages
      // https://github.com/rafgraph/spa-github-pages
      // Copyright (c) 2016 Rafael Pedicini, licensed under the MIT License
      // ----------------------------------------------------------------------
      // This script checks to see if a redirect is present in the query string
      // and converts it back into the correct url and adds it to the
      // browser's history using window.history.replaceState(...),
      // which won't cause the browser to attempt to load the new url.
      // When the single page app is loaded further down in this file,
      // the correct url will be waiting in the browser's history for
      // the single page app to route accordingly.
      (function(l) {
        if (l.search) {
          var q = {};
          l.search.slice(1).split('&').forEach(function(v) {
            var a = v.split('=');
            q[a[0]] = a.slice(1).join('=').replace(/~and~/g, '&');
          });
          if (q.p !== undefined) {
            window.history.replaceState(null, null,
              l.pathname.slice(0, -1) + (q.p || '') +
              (q.q ? ('?' + q.q) : '') +
              l.hash
            );
          }
        }
      }(window.location))</script>
 <script src="static/js/main.js"></script>
 <script src="static/js/interact.min.js"></script>
 <script src="static/js/highlight.min.js"></script>
 <script src="static/js/katex.min.js"></script>
 <script src="static/js/html2canvas.min.js"></script>
 <script src="static/js/code-editor.js"></script>
 <script src="static/js/custom.js"></script>
</body>
